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ABSTRACT
An Investigation into the Immunomodulatory Activities of Human Placental Protein 14 (PP14).
By
Alan Graham Pockley BSc CBiol MIBiol
2 PP14 has been shown to suppress the incorporation ofH-Thymidine into both mitogenically and allogeneically stimulated lymphocytes in a dose dependent manner. The suppressive activity was shown to be specific, in that PP14 did not affect cellular viability, nor interact with the mitogen phytohaemagglutinin (PHA). Flow cytometric analysis indicated that PP14 had no effect on the expression of the Tac antigen, the transferrin receptor or HLA-DR molecules on the surface of stimulated lymphocytes. Neither did PP14 affect the interaction of interleukin-2 (IL-2) with its cell surface receptor. The suppressive activity was partially reversed by the 
addition of exogenous IL-2. PP14 inhibited the production of IL-2 from mitogenically stimulated lymphocytes and led to a small, but significant reduction in soluble IL-2 receptor release. Radiolabel binding studies and IL-2 dose response curves indicated that PP14 affected the affinity of the IL-2 receptor on PHA stimulated lymphocytes. This was supported by the observation that PP14 increased the level of cell surface-associated IL-2 on stimulated lymphocytes. There was a small inhibition of gamma interferon levels early in the culture period. PP14 had no effect on the CD4/CD8 ratio following stimulation and was not found to be associated with the cell surface, nor mask cell surface expression of the CD2 antigen.
These data suggest that the^immunosuppressive activity of PP14^ may, in part, be mediated via a modulation of the functional, high affinity IL-2 receptor. It is not known as yet whether such an activity is effective at the level of induction of the receptors or whether the primary control is at another level of the response. PP14 may have implications in the study of implantation and fertility and prove of wider interest in the field of transplantation biology and the control of the immune response.
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CHAPTER ONE
INTRODUCTION-THE ESTABLISHMENT OF PREGNANCY.
1.1 Implantation.
Three to four days after fertilisation of the human oocyte by 
the male spermatozoon, the morula arrives at the uterus through the 
tubal isthmus. At this stage it is important for the blastocyst to 
implant into the maternal endometrium as nutrients are rapidly 
exhausted. The zona pellucida is shed due to trophoblastic activity 
which enables the trophoblast to come into direct contact with the 
endometrium allowing attachment. The presence of the zona pellucida 
until this stage prevents premature attachment of blastomeres to the 
tubal mucous membrane. The extent of the trophoblastic penetration 
subsequent to attachment determines the thickness of the membrane 
(placental membrane) interposed between the embryonic (later foetal) 
blood stream and that of the mother and across which the exchanges 
between mother and foetus must take place. The extent of 
trophoblastic invasion varies between species, from the situation 
where trophoblastic penetration is minimal, leaving the chorion 
(trophoblast plus supporting vascular mesenchyme) lying merely in 
contact with the endometrium epithelium (EPITHELIOCHORIAL 
plaoentation) to the situation in the human and some other species, 
where the trophoblast destroys the maternal epithelium and connective 
tissue stroma and also the endothelium of the maternal blood vessels 
to leave the maternal blood bathing the chorion directly and to form 
a HAEMOCHORIAL placental structure (Grosser etal., 1927).
1
1.2 The Decidua/Decidual Reaction
From the time of the seventh day after fertilisation, two 
simultaneous events begin to occur, the embedding of the fertilised 
ovum and the formation of the decidua. The term decidua was first 
used for that part of the uterine tissue which is shed on parturition 
(the gestational endometrium). Ultrastructurally the metabolic 
activity of the decidual cells appears to be maximal by the 
seventieth day of pregnancy and begins to decline after the hundredth 
day (Wynn 1974).
As the embedding of the ovum is in progress changes occur in the 
secretory endometrium which results in its beccming transformed into 
the decidua
1) The endometrium hypertrophies, reaching 6mm to 8mm in 
thickness.
2) The stroma becomes increasingly vascular and oedematous.
3) The stroma cells sweLl and enlarge with the result that they 
become closely packed together in the superficial part of 
the functional layer. They now form what is known as the 
compact layer. These decidual cells are polygonal in shape 
as a result of the mutual pressure they exert upon each 
other.
The deciduum is thicker, richer and more vascular than the 
secretory endometrium. The decidual cells are a characteristic 
feature of pregnancy, rarely occuring apart from it. The development 
of the deciduum results from an increased output of progesterone from 
the corpus luteum. The stimulus to maintain the corpus lute urn and 
the increased production of progesterone is chorionic gonadotrophin
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which is released from the invading trophoblast. As a result of the 
embedding of the ovum into the decidual lining of the uterus, the 
deciduum becomes divided into three parts
1) The decidua basalis, being that part of the decidua which 
lies between the developing ovum and the myometrium.
2) The decidua capsularis, which covers the ovum and separates 
it from the uterine cavity.
3) The decidua vera (parietalis) which lines the remainder of 
the cavity of the uterus (Fig 1.1).
1.3 Development of the Trophoblast
Whilst the blastocyst is becoming embedded in the decidua, a 
continuous process of growth and development is progressing in 
trophoblast cells which proliferate and differentiate into three 
layers
1) An outer layer of fused cells known as the syncytium or the 
syncytiotrophoblast.
2) An inner layer known as Langhans1 layer or the 
cytotrophoblast, composed of single cells with complete cell 
membranes (Langhans' cells) lying beneath the syncytium.
3) Below the cytotrophoblast lies a layer of loose connective 
tissue, known as primitive mesenchyme.
Digestive enzymes secreted by the trophoblast are responsible
for the invasion of the decidua. All cells in the decidua are
invaded by the trophoblast including the walls of the smaller blood
vessels leading to the syncytial meshwork which fills with
circulating maternal blood. Finger like projections of trophoblast
(primitive villi) containing all three layers grow in all directions
in the decidua, and are bathed on their outer surface by circulating3
Decidua basalis 
Vitelline sac
Chorion frondosum
OviductAllantoicsac
ft.'
Amniotic sac
Uterine cavity
' / ^ «  ,1/  / 7*^  Muscle
^  Uterine glands 
Decidua parietalis
DeciduacapsularisMucous plug in cervical canal
Figure 1.1 Relationships of structures in the uterus at the end of the 
seventh week of pregnancy (Benson 1977).
4
maternal blood. The trophoblast becomes the primitive chorion.
Three weeks after fertilisation, the villi begin branching to 
form a tree-like structure, some floating freely in the maternal 
blood .lakes, others passing deeply into the endometrium and acting as 
anchoring villi. Each villus is bathed in maternal blood and still 
contains the same three layers. The blood filled spaces between the 
villi are now known as the intervillous spaces.
1.4 The Immunological Implications of Pregnancy
Pregnancy in animals imposes dramatic physiological and 
biological changes on the mother. Many of their implications have 
been studied, however the immunological consequences of the presence 
of the foreign foetal allograft still remain obscure. From an 
immunological standpoint, for a successful pregnancy to occur the 
maternal immune response must be modulated at a number of sites.
From the time of implantation human trophoblast possibly
exhibiting foreign paternal antigens is exposed directly to the
maternal tissues. This leads to the possibility of soluble antigens
of foetal origin being released into the maternal circulation. The
trophoblast may be regarded as a semi-foreign allograft which would
normally institute a classical graft rejection reaction. When it is
realised that the total area of chorion exposed directly to the
2maternal blood and tissue is around 14m it is remarkable that no 
allograft rejection occurs. In the course of the decidual reaction 
an immunological response does occur, as observed by the infiltration 
of small lymphocytes into the endometrium surrounding the implanting 
conceptus, however this reaction does not normally lead to foetal 
rejection.
SECTION A
THE ALLOGRAFT REJECTION RESPONSE
1.5 The Mechanism of Graft Rejection.
Graft rejection between unrelated individuals has been 
recognised for many years, however it is only in the last 30 years 
that this has been shown to be mediated via the adaptive immune 
system, exhibiting the two key features of adaptive immunity namely 
memory and specificity. Only graft sites which are accessible to the 
immune system exhibit graft rejection and privileged sites exist in 
the body where allogeneic grafts can survive indefinitely.
The major histocompatibility complex (MHC) is the genetic region 
found in all mammals which codes for two biochemically and 
functionally distinct classes of cell surface histocompatibility 
antigens. In man the cell surface histocompatibility antigens are 
kncwn collectively as HLA antigens with the MHC region being found on 
chromosome 6. Class I MHC alloantigens include the glycoprotein 
products of the gene loci HLA-A, -B and -C and are involved as target 
antigens in the allograft responses. Class I MHC antigens are 45 kDa 
glycoproteins non-covalently associated at the cell surface with a 12 
kDa polypeptide beta2-microglobulin (encoded in chromosome 15).
The class II MHC antigens (including products of the HLA-D 
region) are surface glycoproteins consisting of a 33-34 kDa heavy 
chain together with a 28-29 kDa light chain and display a more 
restricted tissue distribution than class I MHC products. They 
appear to be essential for antigen presentation to the
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immunocompetent calls which regulate immune responses. The class II 
transplantation antigen is a simple receptor containing a single 
binding site for peptides and functions to position the antigen 
uniquely for T cell receptor binding (Guillet et al., 1986).
The products of the MHC are responsible for the rapid rejection 
of grafts between individuals and function in the signalling between 
lymphocytes and the cells expressing antigen. They are the major 
obstacle to successful graft survival. In addition to the MHC there 
are a number of independently segregating loci the products of which 
in some cases are sufficient to cause graft rejection, however graft 
rejection arising from such allogeneic differences can usually be 
overcome by immunosuppressive therapy.
1.6 The Cellular Components of the Adaptive Immune System.
The cellular components of the adaptive immune system are the T 
and B lymphocytes and the antigen presenting cells of the mononuclear 
phagocytic system including macrophages, whose role is to present 
antigen to specific antigen sensitive lymphocytes. The major 
accessory functions of macrophages are believed to be interleukin-1 
(IL-1) production and the cross-linking of the T cell antigen 
receptor (T3-Ti) complex (Williams et al., 1985). T lymphocytes are 
mainly responsible for the rejection of solid grafts and are 
sufficient alone to cause graft rejection. Histological studies show 
infiltration by mononuclear cells, mainly small lymphocytes, 
preceding graft destruction by several days. Although the main cause 
of graft rejection is via the cell-mediated immune system, antibody 
can cause rejection, but to a lesser degree. Such a role for
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antibody is enhanced in situations where the recipient is sensitised 
to particular donor antigens or in reactions to haemopoietic cells.
It was originally thought that graft rejection was effected by 
cytotoxic T cells, however later work in mice showed that graft 
destruction did not correlate with cytotoxic T cell development and 
other studies have shown helper cells to be the effectors in 
rejection reactions due to MHC differences. These observations have 
led to the proposal that graft rejection may be a response related 
to delayed hypersensitivity reactions with graft rejection being 
mediated by monocytes and macrophages recruited to the site. 
In summary there are two proposed mechanisms which may mediate graft 
destruction
1) Foreign MHC class II antigens on the graft stimulate host T 
helper cells (Th) to help cytotoxic cells (Tcyt) destroy the 
target graft cell. Tcyt cells recognise the graft cell via 
the foreign MHC class I antigens.
2) The cells reacting to the graft release lymphokines which 
stimulate macrophages to enter the graft and destroy it.
The rejection of foreign allografts has no physiological basis, 
however it is analogous to the in vivo recognition and rejection of 
virally infected cells. The HLA molecule on the surface of the 
virally infected cell acts as a code guiding the cytotoxic T cell to 
its target.
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1.7 Regulation of the Immune Response
Once an immune response has been initiated there is a capability 
for amplification. The primary regulator of an immune response is 
the antigen causing it, however there is also a need for regulation 
by intrinsic components of that response.
Antigen specific regulation of the immune response appears to be 
mediated by sub-sets of the T lymphocytes which are distinguishable 
by surface antigen markers, namely the suppressor T cell (Ts, CD8+)
-fand the helper or inducer T cell (Th, CD4 ) (Cantor and Boyse 
1977). T suppressor cells appear to be essential for the regulation 
of the immune response (Green et al.,, 1983), however the nature of 
the antigen receptor on these cells is unclear. It has been reported 
that the activity of at least some human CD8 suppressor cells is 
likely to be mediated by the T cell receptor (Modlin et al., 1987). 
The suppressor T cells only function if continually stimulated, 
however the helper T cell which activates the Ts cell is itself 
inhibited by the suppressor cell thus facilitating a feedback 
response. The interaction of regulatory T cells with other T cells 
may be mediated by the recognition of foreign antigen which has 
become attached to the surface of the interacting cell (Mitchison et 
al., 1970).
Very little is known about the molecular mechanisms by which 
lymphocytes communicate with one another, one possibility is that 
they interact directly via antigen bridging allowing short range 
membrane bound or secreted molecules to act. Many immunologists now 
believe that lymphocytes may communicate by secreting specific 
signalling molecules which operate over relatively long distances
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(Tada and Okumura 1979). A variety of soluble protein regulatory 
factors have been isolated from T lymphocytes, termed helper and 
suppressor factors, which have the same antigen specificity and 
activity as the cells which produced them (Germain and Benacerraf 
1980). It is still uncertain, however, whether antigen specific 
factors normally function in soluble form, as it is possible that 
they represent membrane bound receptors which have been shed from 
cells.
In addition to antigen specific regulatory molecules there also 
exist non antigen specific mechanisms of regulation, the non-specific 
regulation being centred around the secretion of regulatory molecules 
termed lymphokines from certain T cells. A number of these molecules 
have been described (Table 1.1).
TABLE 1.1 Lymphokines and their activities.
Regulation of other lymphocytes (non antigen-specific)
Interleukin-2 IL-2
Interleukin-3 IL-3
Interferons alpha and gamma IFN
Soluble immune response suppressor SIRS
Inhibitor of DNA synthesis DDS
Allogenic effector factor AEF
T cell replacing factor TRF
Regulation of other lymphocytes (antigen specific factors)
Assorted antigen-specific helper factors Th F
Assorted antigen-specific suppressor factors TsF
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The regulatory polypeptides secreted by T cells affect both 
lymphoid and other haemopoietic cells including erythroid, 
megakarocytic, granulocytic and macrophage precursors and mast 
cells. T cells themselves are subject to regulatory influences by 
other cytokines such as interleukin-1 (Gillis 1983).
1.8 Interleukin-1 (IL-1)
Macrophages are activated by the stimulation of resting cells by 
a number of soluble or particulate stimuli. The activation is 
accompanied by the expression of class II histocompatibility 
molecules on the cell surface and the secretion of a range of soluble 
products such as the multipotent cytokine interleukin-1 (IL-1) 
(Unanue 1981). It is suggested that IL-1 may be a key intercellular 
messenger for host defence and has a critical role in the clonal 
expansion of T lymphocytes (Wood 1984) and in B lymphocyte activation 
(Aarden et aL, 1979). IL-1 appears to be a biologically fundamental 
molecule; this concept being supported by the fact that IL-1 in 
evolutionary terms is old (estimated at 400 million years) and 
evolved before lymphocytes and immunoglobulins. The most potent 
soluble inducer of IL-1 from monocytes and macrophages appears to be 
endotoxin or lipopolysaccharide (LPS) from Gram negative bacteria 
(Munoz et al., 1987).
1.8.1 The biochemistry of Interleukin-1
IL-1 has been purified to apparent homogeneity in many different 
laboratories (Mizel and Mizel 1981, Pacak and Siegert 1982) and the 
activity has been found to be associated with a small protein whose
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molecular weight is usually estimated as 12-15 kDa. In almost all 
species it has been found that IL-1 activity is mediated by several 
distinct proteins with differing molecular weights ranging from 2-75 
kDa (Kimball et al., 1984). In addition to molecular weight 
heterogeneity of IL-1 there is also a charge heterogeneity with two 
peaks of activity being observed at isoelectric points of 
approximately pH 7 and 5 and other peaks reported between the two 
(Lachman et al., 1977).
The identity of the 'real' interleukin-1 has been a 
controversial issue for many years and it is now generally accepted 
that the smaller molecular weight species are proteolytic breakdown 
products and the 75 kDa represents an aggregated form of the molecule 
(Dinarello et aL, 1984). Auron et al. (1984) isolated a human IL-1 
cDNA clone from peripheral blood monocytes encoding a 269 amino acid 
precursor lacking a signal peptide, which is cleaved to a product 
with most of the reported biological activities of natural IL-1 of pi 
7.0. A second human IL-1 gene was discovered when March et al., 
(1985) isolated two distinct but distantly related cDNA clones from a 
human macrophage DNA library encoding proteins sharing IL-1 
activity. The proteins were termed IL-1 alpha and IL-1 beta with the 
latter showing considerable homology to the human pi 7.0 cDNA.
1.8.2 The production and release of Interleukin-1
Although both species of IL-1 are produced by a population of 
macrophages in response to the same stimulant, it is not known 
whether a single cell is capable of producing both IL-1 alpha and 
beta simultaneously. The absence of a characteristic signal sequence
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which is usually a feature of secreted proteins transported from an 
intracellular to an extracellular environment has raised questions as 
to whether IL-1 is truly a secretory protein. Gery and Lepe-Zunige 
(1984) have proposed that perforation of the plasma membrane provides 
one mechanism for the release of IL-1 from intracellular sites. 
Alternatively IL-1 may be released from non-injured cells by a 
sequence of intracellular enzymatic cleavages.
In addition to a secreted form of IL-1, a plasma membrane 
associated form which stimulates the proliferation of thymocytes has 
been described on murine peritoneal macrophages. The degree of 
stimulation of T cell lines and clones is quantitatively related to 
the amounts of membrane IL-1 expressed as well as class II antigens 
(Kurt-Jones et al., 1985a). It has been suggested that the antigen 
presenting/accessory functions of the macrophage are mediated by IL-1 
which is only present on the plasma membrane of stimulated 
macrophages (Kurt-Jones et al., 1986). The concept of a 
membrane-associated form of IL-1 may be exciting, however it has not 
been demonstrated using either iodination with lactoperoxidase of 
stimulated cells nor by immunoprecipitation analysis (Mizel 1987).
1.8.3 Mechanism of action of Interleukin-1
The effects of IL-1 on T cells are summarised in Table 1.2 
TABLE 1.2 Effects of IL-1 on T cells
Comitogenic with lectins or Ag + la
Increased lymphokine secretion (IL-2, BCGF, CSF etc)
Increased expression of IL-2 receptors
Increased stability of E-rosettes
Chemotaxis
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The exact mechanism of the activating action of IL-1 on T cells 
is not yet known but cell cycle studies have shown that IL-1 is not 
required for lectins to induce the GQ to G^a blast 
transformation, however, having entered G^a cells can then respond 
to IL-1 by proceeding through G ^  to the S phase of the cell cycle 
(Kristensen et al., 1982). These events appear to involve the 
induction of S phase by the intermediate formation of interleukin-2 
(IL-2).
IL-1 appears to regulate IL-2 in two ways, firstly at the level 
of production, and secondly at the level of action, this proposal 
being based on the following evidence:-
.1) IL-1 induces IL-2 production by lectin activated T 
cells (Larsson et al., 1980).
2) IL-1 increases the expression of structures recognised 
by anti-IL-2 receptor antibodies and induces 
receptivity to IL-2, possibly by increasing the 
receptor affinity rather than by increasing receptor 
number (Oppenheim et al., 1986).
1.8.4 Does T cell activation depend on IL-1?
Macrophages are required at the time of the primary signal for T 
cell activation otherwise early (IL-2 production, IL-2 receptor 
expression and RNA synthesis) and late (DNA synthesis) T cell 
•responses are prevented (Williams et al., 1985). IL-1 can partially 
restore T cell responses (Williams et al., 1985), but full activation 
seems to require the accessory cell membrane, presumably to present 
antigen in the context of class II MHC (Unanue et al., 1984). Such
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data suggest an enhancing ro]e, as opposed to an obligatory role for 
IL-1 in T cell activation, with IL-1 having a limited ability to 
activate T cells in the absence of accessory cells (Koide et al., 
1987).
The following working model for T cell activation has been 
proposed by Mizel (1987) :
In the presence of T cell mitogen or antigen, T cells and 
accessory cells are mutually stimulatory. The accessory cell is 
induced to begin IL-1 synthesis and secretion, the induction 
involving a complex of processed antigen, class II MHC and T cell 
receptor. The T cells initiate IL-2 and IL-2 receptor synthesis and 
expression and are stimulated to produce IL-1 receptors to become 
fully responsive to IL-1 (Shirakawa et al., 1987). IL-1
responsiveness confers a heightened ability of T cells to produce 
IL-2 and IL-2 receptors in response to antigen/class II MHC antigen 
complexes or mitogen. The interaction of IL-2 and its receptor then 
results in T cell proliferation. It may also be that activated T 
cells produce a lymphokine which augments the ability of the 
accessory cells to produce IL-1 giving rise to a secondary 
amplification loop in the interactions of accessory cells and T 
cells.
1.8.5 The Interleukin-1 receptor (IL-1R)
The murine IL-1 receptor was originally reported to be a 79.5 
kDa T cell plasma membrane protein which bound the 17.5 kDa form of 
human IL-1 beta with high affinity (Dower et al., 1985). Subsequent 
studies have shown that a similar IL-1 receptor is present on a
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variety of cell types of both human and murine origin. The existence 
of two distantly related species of interleukin-1 (IL-1 alpha and 
IL-1 beta) raises the question as to which form of IL-1 can bind to 
cells. The two forms of IL-1 have been shown to share a common 
receptor (Dower et aL, 1986 a,b). One presumes that the two forms 
of the hormone were produced by a gene duplication event followed by 
evolutionary divergence, however both gene products have conserved 
the receptor binding function and it may be that some advantage is to 
be gained from the existence of two distinct molecules with an 
identical spectrum of activities.
1.9 Interleukin-2 (IL-2)
Interleukin-2 was originally termed T cell growth factor (TCGF) 
or T cell derived glycoprotein hormone and was initially thought to 
be strictly a T cell trophic growth factor, stimulating replication 
by binding to specific cell surface receptors. However highly 
purified IL-2 can cause the proliferation of natural killer cells 
(Hefneider et al., 1983, Henney et al., 1981) and other cytotoxic 
effector cells (Merluzzi et al., 1983, Grimm et al., 1983). IL-2 
receptors have been described on B cells activated by pokeweed 
mitogen (PWM) (Waldmann et aL, 1984). IL-2 also induces or enhances 
the production of a variety of other cytokines such as B cell growth 
factor (IL-4), colony stimulating factor and interferons (Farrar et 
al., 1982, Pearlstein et al., 1983) and appears to play a central 
role in the regulation of immune function.
Resting T cells have been reported to be unresponsive to the 
effects of IL-2 although IL-2 receptors appear to be present (Robb et
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al., 1981, 1984; Pepper et al., 1984). Using recombinant IL-2 
(rIL-2), resting T cells have been shown to respond by an increase in 
DNA synthesis, an increased IL-2 receptor (Tac protein) expression 
and the production of interferon and morphologic blast transformation 
(Hammer and Gillis 1986). Given the potential for therapeutic 
administration of rIL-2 (Lotze et al., 1985) effects on resting T 
cells may become increasingly important.
Normal human monocytes also express receptors for IL-2 on their 
surface (Herrmann et al., 1985) which indicates that IL-2 is not 
exclusively a lymphocytotrophic hormone (Benveniste and Merril
1986). The biological significance of the effect of IL-2 on 
monocytes has yet to be determined.
The detectable levels of IL-2 in culture supernatants of 
lymphocytes stimulated with either PHA or inactivated mumps virus 
peaks at 18-24 hours and 48 hours respectively. A decrease in IL-2 
levels in the culture supernatant after day 2 is paralleled by an 
increased expression of IL-2R. The maximal T cell proliferation 
occurs shortly after or simultaneously with the maximal expression of 
IL-2R (Bruserud et al., 1986).
The major physiological role of IL-2 is thought to be the 
activation of resting T lymphocytes (in G^ phase) to progress 
through the proliferative phases (S^ , G2 and M) of the cell cycle 
with IL-2 mediating its effects on T cells via hormone-like 
interactions with surface receptors.
Production of IL-2 has been shown to increase the rate of 
synthesis of RNA for the transferrin receptor which is essential for 
the iron uptake required for cellular growth and proliferation
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(Blazsek and Mathe 1984) and for the cells to enter the S phase of 
cell division. IL-2 has also been reported to cause the secretion of 
gamma interferon (Miedema et al., 1985) and tumour necrosis factors 
alpha and beta (Nedwin et al., 1985), but does not alter T cell 
antigen receptor mRNA levels.
How IL-2 binding leads to a biochemical response is unknown. 
The cytoplasmic domain of the receptor, which is very short (13 amino 
acids), or the transmembrane domain may bind a subunit protein which 
functions as a signal transducing unit (Watson 1986).
1.9.1 Biochemistry of Interleukin-2
Human IL-2 is a 133 amino acid glycoprotein (Lowenthal et al., 
1985) with a molecular vreight range of 14.5-17.0 kDa, depending on 
the stimulators and/or co-stimulators used in its production and has 
a secondary structure predominantly of alpha helix (Liang et al., 
1985). The observed heterogeneity is a result of differential 
glycosylation (Welte et al., 1982) which has no apparent effect on 
IL-2 action on purified T cell populations.
The role of the carbohydrate may reside in the mechanism of 
clearance (Robb and Smith 1981). The rapid removal of circulating 
desialylated glycoproteins is well documented and is mediated by a 
carbohydrate recognition system present in hepatocytes (Neufeld and 
Ashwell 1979). From the potential immunotherapeutic standpoint, 
recombinant IL-2 which is non-glycosylated might be expected to have 
a privileged life span in vivo.
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1.9.2 The Interleukin-2 receptor (IL-2R)
The interleukin-2 receptor gene is localised on chromosome 10 
and codes for a 272 amino acid glycoprotein with a cytoplasmic domain 
of 13 amino acids (Greene et al., 1985b). Using monoclonal 
antibodies to the IL-2R (anti-Tac) the receptor has been shown to 
contain a 55 kDa glycoprotein (Tac antigen). The binding of antigen 
to specific receptors present on the surface of resting T cells in 
the presence of macrophage-derived IL-1 triggers the de novo 
synthesis and secretion of interleukin-2 (Morgan et al., 1976), the 
IL-1 modulating/enhancing the transient expression of high and low 
affinity IL-2R. The continuous expression of the receptors on the 
cell surface and consequently IL-2-dependent cell proliferation 
requires repeated stimulation by the antigen (Diamantstein and Osawa 
1984, Reske-Kunz et aL, 1984). The IL-2-dependent proliferation of 
cells without external stimuli is either due to the presence of a 
small number of IL-2 receptor-bearing cells in the respective 
population or to a small number of IL-2 receptors present on the 
surface of cells.
1.9.3 High and low affinity IL-2 receptors
The evidence for high and low affinity IL-2 receptors came from 
early IL-2 receptor binding assays using radiolabelled IL-2 and 
radiolabelled anti-Tac antibodies. Anti-Tac antibodies react 
equivalently with both high and low affinity types of IL-2R. The 
number of IL-2 receptors on the surface of PHA-activated lymphoblasts 
has been reported to be between 2000 and 6000 (Robb et al., 1981; 
Pepper et al., (1984). Robb et al., (1984) demonstrated a large
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pool of IL-2 receptors with 1000 to 10000 fold lower apparent 
affinity* this finding was supported by Lowenthal et al (1986) 
although these workers reported a 100 fold affinity difference. For 
the high affinity IL-2R the affinity for IL-2 is relatively high (Kd 
= 5-20 pM) with the IL-2 receptors fully saturated at concentrations 
around 10~^ M (1.5 ng/ral). The sensitivity with which a T cell 
responds to IL-2 is not determined solely by the number of high 
affinity receptors it bears. Using cDNA transfection experiments it 
appears that the Tac protein is only part of the high-affinity 
functional IL-2R molecules and not necessarily the most important 
part (Greene et al., 1985b, Sabe :et al., 1986).
Investigators have now turned their attention to a search for 
the so-called "converter" protein that would confer high affinity 
IL-2 binding on the Tac antigen protein. A 75 kDa protein completely 
separate and distinguishable from the high affinity receptors and low 
affinity binding sites has been identified (Teshigawara et al., 1987) 
which is easily distinguishable from the 55 kDa Tac antigen protein. 
Clones expressing the high affinity receptors have been shown to 
clearly display both IL-2 binding proteins, suggesting both proteins 
may be involved in the formation of fully functional, high affinity 
receptors (Smith 1988). High affinity IL-2 binding results in the 
occupation of sites on two distinct proteins with the binding site 
cooperating to form biologically relevant high affinity IL-2 
receptors. The 75 kDa chain has been referred to as the alpha-chain, 
the 55 kDa (Tac antigen) as the IL-2 receptor beta-chain (Fig 1.2). 
Tac antigens expressed in the absence of 75 kDa chains cannot trigger 
a cell growth response. The 75 kDa protein can mediate rapid
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Figure 1.2 The Proposed Structure of High-Affinity
Interleukin-2 Receptors (from Smith 1987).
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internalisation of membrane bound IL-2 (^ 2/2 ~ ^  minutes) whereas 
internalisation after binding to the Tac antigen is negligable (Robb 
and Greene 1987). Unlike many receptors composed of multiple 
subunits the 75 kDa and Tac antigen proteins appear to be able to be 
transported to and displayed on the surface of cells in the absence 
of any other protein.
There are three possible mechanisms by which IL-2 binding may 
stimulate T cell proliferation. The binding of IL-2 to Tac antigens 
may be stimulatory, however this possibility is unlikely as 
saturation of the Tac low affinity binding sites does not affect the 
rate of cell proliferation. Binding to 75 kDa chains alone can 
stimulate signal transduction, but the concentrations required to 
stimulate cell growth are 100 fold higher than those required on 
binding to the 75 kDa - Tac heterodimer. It therefore appears that 
the 75 kDa subunit is the biologically relevant moiety with the Tac 
antigen appearing to function as a helper binding protein having no 
signalling capacity of its own (Smith 1988).
Kinetic binding studies comparing cells which solely express 75 
kDa chains or Tac antigens with cells expressing both chains have 
shown that:
1) IL-2 dissociates from the Tac antigen rapidly (1.7 s).
2) IL-2 binds to the 75 kDa chain 2 - 3  orders of magnitude
5more slowly than to the Tac antigen (k = 3.8 x 10 /M.s).
3) Hybrid binding characteristics are observed in cells 
expressing both chains.
(Wang and Smith 1987)
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IL-2 binding to high affinity receptors takes on the 
characteristics of binding to the Tac antigen for the forward 
reaction, associating rapidly to the Tac - 75 kDa dimer. The reverse 
reaction follows the behaviour of IL-2 as if it were binding to the 
75 kDa chain and exhibits a slow dissociation (t^^ 50 minutes) as 
compared to the dissociation from the Tac antigen (^2/2 "
There is no covalent linkage between alpha and beta chains and it is 
a non-covalent association which is responsible for the formation of 
high affinity binding sites, such interaction is likely to be dynamic 
and subject to association and dissociation.
The incubation of cells with anti-Tac antibody causes a shift 
towards intermediate affinity and leads to an abrogation of cellular 
responses to low levels of IL-2 (Wang and Smith 1987) by preventing 
the binding of IL-2 to the Tac antigen and disrupting IL-2 binding to 
the alpha/beta heterodimer.
The observation of the generation of high affinity receptors 
from the two distinct low affinity binding proteins is of great 
importance. This system appears to have been selected and conserved 
(the murine IL-2R appears to be similar) and appears to be operative 
in other polypeptide hormone receptor systems, with interleukin-3 and 
nerve growth factor receptors comprising two distinct binding 
proteins (Nicola and Peterson 1986, Hosang and Shooter 1985).
1.9.4 The stimulation of IL-2 receptor expression
Once expressed on the cell surface high affinity IL-2R, 
representing around 10% of the IL-2R are at least partially 
internalised as a consequence of IL-2 binding (Smith and Cantrell
1985). However it is uncertain whether the receptor-mediated
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endocytosis is involved in signal transduction. The interaction of 
IL-2 with its high affinity membrane receptor triggers the expression 
of additional receptors on the cell surface (Pepper et al., 1985), 
stimulates an expansion of the antigen reactive clonal T cell 
population and generates specific effector cells which mediate 
helper, suppressor and cytotoxic T cell functions.
The activation of resting T cells with phytohaemagglutinin (PHA) 
leads to the induction of IL-2R expression which peaks at 48-72 hours 
(Pepper et aL, 1984). IL-2R levels decline after extended periods 
in culture with 80-90% of the IL-2R being lost after 10-12 days 
(Pepper et al., 1984), possibly indicating an important regulatory 
role in the termination of the T cell immune response. Such cultured 
non-proliferating T cells are still capable of restimulation of IL-2R 
expression and a second round of cellular proliferation (Pepper et 
al, 1985), with mitogenic lectin or antigen producing up-regulation 
of IL-2R expression (Kaplan et al., 1984). The greatest increase in 
receptor number on restimulation is obtained by re-exposure to 
mitogenic lectin (Pepper et al., 1984) which causes a 2 to 10 fold 
increase in IL-2R number in 24 hours. The increase is dependant on 
de novo RNA and protein synthesis and is not solely the result of the 
mobilisation of preformed intracellular receptors to the cell surface 
(Greene and Leonard 1986).
Phorbol myristate acetate (PMA) also increases receptor 
expression as does phospholipase C (Pepper et al., 19 84) which 
suggests that activation of protein kinase C may play an important 
role in IL-2R expression. Of the two types of receptor, the low 
affinity receptors are preferentially induced in re-expression,
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however the functional high affinity receptors must also be induced 
as proliferation is observed.
In the absence of cell cycle progression the number of IL-2R 
positive cells increases as does receptor density suggesting an 
initial threshold of IL-2R density to be required for the commitment 
to cell cycle progression as IL-2R expression precedes the onset of 
DNA synthesis (Smith 1984). After cell division in response to IL-2, 
daughter cells must be triggered by antigen once again to express 
IL-2R. In vivo it may be supposed that once antigen is cleared T 
cell clones lose IL-2R and revert to resting (Gq) cells. IL-2R 
binding reaches equilibrium within 15 minutes with several hours of 
IL-2R interaction being required to initiate cell cycle progression. 
It may be that it is an accumulation of a critical concentration of 
intracellular signals which ultimately determines the quantal 
response of the resulting DNA replication.
1.9.5 Interleukin-2 receptor release
On day 2 of culture, IL-2R can be detected in the supernatant of 
Con A stimulated murine splenocytes, the released IL-2R representing 
the majority of IL-2R present on the cell surface (possibly the low 
affinity type). Released IL-2R can also be detected in the culture 
supernatants of stimulated human lymphocytes, the isolated soluble 
IL-2R is of lover molecular weight than the Tac antigen isolated from 
the cells (Rubin et al., 1985). It has been suggested that the 
receptors are cleared from the cell by cell-associated proteases 
which may represent a method by which an immune response is 
terminated or it may serve as an immunoregulatory signal by competing
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for available IL-2 (Rubin et al.f 1985). Such observations are not 
in vitro artefacts as soluble IL-2R are detectable in the serum of 
mice bearing IL-2 binding protein positive tumour cell lines (Osawa 
et al., 1986a). The soluble proteins detected have anti IL-2R 
reactive epitopes and at least part of them can react with IL-2 
(Osawa et al., 1986b).
In the human, levels of soluble IL-2R have been shown to be 
elevated in a number of pathological conditions. The released 
protein may be of significant prognostic value in patients with a 
number of lymphomas and leukaemias (Wagner et al., 1987). 
Significant elevations of soluble IL-2R have also been documented in 
transplant recipients experiencing rejection episodes (Colvin et al., 
1987; Cornaby et aL, 1987) and in persons with viral infections such 
as acquired immune deficiency syndrome (AIDS) (Durno et al., 1986).
1.10 The Temporal Sequence of Gene Activation Following Mitogenic 
Stimulation.
Analysis of RNA levels have shown that PHA, PMA and IL-2 augment 
IL-2R mRNA production (Pepper et aL, 1985). The temporal sequence 
of gene activation by PHA/PMA in human T cells has been defined 
(Kronke et aL, 1985). IL-2 receptor gene transcription occurs at a 
high level 3 hours after activation and continues at a high level for 
24 hours before declining. An increase in transcription accounts for 
an initial increase in IL-2R mRNA levels, however mRNA levels appear 
to fall before there is a significant decline in IL-2R nuclear 
transcription. Observed post transcriptional rates of mRNA 
processing or degradation may be important for the regulation of
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IL-2R gene expression. The lag between peak mRNA levels (around 24 
hours) and the peak receptor expression at the cell surface (48-72 
hours) is currently unexplained.
The transferrin receptor gene is not expressed until 24 hours 
after mitogen activation and does not reach peak levels until 48 
hours. The transcription of the transferrin receptor gene is 
dependent on protein synthesis which suggests that its expression is 
mediated by prior interaction of IL-2 with its cellular receptor 
(Neckers and Cossman 1983).
1.11 IL-2 Regulation of the T Cell Immune Response
Due to the feature of the IL-2 hormone-receptor system that both 
the secretion of the ligand and the cell surface expression of the 
receptor must each be specifically induced by antigen or mitogen, the 
external signals and pathways which ultimately lead to expression of 
the two gene products in T cells should represent one level by which 
T lymphocyte clonal expansion is regulated. T cells possess 
differential requirements for induction of IL-2R, although all murine 
T cells express IL-2R after Con A stimulation, T cell-accessory cell 
interactions might be necessary for IL-2 expression by some T 
lymphocytes (Malek et al., 1985). Such differential activation 
requirements for IL-2R expression may represent an important level of 
immunoregulation since it may promote a selective or sequential 
growth of functional T cell subsets.
In addition, the ability of IL-2 to regulate IL-2R number and 
perhaps subsequent signal transduction may have important 
implications relating to regulation of a T cell immune response, as
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IL-2R upregulation should permit T cells recently activated by 
antigen to proliferate solely in response to IL-2 without the 
necessity far each daughter cell to encounter antigen. Obviously 
such a response must be controlled and three levels of regulation may 
exist:-
1) IL-2 deprivation of the cells, possibly by competition with 
soluble IL-2R for available IL-2.
2) Action of specific suppressor cells.
3) Activated T cells may require an increasing number of 
occupied IL-2R for proliferation, ie a higher local 
concentration of IL-2 (Malek et al., 1986).
The mechanisms by which such control would be mediated are as 
yet unknown.
1.12 T Cell Antigen Receptor Triggering.
The T cell antigen receptor is a molecular complex comprising 
at least five polypeptide chains (Meuer et al., 1983). Two of these 
chains are highly variable disulphide linked Ti alpha and beta 
subunits (90 kDa) which are non -covalently associated with the three 
monomorphic CD3 (T3) subunits which are believed to mediate signal 
transduction when the T cells are activated by receptor binding. 
Most CD3-Ti alpha beta type T cell receptors recognise foreign 
antigens in association with cell surface molecules encoded by the 
MHC (Benacerraf and McDevitt 1972). This phenomenon, termed MHC 
restriction, distinguishes T cell recognition from the direct antigen 
speci.fj.cLty of the immunoglobulin receptor on most B cells. Such MHC 
restriction is learned or selected for during T lymphocyte ontogeny
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in the thymus (Zinkernagel and Doherty 1975). Some Ti alpha beta 
heterodimers recognise target structures without binding to MHC (Ritz 
et aL, 1985). In addition to MHC restriction, T cells also respond 
to an MHC-encoded protein from another individual in the absence of 
antigen; it is this effect that accounts for the rejection of grafted 
or transplanted tissue (Marrack and Kappler 19 86).
The precise molecular nature of the antigenic determinant 
recognised by the T cell receptor of the CD4+ cells has not been 
completely resolved. Werdelin (1987) has suggested that la molecules 
serve to bind antigen fragments and stabilise them in the membrane of 
presenting cells, shielding them from proteolytic degradation and 
permitting T cells to bind the epitopes so displayed. It is this 
antigen-Ia complex which is recognised by the T cell receptor (Fig
1.3). The effective interaction between T cells and their target 
antigens is not exclusively controlled by the affinity and density of 
T cell receptors, rather it is the result of multiple contributions 
made by a combination of surface receptors and ligands. Results 
strongly indicate that CD4:HLA-DR binding occurs and this interaction 
augments T cell activation (Gay et al., 1987), the CD4 molecule 
serving an accessory function and stabilising cell interaction (Fig
1.3). Anti CD4 antibodies inhibit antigen-induced in vitro 
proliferation (Biddison et al., 1982) and lymphokine release (Swain 
et aL, 1983). Work has shown there to be a physical association of 
the T cell receptor complex and CD4 (Saizawa et al., 1987) with the 
CD4 antigen migrating together with the T cell receptor into the 
contact site between the T cell and the antigen presenting cell 
(Kupfer et al., 1987).
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ANTIGEN-PRESENTING CELL
HLA-DR 
(class II)
ANTIGEN
CD 3-Ti 
complex
Figure 1.3 Recognition of Antigen by T cells. T helper 
cells are stimulated by antigen in association 
with MHC class II molecules on the surface of 
antigen-presenting cells. (Male et al., 1987).
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The binding of antigen or mitogen to the T cell receptor complex 
leads to a calcium flux which is then followed by general 
activation. The binding of soluble or monovalent ligands to the T 
cell receptor is not sufficient to initiate the process of T cell 
activation. A second signal is required from macrophages which does 
not involve class II gene products and is possibly IL-1. That 
differential stimulatory requirements exist regarding growth and 
lymphokine release underlines the critical role of macrophages in T 
cell activation. Proliferation of resting T cells in response to 
IL-1 is only observed after triggering of the T cell receptor 
complex with surface linked anti-CD3 (ie antigen). One proposed 
mechanism is that interaction of antigen with the CD3 complex induces 
IL-2R expression which is then up-regulated by IL-2 (Smith and 
Cantrell 1985, Welte et aL, 1984, Reem and Yeh 1984). This supports 
the idea that regulation of IL-2R expression on both resting and 
presensitised lymphocytes is ultimately linked with the T cell 
receptor for antigen (Meuer et al., 1984a). This linkage, in concert 
with ligand induced down-regulation of IL-2R, provides an essential 
mechanism to prevent uncontrolled growth in the IL-2 hormonal system 
and may represent the basis of clonal T cell selection by antigen.
There are two pathways to T cell activation, either via the 
CD3-Ti antigen receptor complex (macrophage and IL-1 dependent) or 
via an 'alternative1 pathway mediated through a 50 kDa glycoprotein 
which occurs in the absence of accessory cell interaction. The 
binding of monoclonal antibodies specific for the E (sheep red blood 
cell) receptor (designated CD2, Til) seems to initiate an alternative 
antigen independent activation (Meuer et al., 1984b) or suppression
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pathway (Wilkinson and Morris 1984) depending on the epitope bound.
One of the signals required for T cell activation through the 
alternative pathway is provided by the interaction of CD2 with a 
naturally occuring 42 kDa complementary cell-surface molecule (Hunig 
et aL, 1987). The molecule is expressed on all blood cells and some 
other tissues (Hunig 1986), however this signal is insufficient to 
trigger T cell activation. It may be possible that there is as yet 
an undefined additional signal involved in T cell macrophage 
interaction which after multimeric antigen receptor ligation is 
directed from the responding T cell towards the accessory cell to 
engage IL-1 production, possibly requiring physical contact between T 
cells and the macrophages (Meuer and Meyer 1986).
An antigen-independent pathway of T cell activation has also 
been reported to be mediated via a novel 103 kDa T cell-specific 
activation antigen which mediates an autocrine IL-2 dependant 
mechanism (Fleischer 1987). These observations suggest the existence 
of antigen-independant pathways of T cell activation that can be 
regulated via other cell surface structures.
1.13 Signal Transduction
Much werk has been done to investigate the results of T cell 
activation such as the production of IL-2 and other lymphokines, 
cellular proliferation and cytolysis of target cells. Surface 
markers of cellular activation such as the production of receptors 
for IL-2 and transferrin have also been identified. All of these 
require de novo activation of genes and hence a signalling system 
effective in transducing signals originating at the cell surface to
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the nucleus. It is still unclear whether the different T cell
subsets have differing signalling requirements to activate their
individual functions or whether multiple activators mediate their
actions through the same signal transduction mechanism.
2 +Increased intracellular Ca concentration is a critical
component of signal transduction by various cell-surface receptors
and plays an important role in T cell triggering via the antigen
receptor. Only the initial phases of the T cell antigen
2+receptor-mediated increase in intracellular [Ca ] is due solely to 
2+the release of Ca from intracellular stores which suggests that
2 +the perturbation of the antigen receptor must activate a Ca
24-transporter or open a Ca channel within the plasma membrane
(Weiss et al., 1986). IL-2/IL-2R interaction does not trigger a
change in [Ca^+] (Mills et al., 1985).
It has been shown that different signalling requirements are
needed for the induction of the IL-2R and IL-2 genes and for the
activation of T cell help or cytotoxicity functions (Isakov and
Altman 1985, Truneh et aL, 1985). Using the phorbol ester PMA and
calcium ionophore A23187 to stimulate lymphocytes, it has been
suggested that the gene controlling IL-2 and IL-2R have different 
2+intracellular [Ca ] concentration requirements for their maximal 
expression (Chopra et al., 1987). Work has shown that IL-2R 
expression does not appear to require an increase in intracellular 
[Ca^+] (Gelfand et al., 1986).
1.14 Protein Kinase C (PKC)
In vitro evidence using TPA, a stimulator of protein kinase C, 
suggests the protein kinase C pathway to be triggered in T cell
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activation. PKC activation induces the expression of the IL-2 
receptor and the disappearance of the antigen receptor complex 
(CD3-TL) from the surface of T cells (Ando et al., 1985). PKC 
activation is not a sufficient signal for IL-2 secretion, the IL-2
24-gene requires both activated PKC and a Ca signal (Isakov et al.,
1987). Activated PKC cannot substitute for the IL-2 dependant 
triggering of the IL-2R (Albert et al., 1985).
PKC phosphorylates a wide range of substrates in vivo or in 
cell-free systems, in T cells the relevant proteins being IL-2R which 
is phosphorylated at ser 247 (Shackelford and Trowbridge 1984) and 
the CD3 complex. On the activation of human T cells with tumour 
promoters such as phorbol esters which can directly activate PKC in 
vitro, no transcription of the IL-2 gene or secretion of IL-2 is 
detectable (Isakov et al., 1985a) and the proliferation cannot be 
blocked by anti IL-2 antibody (Isakov et al., 1985b). These 
observations suggest the presence of an IL-2 independent pathway of 
cellular proliferation possibly via the activation of PKC and 
indicate that IL-2 may not be a universal signal for the 
proliferation of all T cells (Isakov et al., 1987).
One of the main functions of accessory cells in the immune 
response appears to be the activation of PKC in T cells by providing 
a matrix for the cross-linking of T cell antigen receptors (Droge
1986). It has been shown that PKC in T lymphocytes may be activated 
by arachidonic acid or other lipid components from accessory cells, 
the former almost as effectively as diacylglycerol (McPhail et al., 
1984) and the transfer of free fatty acids from macrophages to 
lymphocytes may explain at least some of the cooperative effects 
between these cell types (Kroner et al., 1981).
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The net effects of PKC activation on T cell proliferation is due 
to at least five different and partly counterproductive mechanisms:
1) Enhanced Gq to transition
2) Retarded G^ to S phase progression
3) Augmented expression of IL-2 receptors
4) Augmented IL-2 production by helper T cells resulting in 
enhanced G^ to S phase progression in cells with IL-2 
receptors
5) Down regulation of the antigen receptor and consequently of 
the antigen driven proliferation
1.15 In Vitro Investigation of the Allograft Rejection Response 
Investigations into the mechanism and control of the 
cell-mediated graft rejection response centre around the capacity of 
human blood lymphocytes to proliferate in culture. The stimulants 
for such a proliferative response may be either sugar binding 
proteins (lectins) or allogeneic MHC antigens. The appearance of 
lymphoblasts in cultures containing lymphocytes from two unrelated 
individuals is termed the allogeneic mixed lymphocyte reaction and is 
recognised to be the in vitro correlate of the in vivo allograft 
rejection response. The degree of proliferation can be determined by 
the incorporation of radioactive precursors into the stimulated 
cells. Alternatively other aspects of the response such as cell 
surface antigen expression and/or soluble mediator release can be 
investigated.
The gross morphological changes and biochemical events occuring 
in lectin stimulated lymphocytes in vitro resemble many of the
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antigen-induced reactions that take place in vivo.
1.15.1 The mitogenic stimulation of lymphocytes by the plant lectin
phytohaemagglutinin (PHA).
The polyclonal activation of T lymphocytes in vitro can be
achieved by the substitution of antigen-MHC stimulation by a variety
of agents including the plant lectin phytohaemagglutinin (PHA).
Whilst such activation is unrelated to the in vivo situation,
mitogenic stimulation provides one of the best models for dissecting
the control of mammalian cell growth and proliferation. How mitogens
work remains obscure, but such in vitro activation may involve a
twD-step signalling system analogous to the in vivo situation. The
initial signal may arise from the binding of the polyclonal mitogen
and the second signal by IL-2 before commitment to DNA replication is
achieved (Robb 1984, Palacios 1982).
The phytohaemagglutinins (PHA) obtained from the red kidney
bean, Phaseolus vulgaris, have been shown to be a mixture of five
glycoproteins that are heterogeneous by several physicochemical and
biological criteria (Allen et al., 1969). One of these proteins is a
potent leukoagglutinin with a low haemagglutinin activity (L-PHA).
L-PHA consists of four identical covalently linked subunits which
have a high affinity for lymphocyte membrane receptors but a low
affinity for red cell membrane receptors (Yachnin and Svenson 1972).
2+It has been proposed that mitogens increase cytoplasmic [Ca ]
which subsequently acts as a trigger for the cascade of intracellular
processes necessary for proliferation (Metcalf et al., 1980). PHA
2+induces a rapid increase in intracellular [Ca ] which reaches a
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peak in less than 1 minute and then falls to maintain a sustained
plateau. Whilst it appears that the initial peak observed is due to
2+ 2+ the release of Ca from intracellular stores, it is Ca uptake
which may be essential for the response induced by PHA (Gelfand et
aL, 1987a). Data indicate that PHA triggers a membrane potential
2+sensitive event, namely Ca entry into the cell and this change m  
2+intracellular [Ca ] regulates IL-2 secretion (Gelfand et al.,
2+1987b). The changes in intracellular [Ca ] are not mediated by
the opening of K+ channels (Gelfand et al., 1987b).
PHA has been shown to bind to the CD3 (Valentine et al 1985) and
the Ti (Kanellopoulos et al., 1985) structures at the lymphocyte
membrane. Blocking of the CD2 molecule by monoclonal antibodies has
2+also been shown to abolish PHA stimulated Ca fluxes (O'Flynn et 
al., 1985).
In addition mitogenic lectins such as PHA and Con A are potent 
activators of phosphatidyl inositol turnover and PHA appears to 
regulate the channel opening through the generation of inositol 
polyphosphates (Kuno and Gardner 1987). It appears that PHA may 
activate lymphocytes via different cell surface structures with the 
different pathways having different requirements for accessory cells 
and factors. Mire et al., (19 85) have shown that lymphocytes 
extensively depleted of monocytes wsre capable of undergoing a single 
round of cell division, further proliferation was dependent on 
exogenous IL-1 and IL-2. The IL-1 is presumably required for 
subsequent phases of the response.
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1.15.2 The allogeneic mixed lymphocyte reaction (MLR).
The co-cultivation of lymphocytes from unrelated individuals 
leads to blast transformation and proliferation similar to that 
observed upon the addition of mitogens, the participating cells being 
peripheral blood lymphocytes. The MLR is a relatively simple test 
yet it exists in many variants. Macrophages are required for an MLR 
to proceed as the reaction does not occur or its strength is sharply 
reduced when all the adherent cells are removed from the mixed 
culture.
Genetic analysis has revealed that it is the HLA-D locus that 
codes for the determinants which stimulate the allogeneic MLR. The 
activation signal is provided in the main by cell surface molecules 
of B lymphocytes, macrophages and dendritic cells and probably some T 
lymphocytes. The responding cells in the MLR are of the T helper 
(CD4 ) subclass. This conclusion is supported by the finding that 
HLA-D antigens are expressed on non-T lymphocytes and monocytes, but 
are absent or weakly expressed on resting cells (Mann and Sharrow 
1980). The proliferative response of the MLR is followed by the 
generation of cytotoxic T lymphocytes which express specificity for 
the allogeneic gene products of the HLA-A, -B, or -C loci. The HLA-D 
locus is distinct, but closely linked to the HLA-A, -B, and -C loci. 
The allogeneic MLR possesses the essential attributes of an immune 
response: memory and specificity.
The stimulated cel Is enter into blastogenesis with the help of 
macrophages and macrophage-produced factors and secrete soluble 
mediators into the medium. Allogeneic MHC antigens are highly 
immunogenic and do not need to be recognised in association with self
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MHC molecules for T cell stimulation to occur. They provide the dual 
recognition signal of self MHC plus antigen.
The nature of the alloantigen recognising receptor is unknown. 
The receptor may be distinct from or the same as the receptor for 
other antigens, a third possibility is that the receptor is a 
compromise between the two. The T cell receptor may be able to 
recognise both self and non-self and treats differential requirements 
as non-self and the shared determinants as self. The allogeneic MHC 
appears to the responder cells as antigen altered self MHC.
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SECTION B
THE IMMUNOBIOLOGY OF THE FOETO-MATERNAL RELATIONSHIP
1.16 Trophoblast and Class I MHC Antigens
Although MHC antigens are absent (or perhaps present at 
extremely low density) from the trophoblast tissues in direct contact 
with maternal blood (Billington and Bell 1983 a,b), other major 
trophoblast populations opposing maternal decidual tissue have now 
been shown to express class I MHC antigens and examination of minor 
trophoblast subpopulations in the placental bed, in contact with both 
maternal uterine cells and blood, may reveal these too to be 
antigenic.
Extravillous (or non-villous) trophoblast (comprising the 
interstitial and endovascular trophoblast in the placental bed, the 
cytotrophoblast in the decidua, the cell islands and in the 
amniochorion) has been shown to express class I antigens during the 
first, second and third trimesters (Redman et al., 1984, Sunderland 
et aL, 1981b). The trophoblast class I MHC antigen expressed on 
extravillous cytotrophoblast cells is different to that of adults in 
that it has a heavy chain of about 40 kDa and does not appear to 
express the polymorphic HLA-A, -B, or -C determinants (Ellis et al., 
1986).
Paternally encoded class I MHC antigens have been described on 
the spongy zone trophoblast layer of the placenta in the rat. In 
this case the survival of the dependent foetus must therefore be
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assured by maternal immunoregulatory factors (Billington and Burrows
1986). The major line of evidence to suggest maternal recognition of 
paternally-inherited foetal alio antigens is the detection of HLA-A 
specific antibody in the serum of pregnant women and also in a 
variety of different species (Terasaki et al., 1970).
1.17 Trophoblast and Class II MHC Antigens
The major barrier to allogeneic transplantation is the presence 
of MHC class II products (HLA-DR). HLA-DR has not been found on 
human syncytiotrophoblast at term nor on immature villous 
trophoblast, trophoblast cell columns or the cytotrophoblast of the 
amniochorion (Sunderland et al., 1981a). HLA-DR positive cells are 
found in the human placenta, but they are not trophoblast and are 
thought to be macrophages (Sutton et al., 1983). These cells are 
separated from contact with the maternal blood and tissue and are not 
present in first trimester human material. Recently it has been 
reported that cytotrophoblast cells in the term amniochorion and 
first trimester chorionic villi can bind antibody specific for the 
MHC class II antigen HLA-DP (Starkey 1987). Weak binding has also 
been observed in 24 week and term syncytiotrophoblast.
1.18 Other Antigens on Trophoblast
The trophoblast surface membrane has a complex structure with 
some antigens being shared by both trophoblasts and lymphocytes (TLX, 
Trophoblast Lymphocyte cross reactive). The TLX antigens are thought 
to be allotypic (McIntyre and Faulk 1982) and there is the 
possibility that TLX expression on trophoblast may modulate maternal
41
lymphocyte function directly or indirectly and be important as 
stimuli of maternal immune responses. Heteroantisera reactive 
against human trophoblast membrane may inhibit in vivo mixed 
lymphocyte culture reactions (McIntyre and Faulk 1979a) as does a 
solubilised trophoblast membrane protein fraction (McIntyre and Faulk 
1979b). Such observations suggest the presence of potent 
immunoregulatory properties associated with trophoblast membrane 
molecules (Pavia and Stites 1981).
Faulk and McIntyre (1981) have proposed a working hypothesis 
suggesting that recognition of non-self TLX antigens by maternal 
immunocompetent cells in pregnancy may lead to a protective response, 
whereas recognition of 'self* TLX antigens in association with 
trophoblast-speciif.ic isoantigen by maternal T cells may lead to early 
abortion. Evidence points towards a form of alloimmunisation by 
trophoblast which underpins successful pregnancy to term.
1.19 The Transferrin Receptor
The primary role for the expression of the transferrin receptor 
must be in the cellular iron uptake essential for growth or 
proliferation. The receptor is a 190 kDa disulphide-bonded dimeric 
glycoprotein containing two identical binding sites for transferrin 
(Loh et aL, 1980) and is encoded for by a gene on chromosome 3 which 
also contains the gene for transferrin itself (Enns et al., 1982). 
The expression of the receptor is a feature of some trophoblast 
populations (placental villous syncytiotrophoblast), but not others - 
non-villous cytotrophoblast (Johnson and McUoy 1983) and trophoblast 
in amniochorion tissues (Hsi et al., 1982).
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The presence of transferrin receptors on the surface of 
syncytiotrophoblast may markedly restrict the amount of available 
iron (as iron-loaded transferrin) in placental intervillous spaces. 
This competition possibly impairs local proliferative responses of 
maternal blood lymphocytes and may suggest a role of immunobiological 
relevance for the trophoblast transferrin receptor.
1.20 The Presence of Immunocompetent Cells at the Foeto-Maternal 
Interface.
Work has identified the presence of infiltrating T lymphocytes 
in human uterine decidua. The decidual T lymphocytes do not 
generally express the CD3 antigen (Bulmer and Sunderland 1984) or the 
IL-2R (Bulmer and Johnson 1986), but do express Til (CD2, sheep red 
blood cell receptor) molecules. The absence of IL-2R may be as a 
result of IL-2 inhibitors produced by the maternal decidua or an 
inherent inability of the lymphocytes to express the receptor (Bulmer 
and Johnson 1986). Alternatively the inhibition of IL-2R expression 
may be mediated by prostaglandins (Nakayama et al., 1985).
Maternal macrophages have been identified within the maternal 
decidualised endometrium (Bulmer and Johnson 1984). Foetal 
macrophages have also been identified within the placental chorionic 
villous mesenchyme and within the mesenchyme of the term 
amniochorion. The phenotype of the macrophage population is 
consistent with phagocytic, pinocytic and degradative functions which 
confirms previous observations of macrophages containing immune 
conplexes within placental connective tissue (Johnson et al., 1977). 
The possible role of the macrophages as accessory cells is still to 
be elucidated.
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POSSIBLE MECHANISMS OF NON-REJECTION OF THE FOETAL ALLOGRAFT
Introduction
A number of mechanisms have been proposed to account for the 
continued survival of the implanted trophoblast despite the fact that 
it is a foreign tissue in a potentially hostile immunological 
environment.
Data indicate that approximately 50% of in vivo fertilised human 
eggs are aborted with a substantial proportion being due to lethal 
genes and chromosome anomalies (Clark et al., 1986a). The idea of 
abortion being a form of graft rejection has come from a number of 
observations. Women who abort lack factors in their serum which are 
capable of blocking the reactivity of the lymphocytes against 
placental and/or paternal leucocyte antigens (Beer et al., 1986). In 
addition in vitro fertilised embryos aborting in the human uterus are 
infiltrated by maternal mononuclear cells (Nebel et al., 1985). It 
has been suggested that there must be a block of both the afferent 
(recognition) and efferent (effector) arm of the maternal immune 
response in order to prevent rejection of the foetus (Sargent et al.,
1987).
It is becoming apparent that maternal immune recognition of 
foetal alloantigens directly contributes to improved placental 
function and foetal survival. In pregnancy there seems to be a 
deviation of T cell function towards an immunotrophic or growth 
promoting role. The trophoblast may be dependent on maternal growth 
factors for the induction of embryonic gene expression for placental 
development with lymphocyte products such as interleukin-3 and CSF-GM
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having been found to stimulate trophoblast growth (Athanassakis et 
al./ 1987). A deficiency of such factors may lead to poor 
plaoentation and abortion. The suppression of the standard immune 
allorecognition events would be a necessary concommitant of this 
deviation in order to prevent a runaway immune reaction.
1.21 The Uterus as an Immunologically Privileged Site
It is possible that the uterus may be an immunologically 
privileged site, in that the arms of the cell mediated immune system 
are ineffective in the uterine environment. However there are rare 
abdominal ectopic pregnancies which do proceed to term and a variety 
of local immune responses can be induced within the uterus of 
laboratory animals (Cohen and Werrett 1975). There is lymphatic 
drainage of the deciduum and myometrium and lymphocyte infiltration 
can be observed near the trophoblast in human pregnancy. 
Work has demonstrated (Head and Gaede 1986) that the virgin rat
uterus is well-endowed with la antigen bearing cells, with the la
• • • "1“ antigen expression being hormonally controlled. Most of the la
cells in the uterine endometrium appear to be dendritic shaped cells,
suggesting the presence of a significant potential for local antigen
processing in the uterus.
1.22 The Placenta as an Immunological Barrier
The placenta could conceivably prevent immunogenic foetal cells 
from reaching the maternal circulation or protect the foetus from 
maternal lymphocyte attack. The placenta is an incomplete barrier in 
this respect and it is well known that small amounts of foetal blood
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containing red cells, leucocytes and lymphoid cells enter the 
maternal circulation prior to the termination of pregnancy (Adinolfi 
1975, Schroder 1975). Cytotoxic antibodies to foetal antigens are 
absent in neonatal blood, possibly due to sequestration in the 
placenta (Carlson and Wegmann 1978, Morisada et al., 1976).
1.23 General Maternal Immunocompetence
During pregnancy the various components of the maternal immune 
system are basically intact with only minor alterations. There 
appears to be a redistribution of the T cells into different lymphoid 
compartments as seen by an apparent reduction in circulating total T 
lymphocytes in early pregnancy (up to 20 weeks of gestation) with a 
compensatory increase in B cells (Strelkauskas et al., 1975). A 
decrease in the helper and suppressor subsets has been found in 
mothers immediately after delivery with cord blood manifesting a high 
suppressor activity on maternal lymphocytes (Shohat et al., 1986, 
Vanderbeeken et al., 1982).
Humoral and cellular immune responses are normal and the 
production of specific antibodies to environmental antigens is 
unaltered which suggest these aspects of the T cell and B cell 
function to be generally intact during pregnancy. Using a variety of 
in vitro techniques, the normal reactivity of maternal lymphocytes is 
only observed in the presence of normal and not autologous maternal 
serum. Studies in the mouse have suggested that the suppression of 
maternal cell mediated sensitisation may occur locally in the decidua 
(Clarke et al., 1984) leaving a systemic immune system unaffected and 
able to function normally.
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Antibody dependent cellular cytotoxicity is also normal, as seen 
by cytotoxicity between maternal lymphocytes and IgG coated 
trophoblast tissue (Taylor and Hancock 1975).
1.24 The Presence of Maternal Immunological Tolerance
A certain degree of immunological tolerance to paternal antigens 
may be produced in the mother due to the initial presence of sperm 
antigens expressed on the foetus. The observation that paternal skin 
allografts are rejected normally when transplanted during pregnancy 
has indicated that there is no apparent induction of tolerance and 
has discounted this theory.
1.25 The Masking of Cell Surface Alloantigens on Trophoblast
Trophoblast surface alloantigens may be masked by the presence
of a fibrinoid layer of sulphated glycoprotein nature, although 
recent evidence has severely weakened the proposed role played by 
such a mucoprotein layer and it is not thought to be responsible for 
foetal allograft survival (Beer and Sio 1982).
Alternative mechanisms of alloantigen masking have been proposed 
by a number of workers. In the rabbit, uteroglobulin, a 15.8 kDa 
protein synthesised in the uterus in early pregnancy, crosslinks with 
beta2“microglobulin, a component of class I MHC antigens, on the 
embryonic cell surface (Mukherjee et al, 1982). The cross-linking is 
mediated by the enzyme transglutaminase which has a four to five fold 
increased activity during early pregnancy, resulting in a masking of 
the MHC antigens on the cell surface. The masking of trophoblast 
antigens can also occur via antigen-antibody complexes which bind
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specifically or non-spedfically via Fc receptors to the surface of 
trophoblast cells. An alternative proposal may be that the 
trophoblast escapes maternal immune rejection by coating itself with 
maternal transferrin.
1.26 Lack of MHC Antigen Expression
The trophoblast may be particularly poorly immunogenic in vivo 
due to the lack of class II MHC antigen expression, although other 
foetal cells possessing MHC antigens can be released into the 
maternal circulation and hence only a delaying effect is possible. 
There is a possibility that antigenic modulation may occur within the 
utero-placental bed. It has been shown that factor(s) are present in 
retroplacental sera which inhibits the expression of class II major 
histocompatibility antigens induced on the human myeloid macrophage 
cell line U937 by recombinant gamma interferon. The inhibitory 
activity was shown to be due to the masking of the antigenic 
determinants rather than an inhibition of induction (Nicholas et al., 
1986). It is not known whether this mechanism occurs in vivo though 
this would of course, account for the absence of MHC antigens on 
trophoblast. The absence of HLA-A, -B, and -C transplantation 
antigens cannot explain the absence of an immune reaction in vivo. 
During pregnancy, components of the maternal system encounter the 
trophoblastic endovascular interface which bear these antigens en 
route to the maternal blood filled intervillous spaces of the 
placenta (Faulk and McIntyre 1983).
The decidual placental barrier theory postulating 
non-antigenicity of the trophoblast is now untenable in the face of
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the clear cat demonstration of class I or class I like MHC antigen 
expression on placental elements in direct contact with maternal 
tissues in all species studied so far (Redman et al., 1984). It has 
been suggested that the non-expression of MHC antigen seen at the 
time of implantation is of no immunological significance and is 
merely a reflection of unrelated developmental or more specific 
trophoblast differentiation events (King et al., 1987).
1.27 The Presence of 'blocking* Antibodies
There are a number of strong candidates for contributors to 
blocking antibody activity including the involvement of the TLX 
system (Faulk and McIntyre 1983), of non-cytotoxic antibodies to an 
MHC linked antigen (Power et al., 1983) and of auto anti-idiotypic 
antibodies reactive with maternal T cell receptors for paternal 
alloantigens (Sucui-Foca et al., 1983).
In the human there is a claim that blocking antibody is 
essential for normal gestation and absent from the serum of 
spontaneous aborters (Rocklin et al., 1979), indeed alio-antibodies 
have been frequently implicated as specific blocking factors in 
pregnancy serum. However there is little evidence for the presence 
of cytotoxic T cells against which antibody would be required 
(Gottesman and Stutman 1980, Pavia and Stites 1981). It is possible 
that they may not be directed against MHC antigens (Morris and Ting 
1982) and may instead be directed against the generation of cytotoxic 
cells, though evidence suggests that this may be a result of the 
activity of suppressor cells localised in the uterine decidual tissue 
(Bell 1983).
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The absence of allo-antibodies from the serum of the majority of 
primiparous women argues against an essential role in maternal 
acceptance of the foetal allograft. The lack of circulating antibody 
is not due to placental bound antibody (Bell and Billington 1983).
It has been reported that pregnant female mice produce 
predominantly non-complement fixing IgG^ antibodies against the 
foetus during pregnancy (Bell and Billington 1980), however no 
isotype bias was observed in mice by Chaouat et al., (1983). Smith 
and Stemlicht (1982) have observed no isotype bias in rats where the 
antibodies have been shown to be complement fixing.
Blocking antibodies may have a role in pregnancy as recurrent 
spontaneous abortion has been treated by immunisation with paternal 
cells (Mowbray et al., 1983). Such a stimulation of blocking 
antibodies is associated with a reduction in the risk of subsequent 
abortion (Mowbray 1986). This situation is analogous to the 
observation that organ allograft rejection is diminished by the 
previous immunisation with a blood transfusion. The majority of 
women in the spontaneous abortion group, unlike normal multiparous 
women do not have detectable cytotoxic antibody against paternal 
lymphocytes (Tongio et al., 1972).
1.28 Impaired Maternal Cellular Responses
It may be that cytotoxic cellular responses to the trophoblast 
antigen are impaired in vivo since recognition of trophoblast antigen 
will be in conjunction with either non-self MHC antigens or an 
absence of MHC antigens on the foetal sub-populations.
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1.29 The Presence of Decidua Associated Suppressor Cells.
During normal successful allogeneic pregnancy in both mice and
humans, suppressor cells have been shown to accumulate in the uterine 
decidua (Clark et al.y 1986b). These cells are non-T cells which 
secrete soluble factors of molecular weights 43 kDa and 21 kDa which 
block the action of IL-2. In addition a second population of larger 
sized factor-releasing suppressor cells has also been identified 
(Clark et al., 1986c).
1.30 The Presence of Immunoregulatory Molecules
An intriguing and attractive explanation is that of local 
immunosuppression of graft rejection reactions within the 
utero-placental bed which is mediated by the presence of local 
suppressor substances. It would appear that immunoregulation must 
normally occur in the suppression of the recognitive and/or 
generative phase of the rejection response as there is no evidence 
for a maternal cell-mediated anti-foetal immune response in the human 
(Sargent and Redman 1985).
In the human a number of proteins have been identified as being 
secreted either uniquely (pregnancy-specific proteins) or at a 
greatly enhanced rate (pregnancy-associated proteins) during 
pregnancy. The pattern of secretion of these factors falls into two 
groups:
Pattern A: Those present at maximum level during the first few 
weeks of gestation, eg human chorionic gonadotrophin 
(hCG, Braunstein 1976).
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Pattern B: Those the secretion of which appears to relate to the 
overall size of the placenta and whose levels increase 
throughout gestation, often reaching a plateau a few 
weeks before term, eg human placental lactogen (hPL).
The possibility that proteins which may have immunosuppressive 
properties may be secreted by the placenta/decidual i sing endometrium 
has aroused much interest both as a possible explanation of foetal 
survival or non-survival and in the wider general field of 
transplantation biology.
Any proposal suggesting that suppression of the maternal immune 
system explains the lack of rejection of the foetal allograft must 
also explain the normal systemic immunocompetence observed in 
pregnancy. This may be explained by the presence of specific 
suppressant molecules or cells such as antibody, anti-idiotype 
antibody or suppressor T cells directed at anti-allotype 
(anti-paternal) responses. Alternatively non-specific mechanisms 
with relatively short half lives may operate locally at the 
foeto-maternal interface.
1.31 Placental Proteins
The first report of the presence of a placental protein was by 
Ascheim and Zondek (1927) who described their discovery of a 
gonad-stimulating substance in the urine of pregnant women now known 
as human chorionic gonadotrophin and which still forms the basis of 
human pregnancy tests. Thirty five years later a prolactin-like 
substance present in the human placenta (now termed human placental
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lactogen hPL) was isolated from pregnancy serum and placenta 
(Josimovich and MacLaren 1962). Like all other placental proteins, 
its physiological function defies precise definition, and it may be 
involved in the control of the flow of energy supplying material to 
the foetus.
Since the early seventies a number placental proteins have been 
reported, however very few of these fit the definition of a protein 
peculiar to pregnancy, i.e. synthesised uniquely by the placenta and 
secreted by it into the maternal circulation. The placental proteins 
have specific activities in connection with the specialised functions 
of the placenta such as the maintenance of pregnancy, the development 
of the foetus or to prepare the mother for delivery.
1.32 Placental Tissue Proteins
Around 40 proteins have been extracted from human placental 
tissue and have been termed soluble placental tissue proteins 
(PP's). Most have been observed to occur mainly in the placental 
tissue with very little being secreted into the maternal bloodstream 
(usually present at less than lmg/1). The biological functions of 
only a few of these proteins have been elucidated. PP5, PP10, PPll, 
PP12, PP13 and PP17 cannot be detected in extracts of other human 
tissues and appear to be more or less 'specific* to the placenta 
whereas PP7, PP8 and PP9 appear to be ubiquitous in human tissues 
(Bohn 1985). In addition to the soluble placental tissue proteins, 
some proteins (PP4, PP19 and PP21) were shown to be only partly 
extracted with saline, total extraction requiring the use of 
solubilising agents, suggesting them to be at least partly associated 
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Due to the number and variety of functions attributed to 
placental/pregnancy proteins, only those proteins/molecules which 
have, or have had immunosuppressive activity associated with them are 
reviewed.
1.33 Pregnancy-Associated Plasma Protein A (PAPP-A)
PAPP-A is a 750 kDa glycoprotein originally described by Lin et 
aL, (1974) and since shown to be a large zinc glycoprotein (Sinosich 
et al., 1983). PAPP-A appears to be localised in the
syncytiotrophoblast (Lin and Halbert 1976) and was initially thought 
to be exclusively a product of the trophoblast. In vitro studies 
have indicated that both trophoblast and decidua are capable of 
producing PAPP-A (Bischof et al., 1984) under the regulation of a 
specific factor present only in the circulation of pregnant women. 
These results have been confirmed using an in vivo study (Bischof et 
al., 1985).
An anticoagulatory function for PAPP-A is implied from its 
ability to bind to heparin (Sinosich et al., 1981), and various 
anticoagulants have a marked effect on PAPP-A measurements (Toop and 
Klopper 1983, Pinto-Furtado et aL, 1984). PAPP-A has been shown to 
act on antithrombin III (AT III) to inhibit fibrin formation from 
fibrinogen (Bischof et al., 1983). In addition to its 
anticoagulatory effects, and due to its localisation at the 
foeto-maternal interface, PAPP-A has been investigated for 
immunomodulatory activity, and has been shown to inhibit 
lectin-induced lymphoblastogenesis (Bischof et al., 1982), however 
suppression was not reported by Sinosich et al. (1984). PAPP-A
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exhibited no suppressive activity on mixed lymphocyte cultures 
(McIntyre et al., 1981). The reasons for these apparently 
contradictory results are as yet unknown, but may relate to 
sequestering of the lectin by PAPP-A rather than a direct effect on 
lymphoproliferation.
1.34 Pregnancy Zone Protein (PZP)
PZP is a 360 kDa alpha2 glycoprotein (von Schoultz and 
Stigbrand 1973) originally reported by Smithies (1959) and appears in 
the literature under several synonyms. It is present in the 
circulation of both men and women with a dramatic rise (10-500 fold) 
in serum levels being observed during pregnancy, with levels reaching 
a plateau in the second and third trimesters. It is not synthesised 
by the foeto-placental unit rather it is synthesised under oestrogen 
induction mainly by the liver and exerts its action upon the 
placenta. PZP inhibits lymphocyte responses to both mitogenic and 
allogeneic stimulation however only at relatively high and 
non-physiological concentrations which casts doubt on its biological 
significance (von Schoultz et al., 1973, Damber et al., 1975, Stimson 
1976). It may be that the suppression reflects a non-specific 
withdrawal of nutritional factors of importance for T cell growth in 
general rather than a specific immunomodulatory activity (von 
Schoultz and Stigbrand 1982).
1.35 Early Pregnancy Factor (EPF)
The existence of Early Pregnancy Factor is highly contentious, 
however it has been suggested to be a pregnancy associated protein
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which causes a significantly higher rosette inhibition titre as 
compared with a non-pregnant control with a standard anti-lymphocyte 
serum (ALS) in the rosette inhibition test. The inhibition is not 
species specific. The results suggest EPF to be an immunomodulator 
possibly affecting cellular immunity. Using the delayed 
hypersensitivity reaction it has been shown that EPF is able to 
suppress the allergic reaction (effector arm), but not the 
sensitisation stage (Fabris 1973). In the mouse, EPF has been shown 
to consist of two components termed EPF-A and EPF-B, both of which 
are required for EPF activity. The oviduct initially produces EPF-A 
and the ovary produces EPF-B under the influences of ovum factor, OF, 
which is released by the embryo, and prolactin from the pituitary. 
Production in this manner continues until day 7.
From day 4 a second source of EPF develops which persists until 
day 15 when production ceases. EPF is present for at least the first 
half of pregnancy. Although this is the situation in mice, there is 
some evidence to suggest that it is also the case in some other 
species including humans (Morton et al., 1982).
EPF appears in the serum in all species within 24 hours of the 
estimated time of fertilisation. Its continued presence is dependant 
on a viable embryo and has provided a means of early diagnosis and 
monitoring of pregnancy (Nancarrow et al., 1979).
1.36 Platelet Activating Factor (PAF).
Alterations to platelet physiology occur immediately following 
conception in the human (O'Neill et al., 19 84). A mild
thrombocytopenia induced by the production of a platelet activating 
factor(s) (PAF) by the fertilised ovum has been observed. This
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factor has been partially purified and shown to have similar 
biochemical and physiological properties to the potent platelet 
activating factor 1-0-alkyl-2-acetyl-sn-glyceryl - 3-phosphocholine 
(PAF acether). PAF acether was first discovered by the observation 
that leucocytes sensitised with specific IgE antibody and challenged 
in vitro, released a potent substance which caused platelet 
activation (Benveniste et al., 1972). PAF is produced by a wide 
range of cell types, has a relatively simple biosynthetic pathway 
(Ninio et al., 1982) and is potent at very low concentrations 
(Camussi et aL, 1983). Such attributes make PAF a candidate for an 
early embryonic message.
Results suggest that embryo-derived PAF may be the ovum factor 
responsible for the triggering of the generation of serum EPF 
activity during the preimplantation stages of pregnancy (Orozco et 
aL, 1986), however as yet there is no evidence to suggest a direct 
immunosuppressive role for PAF.
1.37 Pregnancy Specific beta^-glycoprotein (SP1).
SP1 is a 90-120 kDa glycoprotein with a carbohydrate content of 
28% (Horne and Towler 1978) and has been demonstrated to be a potent 
suppressor of both mitogenically and allogeneically stimulated 
lymphocytes at physiological concentrations. When stimulated by 
phytohaemagglntinin (PHA) SPl suppressed lymphocyte proliferation 
both in the phase of the cell cycle as well as the period of DNA 
synthesis (S phase), but only at the very early mitosis phase when 
pokeweed mitogen (PWM) was used. SPl is synthesised by placental 
trophoblast, trophoblastic tumours (Heikinheimo et al., 1981,
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Tatarinov et al., 1976) and certain types of non-trophoblastic 
tumours and fibroblasts in vitro (Rosen et al., 1979, Azer et al., 
1980). SPl is detectable in the serum of normal males and 
non-pregnant females and levels rise in maternal serum with advancing 
gestation to a peak as high as 330 mg/1 (Bohn 1972).
1.38 Alpha Foeto Protein (AFP).
AFP is a glycoprotein synthesised in the yolk sac and foetal 
liver and is present at high levels in blood and amniotic fluid. 
Conflicting reports have appeared regarding immunosuppressive 
properties of both murine and human AFP. In the human it has been 
suggested that AFP has variable suppressive properties, being 
suppressive in mitogen and antigen-induced proliferation and antibody 
synthesis, but not in mitogen and alio antigen-induced cytotoxicity or 
migration inhibitory factor production (Littman et al., 1977). There 
is both in vivo and in vitro evidence to suggest that alpha foeto 
protein can act directly on antigen presenting cells to inhibit cell 
surface antigen expression (Lu et al., 1984).
The variability of results has led some workers to suggest that 
AFP is not a biologically significant immunoregulator. Both highly 
purified rat AFP (Parmely and Thompson 1976) and human AFP (Goecken 
and Thompson 1977) have been reported to lack the suppressive 
activities described earlier. Such variability of results may be due 
to a number of reasons, which have been reviewed by Tomasi (19 78), 
with one proposal being that the suppressive activity is, in fact, 
due to the presence of contamination in the preparations.
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Certain T cells express receptors for AFP with binding possibly 
being mediated by sialic acid residues (Dattwyler et al., 1975). AFP 
may mediate its proposed immunosuppressive activity by the induction 
of suppressor T cells (Bankhurst et al., 1978).
1.39 Human Chorionic Gonadotrophin (hCG)
HCG is a 38 kDa glycoprotein with a carbohydrate content of 30% 
which is higher than any other human hormone. HCG consists of two 
dissimilar non-covalently linked subunits designated alpha and beta 
with hCG beta being localised only in syncytiotrophoblast whereas hCG 
alpha is localised both in the cytotrophoblast and the 
syncytiotrophoblast (Tojo et al., 1982). HCG has a strong 
luteotropic function in the human female and plays an important role 
in maintaining the function of the corpus luteum during the early 
stage of pregnancy.
HCG is detectable in normal pregnancy as early as six to nine 
days following presumed conception (Braunstein et al., 1973). Levels 
rise logarithmically to a peak at 10 gestational weeks, followed by a 
decline and nadir at 17 wseks with relatively constant levels being 
maintained through the rest of pregnancy (Braunstein et al., 1976).
In addition to its role as a luteotropic hormone, rescuing the 
corpus luteum from its normal decline during the last week of the 
menstrual cycle, it has been suggested that hCG has immunosuppressive 
properties which may play a role in preventing the rejection of the 
foetus in pregnancy. Material extracted from pregnancy urine 
inhibited phytohaemagglutinin and antigen induced lymphocyte 
stimulation and mixed lymphocyte reactivity (Han 1974), however
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purified hCG preparations were much less inhibitory than crude 
preparations suggesting other molecules were involved (Morse et al., 
1976). Rdlfe et aL, (1983) have demonstrated that EPF contamination 
of some commercial hCG preparations accounts for its 
immunosuppressive activity, suggesting that there is unlikely to be a 
direct role for immunosuppression by the pure hormone during 
pregnancy.
The manner by which hCG is secreted differs from other hormones 
in that hCG is not packaged in secretory granules and released by 
exocytosis. Rather the carbohydrate portion of the hormone is 
completed on the cell membrane from which the hormone diffuses away. 
The resulting close association between hCG and the 
syncytiotrophoblast plasma membrane may have an effect on surface 
sialylation. One mechanism may be that the negatively charged 
trophoblast and similarly charged maternal lymphocytes would result 
in mutual electrostatic repulsion and thus interfere with maternal 
effector lymphocyte cytotoxicity (Loke 1986).
1.40 Placental Protein 15 (PP15)
Placental protein 15 was first isolated by Bohn et al., (1980) 
and shown to be a 30.7 kDa glycoprotein with 3.3% carbohydrate 
content. PP15 is composed of two identical subunits held together by 
non-covalent bonds. On investigating its effect on lymphocyte 
transformation in the mixed lymphocyte culture system, a significant 
inhibitory activity was demonstrated suggesting a possible role as an 
imrnuncmodiilatory protein during pregnancy. Studies on PP15 have been 
hampered by its poor antigenicity which hinders antiserum production 
(Bohn et al., 1982).
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1.41 Placental Protein 14 (PP14)
Placental protein 14 was originally isolated from term placentae 
(Bohn et al., 1982), but subsequently found to be synthesised by 
decidua. PP14 appears to be a major component of decidual tissue, 
indeed, by the seventh waek of gestation PP14 comprises some 10% of 
the total soluble protein extracted from this tissue (Julkunen et 
aL, 1985). PP14 has been reported as a 42-43 kDa glycoprotein with 
a carbohydrate content of 17.5% (Bohn et al., 1980) and is one of a 
group of proteins independently described by a number of workers 
which exhibit great structural and immunological similarity and some 
of which at least may be identical. All of these proteins appear to 
be secreted by decidual tissue and include placenta specific 
alpha2“microglobulin (Petrunin et al., 1976) (also called chorionic 
alpha2-microglobulin (Petrunin et al., 1978)), which has been shown 
to be antigenically identical to PP14 (Bohn et al., 1982), 
alpha-uterine protein (Sutcliffe et aL, 1980) which was subsequently 
found to be immunologically identical (Sutcliffe et al., 19 82) to 
progestagen-dependent endometrial protein (Joshi et al., 1980) which 
in turn is immunologically indistinguishable from PP14 (Julkunen et 
al., 1986a); and pregnancy associated endometrial alpha2~globulin 
(Bell et aL, 1985) which shows immunological cross-reactivity with 
PP14 (Bell and Bohn 1986).
Although PP14 is found in endometrial tissue and in the 
peripheral circulation of non-pregnant women (15-40 ug/ml, Seppala et 
al., 1985), levels rise rapidly in early pregnancy and as soon as 
2-12 days after embryo replacement in IVF (Julkunen et al., 1985). 
Highest levels are found in the deciduum and peak activities of the
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protein appear in the maternal circulation between 6 and 12 weeks of 
gestation (Julkunen et al., 1985), declining thereafter. The 
secretion pattern of PP14 resembles that of hCG, however the two 
proteins are immunologically distinct. The observation that PP14 is 
extra placental in origin is supported by the fact that PP14 
concentrations are significantly higher in amniotic fluid compared 
with maternal serum (peak values 232 mg/1 and 2.2 mg/1 
respectively). Decidual origin and transport through the membranes 
into the amniotic fluid explain this kind of distribution of the 
protein in foetal and maternal compartments (Julkunen et al., 1985).
PP14 has been localised in the cytoplasm of villous 
syncytiotrophoblast in early human placentae (Inaba et al., 1987). 
In term placentae the positive staining for PP14 was weakened in the 
trophoblast cells. The umbilical epithelium has been shown to be 
cytoplasmically positive for PP14 and there has been clear positive 
staining for PP14 demonstrated in the cytoplasm of foetal 
polymorphonuclear neutrophils (Inaba et al., 1987). The decidual 
large cells were also positive for PP14. In cynomolgus monkey 
placentae, similar immunostaining results have been obtained. The 
observation that PP14 was clearly localised in certain decidual cells 
suggests it to be produced by the decidua. It still remains to be 
confirmed as there is the possibility that the decidual cells may be 
invading trophoblastic cells (Inaba et al., 1987).
Using radioimmunoassay a cyclic variation in the circulatory 
levels of PP14 in serum from non-pregnant females has been observed 
in ovulatory menstrual cycles which suggests an association with 
endocrine events (Julkunen et al., 1986b). The levels of PP14 in
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serum begin to rise at the time when serum progesterone is at a peak 
and continue to rise after the decline of progesterone levels. This 
observation does not preclude the possibility that PP14 is 
progesterone controlled as the delay may represent the time taken for 
PP14 to enter the bloodstream from its localised site of secretion. 
Non-pregnant human secretory endometrium is capable of synthesising 
PP14 in vitro with the PP14 content of the endometrium being highest 
in the late secretory phase which explains its appearance in the 
absence of conception. No similar increase takes place in 
anovulatory cycles indicating that the synthesis of PP14 is related 
to the action of progesterone (Julkunen et al.f 1986a). These 
results are compatible with the observation that immunochemical and 
immunohistochemical methods have shown the occurrence of placental 
protein 14-like material in the human fallopian tube, with the tubal 
PP14 content being higher in the secretory rather than the 
proliferative phase (Julkunen et al., 1986d).
PP14 has also been found in the luteinised granulosa cells of 
preovulatory follicles, corpus luteum and endometrium after the third 
postovulatory day (Seppala et al., 1985) and in 59 of 122 follicular 
fluids examined (7.9 - 122 ug/ml). PP14 has also been detected in 
extracts of cervical mucus (Pockley et al., 1988a, 1988b). Results 
have also shown that low serum PP14 levels in the late luteal phase 
are typical of anovulatory cycles and measurement of serum PP14 
levels has a potential, to become a novel means to identify ovulatory 
cycles retrospectively for the first days of the next menstrual cycle 
(Julkunen et al., 1986c).
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Table 1.3 details the PP14 levels in a variety of sites, both in 
pregnant and non-pregnant individuals:
TABLE 1.3 PP14 levels at various sites (Julkunen et al., 1985)
Non-pregnant serum
Peak in normal pregnancy serum (6-12 weeks) 
(plateauing after 24 weeks to)
Amniotic fluid (peak 12-20 weeks)
Cord blood (undetectable or)
Early pregnancy decidua 
Late pregnancy decidua 
Early pregnancy placenta 
Late pregnancy placenta
15-40ug/l 
2200ug/l 
200ug/l 
23 2mg/l 
15-22ug/l 
41-16 Omg/g protein 
60-2700ug/g protein 
0.25-15mg/g protein 
3-430ug/g protein
It has been suggested that the elevation of serum PP14 levels 
may not be a reflection of implantation, but rather a decidual 
reaction (Julkunen et al., 1985). High levels of PP14 have been 
detected by RIA in seminal plasma where it may comprise up to 2.5% of 
the total protein, with the reference range being 19-515 mg/1 (Bolton 
et aL, 1986a). PP14 isolated from human plasma and seminal plasma 
are immunologically indistinguishable, however the isoelectric point 
of seminal plasma derived PP14 has been reported to be slightly 
higher than that of maternal serum PP14 which may be explained by a 
difference in the glycosylation (Julkunen et al., 1984). The 
observation that PP14 levels are similar in both vasectomised and 
non-vasectomised men suggests that the protein is not derived from 
the testes or epididymis even though it could be detected in saline 
extracts of both these tissues (Bolton et al., 1986a).
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PP14 has been recently characterised to be a dimeric 60 kDa 
glycoprotein with homologous 28 kDa subunits (Westwood et al., 1988), 
is highly glycosylated (30%) and highly hydrophobic (O.M.R. Westwood, 
personal communication). The first 24 amino acids of the N terminal 
were found to be;
Met Asp lie Pro Gin Thr Lys Gin Asp Leu Glu Leu
Pro Lys Leu Ala Gly Thr Glu His Glu Met Ala Met
The first 17 amino acids showed identity with the sequence data 
determined by Huhtala et al (1986), the differences observed further 
along the polypeptide chain possibly being explained by genetic 
polymorphism. Significant homology exists between
beta-lactoglobulins of a number of species and PP14 (Pervais and Brew 
1985; Godovac-Zimmerman et aL, 1985). Beta-lactoglobulins (BLG) are 
found in the milk of many animals and possibly man. The protein 
exists as a dimer and many species appear to possess genetic 
variants. A possible binding site for retinol in BLG has been
identified suggesting a possible role for BLG in vitamin A transport
(Papiz et al., 1986).
Pregnancy associated alpl^-globulin (alpl^-PEG) has been 
shown to be immunologically and biochemically related to PP14 (Bell 
and Bohn 1986). The 15 amino acid N terminal sequence reported by 
Huhtala et al. (1986) is identical to the N terminal sequence of 
alph^-PEG apparently confirming the work of Bell and co-workers.
Alph^-PEG appears to be synthesised by the decidua spongiosa 
of the decidua parietalis (Bell 1985) and has been detected at the 
highest levels in amniotic fluid with peak levels being observed at
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20-25 weeks (Bell and Bohn 1986). From previous studies on 
alpt^-PEG it has been deduced that although the major route of 
secretion is into the amniotic fluid (Bell et al., 1986), the protein 
may also be bound by populations of trophoblast in the placenta 
resulting in a localisation to the placental trophoblast.
Alpt^-PEG is also the major secretory protein of the mid-late 
secretory endometrium during the luteal phase of the menstrual cycle 
and has been suggested as representing the human analogue of rabbit 
uteroglobulin (Bell et ai, 1986). It has been clearly demonstrated 
that alpb^-PEG is principally associated with glandular epithelium 
and its secretions and is modulated during the menstrual cycle 
(Waites et al., 1988). Alph^-PEG secretion was observed to be 
Initiated well after the histologically defined secretory phase had 
begun, suggesting a dependance on an extended progesterone exposure 
or a link with predecidualisation of the stroma rather than a direct 
steroid hormonal control (Waites et al., 1988).
The observed sequence homology between alpha2~PEG and equine 
beta-lactoglobulin is intriguing since the latter species exhibits 
epitheliochorial placentation. In the horse, beta-lactoglobulins 
have been demonstrated to bind vitamin A and have been suggested to 
be involved in its transport (Pervais and Brew 1985). Such a role 
for alpI^-PEG as a vitamin A transporter to the implanting embryo 
and developing placenta has still to be elucidated. Binding studies 
attempting to show that PP14 is a retinol binding protein are 
unconvincing (O.M.R. Westwood, personal communication) and it is 
unlikely to be of physiological significance.
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Due to its tissue and temporal distribution, interest has arisen 
into a possible immunosuppressive role for PP14 in human 
reproduction, and preliminary data suggest that both crude decidual 
extract and purified PP14 exhibit immunosuppressive activity in the 
allogeneic mixed lymphocyte reaction (MLR) (Bolton et al., 1986b).
1.42 Steroids as Immunosuppressive Molecules in Pregnancy
Progesterone is widely distributed in nature. Its synthesis 
from cholesterol requires only tvro enzymatic steps, and many studies 
have shown it to be essentia], for the maintenance of pregnancy in a 
variety of mammalian species. Progesterone production appears to be 
related to placental structure with higher levels being produced in 
haemochorial placentae with the levels in humans being by far the 
highest (1-5 ug/ml) (Stites and Siiteri 1983).
The potential role of high local concentrations of progesterone 
as a natural anti-inflammatory and immunosuppressive agent was 
proposed by Stites and Siiteri (1983), and in vitro studies have 
shown progesterone to block T cell activation in concentrations of 
5-20 ug/ml (Mori et al., 1977; Clemens et al., 1979). Progesterone 
suppresses the recruitment of cells from Gq to and S phases of 
the cell cycle (Mendelsohn et al., 1972), however at concentrations 
above 20 ug/ml progesterone has significant cytotoxicity. It has 
been established that cortisol and progesterone exert a
3dose-dependant suppression of H-thymidine incorporation with 
either mitogenic or allogeneic stimulation in the MLR (Clemens et 
al., 1979). The effect of progesterone is readily reversible and 
work suggests that progesterone both reduces DNA synthesis and
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inhibits thymidine incorporation. The levels at which these effects 
were observed (20 ug/ml) are comparable to the possible localised • 
levels at the foeto-maternal interface, but much higher than those 
levels in the maternal circulation.
It has also been shown that the mechanism by which progesterone 
and cortisol inhibit T cells differ. Progesterone is primarily 
directed towards T cells and not the accessory cell function of 
monocytes (Stites and Siiteri 1983) whereas glucocorticoids seem to 
have effects on both monocyte and T cell populations. A local 
anti-inflammatory activity of progesterone has been observed in vivo 
as confirmed by the absence of inflammatory cells in the pregnant 
uterus until a few days before birth, although whether this is 
mediated directly by progesterone is unknown. The appearance of 
inflammatory cells at the time of removal of progesterone activity 
may lead to parturition mediated by prostaglandin production and 
possibly suggests parturition to be a delayed rejection reaction 
(Stites and Siiteri 1983).
An important additional feature in the process of immunological 
recognition and proliferation is the capacity of lymphocytes to form 
aggregates possibly allowing local exchange of immunological 
information, via messengers such as lymphokines. It has been 
demonstrated that progesterone directly interferes with cell-cell 
contact possibly having immunological consequences at the 
foeto-maternal interface. Inhibition of lymphocyte aggregation in 
the presence of progesterone is reversible implying that once 
maternal lymphocytes leave the placental bed they may regain their 
immunological capability (Van Vlasselaer et al., 1986).
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Oestrogens are also produced by the corpus luteum and placenta, 
however their function in the immunological aspects of the 
foeto-maternal relationship is unknown.
1.43 Aims of the Study
The aim of this study was to confirm the previously reported 
immunosuppressive activities of PP14 using both the allogeneic MLR 
and mitogenic stimulation assay systems. The level of action of the 
suppressive activity was also investigated, primarily using mitogenic 
stimulation. The effect of PP14 on interleukin-2 and gamma 
interferon production were assessed as was the expression and 
affinity of the IL-2R and the release of the IL-2R from activated 
lymphocytes. Flow cytometry was used to investigate the expression 
of activation antigens on stimulated lymphocytes and analyse cell 
cycle progression. Potential non-specific effects of PP14 on aspects 
of lymphocyte responsiveness were also investigated.
69
CHAPTER TWO
MATERIALS AND METHODS
The reagents, equipment and their suppliers are detailed in 
Appendix I.
Blood samples used in this study were obtained from normal 
healthy volunteers in the Department of Biomedical Sciences, 
Sheffield City Polytechnic and the University Department of 
Haematology, Royal Hallamshire Hospital, Sheffield. Decidual tissue 
samples were provided by Mr M.G. Chapman of the Department of 
Obstetrics and Gynaecology, Guy’s Hospital, London and Mr P. Stewart 
of the Department of Obstetrics and Gynaecology, Northern General 
Hospital, Sheffield.
Monoclonal antibodies to placental protein 14 were produced and 
kindly provided by E.A. Mowles of the Department of Biology and 
Biochemistry, North East London Polytechnic, Romford Road, London. 
The monoclonal antibody has been shown to have less than 1% 
cross-reactivity with purified hCG, hPL, SPl, PP5, PP12, PAPP-A, 
prolactin and the human placental enzymes alkaline phosphatase, malic 
dehydrogenase, sphingomyelinase, arylamidase and choline acetyl 
transferase. The binding specificity of the monoclonal antibody was 
tested by the examination of its binding to radioiodinated proteins 
and its specificity as the labelled antibody reagent in a two-site 
immunoradiometric assay.
Purified PP14 for use in the in vitro assays was provided by 
O.M.R. Westwood of the Department of Obstetrics, Guy's Hospital, 
London.
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Purified PP14 (lot 120/135) and PP14 antiserum (lot 201ZA) for 
use in the radioimmunoassay was kindly provided by Dr. Hans Bohn of 
Behringwerke AG, Germany.
2.1 Isolation of Peripheral Blood Mononuclear Cells (PMC)
Peripheral blood mononuclear cells (PMC) were isolated from 
whole blood by density gradient centrifugation as described by Boyum 
(1968). Peripheral blood was taken aseptically from normal healthy 
male volunteers into vacutainers containing lithium heparin as 
anticoagulant and diluted in 2 volumes of Dulbecco's modification of 
Eagle's medium (DMEM). Fifteen millilitres of the diluted blood was 
layered onto 10ml of Lymphopaque separation medium (relative density 
1.084) contained in sterile plastic universal containers, and 
centrifuged at 400 x g (calculated at the interface) for 20 minutes 
at room temperature. The opaque layer of lymphocytes formed at the 
Lymphopaque interface was carefully aspirated. The lymphocytes were 
transferred to clean universal containers and the cells washed in 
approximately 25ml of DMEM. The cells were sedimented at 800 x g for 
10 minutes, the supernatant removed and the lymphocytes resuspended 
gently in DMEM by repeated aspiration into a sterile 1ml pipette tip 
attached to an adjustable pipette. The washing procedure was 
performed a total of three times and the cells were finally suspended 
in 1ml of DMEM containing 3.7g/l NaHCO^, 200iu/ml penicillin,
-f200ug/ml streptomycin and 10% foetal calf serum (designated DMEM ), 
or SF1 serum-free Hybridoma growth medium containing the same 
antibiotic concentration (designated SF1+). All manipulations were 
performed under sterile conditions using a laminar flow hood.
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The viability of the isolated lymphocytes was assessed by Trypan 
Blue dye exclusion by adding an aliquot of the cell suspension (25ul) 
to 25ul of Trypan Blue dye (0.2% w/v Trypan Blue in physiological 
saline). The plasma membrane of viable cells does not permit the 
entry of non-electrolyte dye substances and non-viable cells stain 
blue. Viable cells were counted using an improved Neubauer counting 
chamber and the lymphocytes diluted to 1 x 10 viable cells/ml in 
DMEM+ or SF1+ growth medium prior to inclusion in the cell 
culture systems. All lymphoproliferation assays were performed in 
triplicate in 9 6 well microtitre tissue culture plates.
2.2 The Two-way Allogeneic Mixed Lymphocyte Reaction (MLR) 
PMC were isolated as described from two healthy unrelated 
volunteers and equal numbers of cells from each donor mixed. Two 
hundred microlitres of the cell mixture or cells from each 
individual, 2 x 10 cells/well, were incubated in the presence of 
50ul of the PP14 preparation containing a known amount of PP14 as 
measured by radioimmunoassay (Bolton et al., 1983). Control cultures 
contained 50ul of phosphate buffered saline (PBS) in place of the 
PP14 preparation. The cultures were restricted to the central 60 
wells of the plate to minimise evaporation.
The microtiter plates were incubated at 37°C, 100% humidity and
5% CO2 for 6 days. Twenty four hours prior to the termination of
3the cultures luCi of tritiated thymidine ( H-Tdr) was added to each 
well and the extent of lymphoproliferation assessed by its 
incorporation into the DNA of the proliferating cells. At the 
termination of the cultures, the cells were harvested onto glass
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fibre filter paper, either manually using 5% trichloroacetic acid 
(TCA) containing 30mM/l pyrophosphate, or by using a Skatron 
semi-automated cell harvester.
For the manual termination of the cultures, the contents of each 
wall were transferred into 3ml plastic disposable tubes on ice, and 
200ul of trypsinising solution (0.05% trypsin, 0.02% EDTA in 
physiological saline) added to each well in order to free the 
adherent cells. The plates were then left to incubate at room 
temperature for 20 minutes after which the contents of each well were 
transferred to the appropriate cell suspension on ice.
One millilitre of ice cold 5% TCA was added to each cell 
suspension which was vortex mixed and left to incubate at room 
temperature for one hour to precipitate the DNA. The TCA 
precipitable material was isolated by filtration through glass fibre 
filter paper using a Millipore sintered glass filter assembly 
attached to a vacuum line.
Each filter was presoaked in TCA, placed into the filtration 
assembly and 5ml of ice cold TCA dispensed onto it. The sample was 
vortex mixed and tipped onto the filter fallowed by two 1ml washes of 
the tube with TCA. Vacuum was applied and the filter allowed to 
drain, 5ml of TCA was then added followed by 5ml of ice cold 
ethanol. The vacuum was ceased, the filters transferred to 
scintillation vials and allowed to dry in air for about 30 minutes. 
The extent of H-thymidine incorporation was assessed by liquid 
scintillation counting in an LKB Rackbeta 1212 for 10 minutes using 
scintillation cocktail f0' (0.3% PPO, 0.01% POPOP in toluene) or LKB 
'HiSafe' scintillation fluid.
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For the harvesting of the cells using the semi-automated cell 
harvester, wash fluid (distil led water) was supplied to the harvester 
by gravity feed and a suction unit positioned over the microplate so 
that pairs of tubes projected into the wells to be harvested. The 
inlet tube which is longer and smaller in diameter, fed the wash 
fluid into the well whilst the shorter and wider outlet tube 
simultaneously aspirated the well contents. The rinse principle 
effectively removes all the cells from the wells including the 
adherent population. The contents of each well were harvested onto
glass fibre filter mats which were allowed to dry. The extent of
3 .H-Tdr incorporation was assessed by liquid scintillation counting
as detailed above.
2.3 The Mitogenic Stimulation Assay (MSA)
PMC from a single donor were isolated as described above and
5lOOul of the washed cell suspension (1 x 10 cells/well) incubated
in the presence of 50ul of the PP14 preparation, 50ul of the mitogen
at the concentration indicated in the results section and 50ul of
+ +growth medium (either DMEM or SFl ). Control cultures contained
PBS in place of PP14 preparations and background stimulation was
assessed by incubating cells with growth medium in place of the
mitogen solution.
The plates were incubated at 100% humidity, 37°C and 5% CO2
for 72 hours. Six hours prior to termination, the cultures were
3pulsed with luCi of H-Tdr and on termination were harvested using 
a Skatron semi-automated cell harvester. The degree of 
lymphoproliferation was assessed as above.
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2.4 Control of Isotope Isolation Procedure
For both of the culture systems and harvesting methods, the
3contamination due to unincorporated H-Tdr was assessed.
3Immediately pnor to the termination of the cultures luCi of H-Tdr 
was added to control wells which were then treated as detailed, this 
procedure also serves as a zero hour control.
2.5 Preparation of Decidual Extracts
Decidual tissue, as confirmed by subsequent histological 
examination, was obtained following elective pregnancy termination at 
about 14 weeks of gestation and rinsed rapidly in cold saline 
containing the protease inhibitor PMSF (0.1 mM phenyl methyl 
sulphonyl fluoride). Samples were stored at -20 °C until use. 
The tissue samples ware homogenised in PBS containing PMSF and the 
cell debris removed by centrifugation at 5000 x g for 30 minutes at 
4 °C. Prior to incorporation into the cell culture systems, the 
extracts (10 ml) ware dialysed overnight at 4°C against PBS ( 3 x 1  
litre of PBS, pH 7.5), diluted in PBS to the concentrations indicated 
in the results section and filter sterilised. Aliquots of the 
decidual extracts were assayed for PP14 and total protein as 
described later.
2.6 The Effect of PP14 on the Production of Soluble Mediators of the
Immune Response from Stimulated Lymphocytes
PMC were isolated as described earlier, washed and resuspended
6 + 6 at 10 viable cells/ml in SF1 growth medium. 10 cells were
cultured in 24 well culture plates in the presence of 200ul of PP14
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preparation and 200ul of mitogen (PHA, 5 ug/ml final concentration) 
for the times indicated in the results section. Control cultures 
contained PBS in place of the PP14 preparation and DMEM in place of 
the mitogen. At the termination of the culture period the culture 
supernatants were harvested and stored at -20 C prior to assay.
2.6.1 Assay of culture supernatants for Interleukin-2
Cell culture supernatants were assayed for Interleukin-2 as per 
the manufacturer’s recommendations using a Genzyme Intertest 2 Human 
Interleukin 2 ELISA kit.
The provided immunoplate was coated by incubating with 
monoclonal anti-IL-2 antibody diluted in coating buffer overnight at 
37°C in a humidified incubator. Immediately prior to use the plate 
was washed four times in PBS/Tween washing buffer and finally patted 
dry on absorbent paper.
One hundred microLitres of each standard (500, 50, 5, 0.5, 0.05 
U/ml), controls and dilutions of the culture supernatants were 
incubated in duplicate in the covered plate at 37°C for 6 hours. At 
the end of the incubation period the plate was washed as above and 
each well incubated with lOOul of a 1:50 dilution of 2nd antibody 
(polyvalent rabbit anti-IL-2) for 1 hour at 37°C.
At the end of the second incubation, the fluid was aspirated and 
the plate washed. lOOul of the 3rd antibody (goat anti-rabbit 
alkaline phosphatase conjugate) was dispensed into each well and the 
plate incubated for 1 hour at room temperature. The washing 
procedure was repeated and lOOul of substrate reagent (p-NPP) 
dispensed into each well. The enzymatic colour was allowed to
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develop at room temperature for 15-60 minutes. The resulting colour 
was read on a plate reader at a wavelength of 405nm and a standard 
curve of absorbance vs log IL-2 concentration plotted. The levels of 
IL-2 in the culture supernatants were determined by extrapolation 
from the standard curve.
2.6.2 Assay of culture supernatants for cell-free Interleukin-2 
receptors
Cell culture supernatants were assayed for the released form of 
the IL-2R protein from activated T cells as per the manufacturer's 
specifications using a T Cell Sciences CELLFREE interleukin-2 
receptor enzyme immunoassay test kit.
The provided immunoplate was coated by incubating with 
monoclonal anti-IL-2R antibody diluted in coating buffer at 4°C for 
72 hours. The coating solution was removed from all wells and each 
well incubated with 300ul of blocking buffer for 2 hours at 37°C. 
The antibody coated plates containing blocking buffer were stored 
covered at 4°C until use. Immediately prior to use the blocking 
buffer was discarded and each well washed three times with washing 
buffer and patted dry on absorbent paper.
One hundred micrdlitres of the provided sample diluent buffer 
was added to each well. Fifty microlitres of each standard (0, 100, 
400, 1600 units/ml), controls and dilutions of the culture 
supernatants were incubated in duplicate in the covered plate at 37 °C 
for 2 hours. At the end of the incubation period the plates were 
washed 3 times and incubated with lOOul/well of horseradish 
peroxidase (HRP) conjugated anti-IL-2R antibody for 2 hours at 37°C.
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After the second incubation, the plate was washed 3 times and each 
well incubated with lOOul of substrate solution (OPD) for 30 minutes 
at room temperature. The reaction was stopped by the addition of 
50ul of 2N and the resultant absorbance of the wells read
at a wavelength of 492raru A standard curve of absorbance versus the 
IL-2R concentrations (u/ml) of the standards was plotted and the 
levels of IL-2R in the culture supernatants determined by 
extrapolation from the standard curve.
2.6.3 Assay of culture supernatants for Interferon-gamma 
(IFN-gamma).
Cell culture supernatants were assayed for gamma interferon as 
per the manufacturer1 s specifications using a SUCROSEP interferon 
gamma immunoradiometric assay kit.
Twd hundred microlitres of standard IFN (1024, 256, 64, 16, 4,
1, 0 U/ml) or unknown sample were incubated with 50 ul of 
125I-anti-interferon gamma monoclonal antibody in 75mm x 13 mm 
disposable tubes. After 2 hours incubation at room temperature, 50 
ul of sheep anti IFN-gamma antibody covalently coupled to solid phase 
particles was added. The tubes were covered and agitated on an 
orbital shaker at 300-350 rpm for 2 hours at room temperature.
One millilitre of the provided pre wash buffer was added to all 
tubes and 2 ml of Sucrosep reagent layered below the incubate in each 
tube using a Sucrodispenser. The sdid phase was allowed to settle 
for 15 minutes and the tube contents aspirated leaving approximately 
0.3 ml in the bottom of each tube. The separation procedure was 
repeated and the pellet counted using an LKB Multigamma. A standard
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curve of log counts vs log standard concentration was plotted and the 
levels of interferon gamma in the culture supernatants determined by 
extrapolation from the standard curve.
2.7 Effect of PP14 on Interleukin-2-Induced Lymphoproliferation.
To investigate the possibility that PP14 may interfere with the 
binding of IL-2 to its cell surface receptor once expressed, the 
effect of PP14 on IL-2-induced lymphoproliferation was assessed.
Peripheral blood mononuclear cells were isolated as described,
6 + washed and resuspended at 10 viable cells/ml in SFl growth
medium. 10^ cells were cultured in the presence of 200ul of PH A
(5ug/ml final concentration) for 6 days at 37 °C and 5% CO2 in 24
wall culture plates. The resulting fPHA blasts* produced little IL-2
as determined in the above assay, but most (70%) expressed IL-2
receptors (Tac antigen) as determined by flow cytometry (see below).
The cells \vere washed once in PBS and the adherent cells harvested by
incubating with 0.5 ml of 2% EDTA at 37°C for 15 minutes. The
harvested cells were washed twice in DMEM growth medium and
6 + resuspended at 10 viable cells/ml in SFl growth medium.
The proliferative response of PHA blasts.
a)_ To PHA.
lOOul of the 'PHA blast' cell suspension or control 
cells (cells incubated as above, but in the absence of 
PHA) were cultured in the presence of 50ul of PHA
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(2.5 ug/ml final concentration, DMEM as control), 50ul 
of PP14 preparation (PBS as control) and 50ul of SF1+ 
medium.
b)_ To IL-2.
lOOul of the 'PHA blast' cell suspension or control 
cells were incubated in the presence of 50ul of 
recombinant IL-2 (rIL-2 ala 125, Amersham 
International; final concentration 0.25 U/ml in DMEM 
growth medium, DMEM as control), 50ul of PP14 
preparation (PBS as control) and 50ul of SF1+ growth 
medium.
All cultures v^re incubated for 72 hours at 37°C, 5% CC^ in 96
3well microtitre plates and H-Tdr uptake into the proliferating 
cells assessed following a 6 hour pulse as detailed above (section 
2.2).
2.8 Cell Surface Marker Analysis of Stimulated Lymphocytes by Flow 
Cytometry
Flow cytometry was used to investigate the effects of crude 
decidual extract and immunoadsorbed decidual extract on the levels of 
surface expression of a number of antigens associated with lymphocyte 
activation.
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2.8.1 Mito genic ally stimulated lymphocytes
Peripheral blood mononuclear cells were isolated as described,
6 + 6  washed and resuspended at 10 cells/ml in SFl . 10 cells were
incubated in 24 well culture plates in the presence of 200ul of the
PP14 preparation and 200ul of PHA at a final concentration of 5ug/ml
for the times indicated in the results section.
Constitutive (background) expression of the cell surface
antigens was assessed by incubating the cells in the absence of both
PP14 preparation and mitogen. Control expression of the cell surface
antigens on stimulated lymphocytes was assessed by incubating the
cells with PHA in the absence of the PP14 preparation.
2.8.2 Allogeneically stimulated lymphocytes
The cell surface marker analysis of allogeneically stimulated 
lymphocytes was assessed using an MLR culture system. Peripheral
blood mononuclear cells from two unrelated individuals were isolated
6 + as described, washed and resuspended at 10 cells/ml in SFl
growth medium. Equal volumes of the two cell preparations were mixedgtogether and 10 cells incubated in the presence of 200ul of the 
PP14 preparation (PBS as control) in 24 well culture plates. Control 
(constitutive) expression of antigens was assessed by incubating 
single cell types.
2.8.3 The staining of cell surface markers using monoclonal
antibodies
All plates were incubated at 37°C, 100% humidity and 5% CO2 
for the times indicated in the results section. On termination of
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the cultures the cells were washed twice with PBS and the cells 
harvested by incubating each well with 0.5ml of 2% EDTA at 37°C for 
15 minutes. The cells were transferred to 10ml plastic conical 
centrifuge tubes followed by 2 x 1ml washes of PBS. The volume was 
made up to 10ml with PBS containing 1% foetal calf serum (PBS/FCS) 
and the tubes centrifuged at 1000 x g for 10 minutes. The cells were 
resuspended, counted and 10 cells transferred into plastic 10mm x 
64mm disposable polystyrene tubes and washed twice in PBS/FCS.
After the second wash in PBS/FCS, the supernatant was discarded 
and the cells resuspended in the residual volume. lOOul of an 
appropriate dilution (1/40) of monoclonal antibody was added to the 
cell suspension and incubated at 4 °C for 20 minutes. After 
incubation with the first layer antibody, the cells were washed twice 
in PBS/FCS, the supernatants decanted and the cells resuspended in 
the residual volume. One hundred microlitres of an appropriate 
dilution (1/40) of FITC goat anti-mouse antibody was added to each 
cell suspension and the cells incubated in the dark at 4°C for 20 
minutes. Non specific binding of fluorescein isothiocyanate- 
conjugated goat anti-mouse IgG antibody (FITC control) was assessed 
by incubating cells with PBS/FCS in place of the first layer 
antibody.
After the incubation the cells were washed twice in PBS/FCS. 
When possible, the cells were resuspended in 300ul of PBS/FCS and 
immediately analysed by flow cytometry on a Beckton Dickinson FACS 
420 flow cytometer at an excitation wavelength of 488 nm. Both the 
percentage of cells expressing antigen and the antigen density as 
determined by the mean channel of fluorescence were measured. If
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immediate analysis was not performed, the cells were resuspended in 
1% paraformaldehyde and stored at 4°C in the dark overnight until 
analysis.
The monoclonal antibodies used in this study were directed 
towards:-
Interleukin-2 receptor (Tac, CD25)
MHC class II (HLA-DR)
Human Transferrin receptor (0KT9)
T helper cell (0KT4, Leu 3a, CD4)
T suppressor/cytotoxic (0KT8, Leu 2a, CD8)
E rosette receptor (OKT 11, Til)
Cells were also stained for the presence of cell-surface associated 
PP14 and interleukin-2 using the relevant monoclonal antibodies.
2.9 Effect of PP14 on the Distribution of Cells in the Cell Cycle 
Subsequent to analysis for antigen expression, cells were 
stained with the nuclear dye propidium iodide and analysed for DNA 
content to determine the distribution of the cells within the cell 
cycle. Cells were cultured, harvested and washed as detailed above. 
One hundred microlitres of Triton X100 (0.2% in PBS) was added to the 
resuspended cell pellet to solubilise the cell membranes and the 
cells left at room temperature for 15 minutes. Propidium iodide (20 
ug/ml in PBS) was added and the cells mixed and analysed after a 
minimum of 15 minutes. In practice the cells were incubated with the 
dye for as long as possible to allow the interaction of the stain 
with the DNA to reach equilibrium.
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The cells were excited at a wavelength of 488 nm and the 
resulting fluorescence measured through red filters at a wavelength 
of 620 nm. The intensity of the resulting fluorescence is 
proportional to the nuclear DNA content and is indicative of passage 
of the cells through the cell cycle.
2.10 The Effect of PP14 on the Expression of High Affinity IL-2R
Peripheral blood mononuclear cells were isolated as described,
6 + washed and resuspended at 10 viable cells/ml in SFl growth
medium. 10 cells were cultured in the presence of the PP14
preparation (200ul) and 200ul of PHA (5 ug/ml final concentration) in
24 well culture plates for the times indicated in the results
section. At the termination of the culture period the cells were
washed once with PBS and incubated with 2% EDTA for 15 minutes at 37
°C to remove the adherent cells. The harvested cells were washed
6twice in DMEM growth medium, counted and resuspended at 5 x 10 
cells/ml in RPMI 1640 medium supplemented with 10% FCS (RPMI/FCS).
The binding of IL-2 to the cells was assessed by incubating
175 5radiolabelled I-IL-2 (4.7 pM - 0.3 pM) with 5 x 10 cells m  a
total volume of 200ul of RPMI/FCS in 12mm x 75mm disposable
polystyrene tubes. The tubes were incubated at 37°C for 20 minutes
and the cell suspension overlayed onto a 200ul mixture of 80%
silicone oil 550 and 20% paraffin oil 0-119 in 1.5ml Eppendorf
microfuge tubes. The tubes were centrifuged at 8500 x g for 90
125seconds and the aqueous supernatant containing unbound I-IL-2 
aspirated. The cell bound and free activity was determined by 
counting on an LKB Multigamma. The number of binding sites/cell and
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the affinity of the receptors for IL-2 were derived by Scatchard 
analysis of equilibrium binding data. All determinations were 
corrected for non-specific binding as assessed by incubating cells 
with a 150 molar excess of unlabelled IL-2.
2.11 Effect of PP14 on the Expression of Functional IL-2R.
It is generally assumed that the response of T lymphocytes to 
exogenous IL-2 is dependent on the number and affinity of the IL-2R 
borne by the cells. It is possible to determine the sensitivity of 
the cells to IL-2 by incubating dilutions of IL-2 with decreasing 
numbers of responding cells and plotting the results as the 
fractional response versus the concentration of added ligand (Ashwell 
et aL, 1986). At some point, as the number of responding cells is 
increased, the normalised dose-response curves will shift so that 
more ligand will be required to achieve a given fractional response. 
The transition point is defined as that number of responding cells 
beyond which shifts in the dose-response curves are discernable and 
is a reflection of the receptor number and affinity.
Peripheral blood mononuclear cells were isolated, cultured and
harvested as detailed in section 2.10. The harvested cells were
6 + resuspended at 1 x 10 cells/ml in SFl growth medium and
assessed for their ability to proliferate in response to exogenous
IL-2. One hundred micrdLitres of an appropriate dilution of the cell
suspension (10**, 5x10^, 2.5x10“*, 1.25x10^ and 6.25x10^
cells/ml) were incubated with 50ul of IL-2 at the concentrations
indicated in the results section, and lOOul of SF1+ growth medium
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for 72 hours in 96 well microtitre plates. The degree of
3proliferation was assessed following a 6 hour pulse with H-Tdr.
2.12 The Radioimmunoassay of Placental Protein 14
Prior to inclusion in the assays, all samples were assayed for
PP14 by radioimmunoassay (Bolton et al., 1983). PP14 was
radioiodinated using the oxidising agent chloramine T. Five
125microlitres (0.5 mCi) of Na I was added to a 12mm x 75mm 
disposable polystyrene tube (LP4) and was buffered by the addition of 
lOul of sodium phosphate buffer (0.25M, pH 7.5 + 0.1% sodium azide as 
preservative). Five micrograms of the purified protein in lOul of 
phosphate buffer (0.05M, pH 7.5 + 0.1% azide) was added, and the 
reaction started by the addition of 5 ug (lOul) of chloramine T in 
the same buffer. After 30 seconds the reaction was stopped by the 
addition of lOOul of cysteine solution (17 ug) in phosphate buffer 
and the volume made up to 1ml with a solution of KI (2 mg/ml) in 
assay diluent buffer (0.05M phosphate buffer, 0.1% azide and 2% horse 
serum). The labelled protein was separated from the unreacted iodide 
by desalting on a 10ml Sephadex G25 column equilibrated with assay 
diluent buffer (Bolton 1985).
The labelled PP14 was further purified by lectin affinity 
chromatography. The protein was applied to a 1ml column of 
Con-A-Sepharose which was then washed with five bed volumes of assay 
diluent buffer and the retained material (PP14) eluted with 0.2 mol/1 
mannose in the same buffer.
For the assay, lOOul of PP14 standards diluted in assay diluent 
buffer, or an appropriate dilution of the preparations, were
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incubated in LP4 tubes overnight at room temperature with 100 ul of 1 
ng/ml PP14 tracer containing a 1/133 dilution of non-immune rabbit 
serum (to bulk up the final precipitate) and lOOul of rabbit 
anti-PPl4 antiserum at a dilution to bind approximately 40 - 45% of 
the available tracer. The tracer bound to the antibody was then 
separated from that unbound using a polyethylene glycol (PEG) 
assisted double antibody system, by adding 0.5ml of a 1/160 dilution 
of donkey anti-rabbit antiserum in 7% PEG in assay diluent buffer.
The tubes were incubated at room temperature for 30 minutes and 
the bound fraction sedimented by centrifugation at 2500 x g for 20 
minutes. The supernatants were aspirated and the radioactivity in 
the bound fraction determined by counting in an LKB Multigamma. A 
standard curve of PP14 concentration versus bound tracer was 
plotted. The PP14 content of the unknown preparations was 
extrapolated from the standard curve as a mean of duplicate 
measurements. All data analysis was performed using an LKB Riacalc 
DM software package.
2.13 The Interaction of RadinLabelled PP14 with Phytohaemagglutinin
The possibility that PP14 could exert suppressive activity on 
PHA-induced lymphoproliferation by binding to the mitogen itself was 
investigated by assessing the binding of radiolabelled PP14 to a 
solid phase linked PHA system. PP14 was iodinated as above and PHA 
linked to cyanogen-bromide activated Sepharose 4B (CNBr-S4B) as 
described below.
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2.13.1 The coupling of PHA to CNBr-S4B
One gram of CNBr-S4B was swollen for 15 minutes in ImM HC1 to 
give a final gel volume of 3.5ml. The swollen gel was washed by 
repeated gentle centrifugation with a total volume of 200ml of ImM 
HC1. HC1 was used to preserve the activity of the reactive groups 
which hydrolyse at high pH.
Five milligrams of PHA was dissolved in coupling buffer 
(NaHCOg buffer, 0.1M pH 8.3). One millilitre of the gel was washed 
in 2.5ml of coupling buffer and rapidly transferred to the solution 
of PHA. This stage was completed immediately as the reactive groups 
on the gel rapidly hydrolyse at the coupling buffer pH. The 
protein/gel suspension mixture was mixed on an end-over-end mixer 
overnight at 4°C.
2.13.2 Blocking of the remaining active groups
After overnight mixing, the gel was.transferred to 0.2M glycine 
(pH 8.0) as blocking agent and incubated for 2 hours at room 
temperature. The blocking agent introduces a small number of charged 
groups into the gel, the effect of these charges is overcome by the 
use of 0.5M NaCl in the buffers. Excess uncoupled ligand was removed 
by washing the gel alternately with high and low pH buffers four 
times (coupling buffer pH 8.3 and 0.1M acetate buffer pH 4.0). The 
washing cycle ensures that no free ligand remains ionically bound to 
the immobilised ligand as no desorption occurs of covalently bound 
protein. After washing, the gel was stored until use at 4°C in an 
equal volume of PBS.
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As a control for the experiment, the procedure was performed as 
above using both bovine serum albumin (BSA) as a ligand and without a 
ligand to act as a non-specific binding control. At each stage of 
the procedure all supernatants were retained and assayed for protein 
content by the method of Ohnishi and Barr (1978) to determine the 
coupling efficiency of the procedure.
2.13.3 Binding of PP14 to the solid phase linked PHA
One hundred micrditres of the PHA sdLid phase (or control solid
125phase) was incubated with lOOul of I-PP14 (5 ng/ml in assay
diluent buffer) in LP4 tubes on an orbital shaker for 2 hours at room
temperature. After the incubation period, the solid phase was washed
twice by gentle centrifugation with assay diluent buffer containing
Tween 20 (1000 x g, Imin) and the activity bound to the solid phases
125determined using an LKB Multigamma. I-carbomc anhydrase III 
125( I-CA III) was used as a further non-specific binding control.
2.14 Immunoadsorption of PP14 using a Monoclonal anti-PP14 Antibody 
Solid Phase System 
To act as controls for the cultures detailed in the results 
section, PP14 was specifically removed from decidual tissue extracts 
by treatment with a monoclonal anti-PP14 antibody sdid phase system.
Monoclonal antibodies to PP14 ware produced as described (Bolton 
et aL, 1987) and linked to cyanogen bromide activated Sepharose 4B 
as detailed above.
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One ndUilitre of decidual extract was reacted with 1ml of the 
monoclonal anti-PPl4 solid phase immunoadsorbent by end-over-end 
mixing for 3 hours at room temperature. After the reaction, the gel 
was gently centrifuged and the supernatant removed using a pasteur 
pipette. After use, the solid phase was regenerated by treatment 
with 3M KI followed by repeated and extensive washing with PBS.
The immunoadsorbed samples were filter sterilised, diluted and 
incorporated into the in vitro culture systems as detailed in the 
results section. Samples were also retained for PP14 determinations 
by radioimmunoassay.
2.15 Determination of Protein
Protein was determined quantitatively by the method of Ohnishi 
and Barr (1978) which involves a combination of the method of Lowry 
et aL, (1951) and the Biuret method. The method produces a more 
stable colour complex and enables large sample numbers to be 
processed with increased reproducibility.
Eight hundred microlitres of BS7 reagent (Appendix H) was added 
to 200ul of the sample, the solutions mixed thoroughly and allowed to 
stand at room temperature for 10 minutes. The colour was developed 
by adding 25ul of Fdlin and Ciocalteau phenol reagent and the tubes 
mixed and left to develop for 20 minutes. The samples were read at 
600nm against a distilled water blank.
A calibration curve was produced using bovine serum albumin 
(BSA, fraction V) dissolved in sodium acetate buffer (0.1M; pH 4.8) 
as a standard and the protein content of the unknowns extrapolated 
from the curve.
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2.16 Two-dimensional Crossed Iinmunoelectrophoresis (2D-CIE) of PP14
Preparations
Two-dimensional crossed immunoelectrophoresis was used in 
addition to the use of radioimmunoassay for confirming the specific 
removal of PP14 from decidual tissue extracts.
2.16.1 Development of antisera to decidual tissue extract proteins 
Decidual tissue extracts ware prepared as described previously 
and emulsified with two volumes of Freund's complete adjuvant either 
using a mechanical emulsifier or by repeated passage through a fine 
bore tube between two disposable syringes. The stability of the 
emulsion was assessed by dropping a sample into distilled water. One 
millilitre of the stable emulsion was injected subcutaneously at four 
sites along the neck and back of a New Zeal and white rabbit. After 3 
- 4 weeks a booster immunisation was given followed by further 
boosters at 2 - 3 week intervals. About 10 days after each booster, 
20 - 30ml of blood was collected from a marginal ear vein into a 
plastic universal and the blood allowed to clot at room temperature 
for 2 hours. The clot was released from the sides of the universal 
using a spatula and the sample stored overnight at 4°C to allow the 
clot to retract.
The universal was centrifuged at 2000 x g for 15 minutes and the 
serum collected and stored in aliquots at -20°C until use. The 
antisera produced were screened for anti-PP14 immunoreactivity by 
assessing the binding of radiolabelled PP14 in an RIA.
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2.16.2 2D-CIE of PP14 preparations
One percent agarose gels in barbitone buffer pH 8.6 (Appendix 
H) were prepared by steaming and allowing the gel to cool to 56°C. 
The agarose gels were cast onto 8cm x 8cm glass plates and placed 
onto the codling plate of an LKB Multiphor electrophoresis bath and 
the samples applied. This procedure avoided the diffusion of the 
sairples into the gel prior to electrophoresis. The PP14 preparations 
were electrophoresed at a constant current of 20mA at 4°C in 0.1M
I
barbitone buffer pH 8.6 for approximately 1.5 hours. Each plate was 
used to run three samples with one sample being mixed with 
bromophenol blue in glycerol to act as a tracker dye. After the 
first electrophoretic dimension, rectangular gel strips which 
contained each of the separated samples were cut from the agarose gel 
(2.5cm x 8cm) and transferred to the cathodic end of a separate clean 
glass plate. Seven millilitres of 1% agarose gel containing 200ul of 
antiserum was cast onto the plate. The sairples were electrophoresed 
at 20mA constant current into the antibody containing gel at 4°C for 
16 - 20 hours.
After electrophoresis the gel was wetted with distilled water 
and covered with one wet and five dry filter papers. A glass plate 
and a weight (1 kg) were placed on top of the filter papers. The 
pressing was repeated twice at three-minute intervals. The gel was 
washed in 0.1 M sodium chloride (2 x 15 min) and the pressing 
repeated twice more.
The plate was placed in staining solution (Appendix II) for 
approximately 10 minutes and, after rinsing with distilled water, was
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placed in destaining solution for approximately 2 hours. The gel was 
dried to a fine film using hot air from a hair dryer and the 
precipitin lines visualised using back illumination from a light box.
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CHAPTER THREE.
RESULTS AND DISCUSSION.
3.1 The Radioimmunoassay of PP14
A typical G25 elution profile for radioiodinated PP14 is shown
125in Fig 3.1. The incorporation of I into purified PP14 was 
typically 60 - 70% of the available isotope with purification of the 
labelled protein on Con-A-Sepharose giving two peaks of activity (Fig 
3.2). The specific activity of the labelled tracer was typically 78 
uCi/ug and its binding to excess antiserum was increased from 
typically 36% before Con-A-Sepharose purification to typically 65% 
after. These results are comparable to those reported by Bolton et 
al. (1983).
A typical standard curve and error profile is shown in Fig 3.3. 
The error profile was derived from duplicate standard curves run 
before and after each batch of samples and from replicate 
determinations of all the unknowns in the assay. The working range 
of each assay was defined as the region of the standard curve which 
exhibited a CV of less than 10%. The intra-assay precision of the 
assay was assessed from the mean of 20 determinations and ranged from 
5 - 1 0 %  Inter-assay variation ranged from 10 - 15%.
3.2 The Standard Curve for Protein
A typical standard curve and error profile for protein 
determinations is shown in Fig 3.4. The working range was derived 
and defined as for the PP14 reference curve detailed above.
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Figure 3.3 A typical standard curve (•) and
error profile (■ ) for the radioimmunoassay 
of PP14.
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3.3 PP14 and Protein Content of Decidual Extracts
The data for nine individual decidual tissue extracts assayed 
for both protein and PP14 content are shown in Table 3.1. PP14 
comprised some 7.1% of the total soluble protein content of the 
extracts which confirmed previous data published by Julkunen et al. 
(1985).
Unless stated, pooled extracts from a number of tissue samples 
were used throughout this study.
3.4 Immunoadsorption of Decidual Tissue Extracts
The treatment of decidual tissue extracts with the anti-PPl4 
immunoadsorbent specifically reduced that protein peak which was 
immunologically indistinguishable from PP14 as assessed by 
two-dimensional crossed immunoelectrophoresis (Plate 3.1). The 
reduction of PP14 content was confirmed by assaying the samples for 
PP14 by radioimmunoassay.
SECTION A
THE EFFECT OF PP14 ON THE RESPONSE OF LYMPHOCYTES TO
ALLOGENEIC STIMULATION
3.5 The Effect of PP14 on the Proliferative Response of Lymphocytes
to Allogeneic Stimulation 
Both purified PP14 and PP14-containing crude decidual tissue
3extracts exhibited a dose dependent inhibition of H-Tdr uptake 
into allogeneically stimulated lymphocytes (Fig 3.5). The inhibitory
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Decidual Extract [PP14] ug/ml [Protein] mg/ml
1 1.92 0.043
2 1.28 0.037
3 2.10 0.047
4 1.05 0.023
5 0.26 0.049
6 0.13 0.024
7 6.65 0.010
8 3.33 0.005
9 1.10 0.016
1.98 + 2.00 0.028 H
Table 3.1 The PP14 and total protein content of 9 individual 
decidual extracts.
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Figure 3.5 The effects of crude decidual extracts (•) and 
purified PP14 (O), related to their PP14 content,3on the uptake of H-Tdr by mixed lymphocyte 
cultures. Results are expressed as means + sd, 
n = 10.
102
activity of the tissue extracts related closely to both their PP14
content as measured by RIA and that observed by purified PP14. There
was no significant difference in the inhibitory activity of decidual
extracts when the cells were cultured in foetal calf supplemented
medium or serum-free medium (Table 3.2). Treatment of the decidual
extract preparations with the monoclonal anti-PP14 immunoadsorbent
3resulted m  a reduction m  the inhibitory effects on H-Tdr 
incorporation (Fig 3.6). The reduction in the suppressive activity 
paralleled the reduction in PP14 content as measured by RIA. The 
data presented in Fig 3.6 suggest that all of the immunosuppressive 
activity of the decidual tissue extracts could be removed by 
treatment with the monoclonal anti-PPl4 immunoadsorbent.
3.6 The Effect of Neuraminidase Treatment on the Inhibitory 
Activity of Purified PP14 
In order to assess whether the high carbohydrate content of PP14 
was necessary for it to exert its suppressive activity, a treatment 
system consisting of neuraminidase linked to a solid phase was 
prepared. Purified PP14 was incubated with the solid phase by 
end-over-end mixing for 3 hours at room temperature. Subsequent to 
this treatment PP14 lost a significant element of its suppressive 
activity (Table 3.3), suggesting that sialo residues may play a part 
in the modulatory activity of the protein. These data need to be 
confirmed by further experimental work as it is possible that the 
apparent inactivation of PP14 may be an artefactual effect of 
impurities such as proteases in the commercial neuraminidase 
preparations.
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[PP14] ug/ml Inhibition of jH-Tdr uptake (%).
4.50 + PCS
4.50 - PCS
Table 3.2 The effect of foetal calf serum supplementation on the 
suppression of the mixed lymphocyte reaction by crude 
decidual extracts. Results are expressed as means + 
sd, n = 9.
69 + 8.0 
67 + 7.0
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Figure 3.6 The effect of treating dilutions of pooled crude decidual extract
with a monoclonal anti-PP14 antibody on its ability to inhibit 
3H-Tdr uptake by mixed lymphocyte cultures. Results are 
expressed as means + sd. (•) unadsorbed; (O) immunoadsorbed.
Inhibition of 3H-Tdr uptake (%).
[PP14] ug/ml + treatment - treatment
8.0 24 +16 51 + 13 **
4.0 20 +18 32 + 13 *
2.0 15 +15 32 + 13 **
1.0 14 +14 21 + 15 ns
** P<0.01; * P<0.05; ns not significant.
(paired Student t test)
Table 3.3 The effect of treatment of purified PP14 with a 
neuraminidase solid phase on the suppression of the 
MLR. Results are means + sd, n = 3.
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Several ciigo- and monosaccharides have been studied for their 
capacity to modulate lymphocyte proliferation in human allogeneic and 
autologous MLR. A defined subset of sugars showed a marked 
inhibitory activity on lymphocyte proliferative responses (Licastro 
et aL, 1987). The inhibitory activity appeared to be effective at 
an early stage of the response, as addition of the sugars after 96 
hours abrogated the inhibitory activity. The data suggested that 
carbohydrate determinants ware involved in the proliferative response 
of lymphocytes in the MLR and may play a role in cell-cell 
recognition during such a response. The possibility that sugars may 
react with soluble mediators or growth factors produced in the MLR 
was excluded with the observation that oligosaccharides did not 
inhibit the response of human lymphocytes to PHA (Muchmore et al., 
1980). The latter observation would appear to eliminate the 
possibility that the activity of PP14 is mediated through the 
carbohydrate moiety, for the mitogenic stimulation at least.
3.7 The Effect of Conditioned Medium* on the Inhibitory Effect of 
PP14
The incorporation of purified PP14 into the MLR resulted in an 
3inhibition of H-Tdr uptake into the stimulated cells. The 
inhibitory activity was partially reversed by the incorporation of 
previously generated MLR supernatant ('conditioned medium1) into the 
assay (Table 3.4). The inhibitory effects of crude decidual extracts 
having a range of PP4 concentrations (2.0 - 10.0 ug/ml) was also 
partially reversed by the addition of conditioned medium (Table 
3.4). These results support a possible level of control at the IL-1 
or IL-2 level of the response.
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Inhibition of 3H-Tdr uptake (%).
- CM + CM
Purified PP14 42 + 12 30 + 12 *
Decidual Extract 58+30 28 + 25 **
* P<0.10, ** P<0.01
(paired Student t test)
Table 3.4 The effect of conditioned medium on the suppression of 
the MLR by purified PP14 and crude decidual extracts 
(PP14 concentrations 2.0 - 10.0 ug/ml). Results are
expressed as means + sd, n = 5. For clarity of
presentation, results are expressed as the means of the 
inhibitions observed at all PP14 concentrations
investigated. Statistical analysis was performed by 
paired Student t test using the data obtained at each 
individual PP14 concentration.
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3.8 The Effect of PP14 on Cell Surface Marker Expression
Low levels of Tac antigen expression were detected on 
unstimulated lymphocytes (5.0% cells staining; Table 3.5). The Tac 
antigen expressed was of low intensity, having a mean channel of 
fluorescence of 20. Incubation with allogeneic cells for 6 days 
increased both the number of Tac+ cells and Tac antigen density. 
Incorporation of both immunoadsorbed and unadsorbed (PP14 
concentrations 2.0 - 8.0 ug/ml) decidual extracts had no significant 
effect on the number of Tac+ cells or antigen density as compared 
to the control (Table 3.5).
Allogeneic stimulation of lymphocytes also increased the number 
of TFR+ cells from 6.0% to 23% with a concomitant increase in 
antigen density (Table 3.6). Incubation of the stimulated cells with 
decidual extract preparations had no significant effect either on the 
number of TFR+ cells nor on the antigen density as compared to the 
control (Table 3.6).
The HLA-DR antigen was detectable on unstimulated cells at low 
levels (8.0%; Table 3.7). The antigen density on unstimulated cells 
appeared to be highly variable. Allogeneic stimulation gave rise to 
an increase in HLA-DR+ cell number. However such expression was 
not significantly affected by incubation of the cells in the presence 
of decidual extract preparations (Table 3.7).
The data presented in Tables 3.5, 3.6 and 3.7 indicate that 
allogeneic stimulation causes an increase in surface expression of
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Tac Antigen Expression
% Cells Mean Channel
Unstimulated 
Stimulated control 
I/A DE 
U/A DE
5 + 4.0 
30 + 7.0 
28 + 3.0 
25 + 6.0
20 + 21 
173 + 64 
154 + 41 
144 + 72
Table 3.5 The effect of immunoadsorbed decidual extract (I/A DE, 
PP14 concentration 0 - 0.10 ug/ml) and unadsorbed
decidual extract (U/A DE, PP14 concentration 2.0 - 8.0 
ug/ml) on the expression of Tac antigen on
allogeneically stimulated lymphocytes. Results are
means + sd, n = 5. The mean channel of fluorescence is 
a measure of the intensity of staining and hence the 
antigen density. Statistical analysis of data obtained 
at individual PP14 concentrations (paired Student t 
test) indicated no significant difference of antigen 
expression in the presence of PP14. For clarity of 
presentation, data are expressed as the means of the 
results obtained at all PP14 concentrations 
investigated.
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Transferrin Receptor (TFR) Expression
% Cells Mean Channel
Unstiraulated 6+2.0 54+74
Stimulated control 23 + 7.0 197 + 130
I/A DE 20 + 3.0 93 + 37
U/A DE 19 +10 81 + 22
Table 3.6 The effect of iimuinoadsorbed decidual extract (I/A DE, 
PP14 concentration 0 - 0.10 ug/ml) and unadsorbed
decidual extract (U/A DE, PP14 concentration 2.0 - 8.0 
ug/ml) on the expression of transferrin receptor (TFR) 
on allogeneically stimulated lymphocytes. Results are 
means + sd, n = 5. The mean channel of fluorescence is 
a measure of the intensity of staining and hence the 
antigen density. Statistical analysis of data obtained 
at individual PP14 concentrations (paired Student t 
test) indicated no significant difference of antigen 
expression in the presence of PP14. For clarity of
presentation, data are expressed as the means of the
results obtained at all PP14 concentrations
investigated.
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HIA-DR Antigen Expression
% Cells Mean Channel
Unstirnulated 
Stimulated control 
I/A DE 
U/A DE
8 + 3.0 
33 + 7.0 
28 + 18 
22 + 13
92 + 106 
114 + 20 
65 + 12 
108 + 51
Table 3.7 The effect of immunoadsorbed decidual extract (I/A DE, 
PP14 concentration 0 - 0.10 ug/ml) and unadsorbed
decidual extract (U/A DE, PP14 concentration 2.0 - 8.0 
ug/ml) on the expression of the HLA-DR antigen on 
allogeneically stimulated lymphocytes. Results are 
means + sd, n = 5. The mean channel of fluorescence is 
a measure of the intensity of staining and hence the 
antigen density. Statistical analysis of data obtained 
at individual PP14 concentrations (paired Student t 
test) indicated no significant difference of antigen 
expression in the presence of PP14. For clarity of 
presentation, data are expressed as the means of the 
results obtained at all PP14 concentrations 
investigated.
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Tac, TFR and HLA-DR antigens. Such stimulation did not give rise to 
the sane degree of expression as did PHA stimulation, however as with 
PHA stimulation, PP14 did not appear to affect such expression. 
These results make unlikely the possibility that PP14 may modulate 
proliferative activity by either modulating activation antigen 
expression or by the masking of such antigens.
SECTION B.
THE EFFECT OF PP14 ON LYMPHOCYTE RESPONSIVENESS TO PHA
3.9 The Response of Peripheral Blood Lymphocytes to PHA
On culturing lymphocytes with varying concentrations of PHA (40
3- 1.25 ug/ml) for 72 hours, maximum incorporation of H-Tdr was 
observed at a final PHA concentration of 2.5 ug/ml (Fig 3.7). When
3cultured with 2.5 ug/ml of PHA, the maximum incorporation of H-Tdr
into the proliferating cells occured after 72 hours (Fig 3.8).
Culturing the lymphocytes in the presence of SFl medium containing
310% foetal calf serum increased the incorporation of H-Tdr into 
unstimulated cells from 877 + 110 cpm to 1876 + 243 cpm. There was
also a decrease in the stimulation index (stimulated cpm/unstimulated
+ + cpm) of the cultures (344 in SFl medium; 154 in SFl medium
supplemented with foetal calf serum). Whilst medium supplementation
with autologous plasma had no effect on the above parameters (data
not shown), serum-free medium was routinely used throughout the
study. Typically the background stimulation of lymphocytes was less
than 2% of the uptake into PHA stimulated cells.
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Figure 3.8 The effect of the culture period on the3incorporation of H-Tdr into PHA 
stimulated lymphocytes. Results are 
expressed as means + sd, n = 3.
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Optimisation was repeated for each preparation of PHA obtained, 
however the parameters remained constant throughout the culture 
period.
3.10 The Effect of PP14 on PHA Induced Lymphoproliferation
Both purified PP14 and PPl4-containing crude decidual extracts
... 3exhibited a dose dependent inhibition of H-Tdr uptake into PHA 
stimulated lymphocytes (Fig 3.9). These data and those obtained 
using the MLR above confirm previous observations on the 
immunomodulatory activity of PP14 on allogeneic ally stimulated 
lymphocytes (Bolton et al., 1986b). On the incorporation of 8 
individual extracts into the assay, there was a significant 
correlation (r=0.96, P<0.001) between the log of the PP14 
concentration and the suppressive activity, but not with the soluble 
protein concentration (Table 3.8). Culturing the cells in the 
presence of either foetal calf serum or autologous plasma had no 
effect on the suppressive activity of the extracts (Table 3.9).
The treatment of the extracts with the monoclonal anti-PPl4 
immunoadsorbent significantly reduced the inhibitory activity (Fig 
3.10). The reduction in the suppressive activity paralleled the 
reduction in the PP14 content as measured by radioimmunoassay and 
confirmed the specificity of the activity. There was no significant 
suppression of the mitogenic response at PP14 concentrations less 
than 1.3 mg/1 (Fig 3.10).
3.11 Time Dependency of the Inhibitory Activity
Decidual extracts were added at timed intervals after the 
initiation of the cultures in order to investigate the level of the
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Figure 3.9 The effect of purified PP14 (#, n = 3) and pooled 
crude decidual extract (O, n = 20, unless stated), 
related to their PP14 content on the incorporation of3H-Tdr into PHA stimulated lymphocytes. Results are3expressed as means + SEM. H-Tdr incorporation into3control cultures = 115223 + 5414 cpm, H-Tdr incorpor­
ation into unstimulated lymphocytes = 1201 + 134 cpm.
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log [PP14] suppression of jp-Tdr log [soluble protein]
ug/ml uptake (%). mg/ml
0.2844 50.7 + 0.6 -1.3617
0.1703 47.9 + 3.1 -1.4365
0.3222 51.7 + 2.9 -1.3298
0.0212 45.4 + 3.4 -1.6308
-0.5918 24.6 + 1.0 -1.3125
-0.8928 1.30 + 1.2 -1.6135
0.8228 64.4 + 4.9 -2.0000
0.5218 49.0 + 8.4 -2.3010
r = 0.96* r = -0.26ns
* P<0.001
Table 3.8 The correlation between log PP14 concentration and log 
soluble protein concentration and the suppression of 
3H-Tdr uptake into PHA stimulated lymphocytes. 
Results are expressed as means + sd, n = 3.
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Suppression of 3H-Thymidine incorporation (%)
SFl Autologous plasma 10% FCS
DE A 50.7 + 0.6 68.8 + CO•o 64.3 + 00.o
DE B 47.9 + 3.1 28.2 + 0.7 36.2 + 1.6
DE C 51.7 + 2.9 34.8 + 0.7 41.6 + 1.3
DE D 45.4 + 3.4 10.4 + 0.9 32.8 + 3.8
DE E 24.6 + 1.0 40.9 + 0.6 55.8 + 1.0
DE F 1.3 + 1.2 18.8 + 0.8 35.2 + 1.5
36.9 + 20.1 33.7 + 20.0 44.3 + 12.
Table 3.9. The effect of medium supplementation (autologous plasma 
or 10% PCS) on the suppression of 3H-Tdr uptake by 6 
individual decidual extracts (PP14 concentrations 0.1 
ug/ml - 5.0 ug/ml). Results are expressed as means +
sd, n = 3.
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suppressive activity. The activity of the extracts was independent 
of the time of addition up to 36 hours (Fig 3.11), with no 
significant inhibitory activity being observed if the tissue extracts 
were added after 48 hours of culture. These results suggest PP14 to 
exert its effect on a level of the immune response occurring early in 
stimulation. Addition after 48 hours of culture may allow 
sufficiently high levels of high affinity IL-2R to be developed to 
allow a normal proliferative response or alternatively allow normal 
levels of IL-1, IL-1R or the IL-1 inducing lymphokine suggested by 
Mizel (1987) to be attained. Addition of decidual extract at the 
time of pulsing the cells (66 hours) had no effect on H-Tdr
incorporation. This discounts the possibility that PP14 merely
. . 3inhibits the uptake of H-Tdr.
When lymphocyte cultures were incubated with PHA for varying
time periods (1, 3, 5 and 7 days) in the presence of immunoadsorbed
3and unadsorbed decidual extracts, maximum suppression of H-Tdr
uptake was observed on day 3 (Fig 3.12), although significant
suppression (P<0.001) could be observed after only 1 day of culture.
... 3Subsequent to day 3, inhibition of H-Tdr uptake was reduced m
3parallel to the reduction of H-Tdr incorporation into the cells of 
the control cultures containing immunoadsorbed decidual extracts (day 
5 115409 + 1982 cpm; day 7 64256 + 969 cpm).
3.12 The Effect of PP14 on Cell-cell Interaction
There are a number of non-specific mechanisms which may lead to 
an apparent immunosuppressive activity.
An important feature in the process of immunologic recognition 
and proliferation is the capacity of lymphocytes to form aggregates.
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stimulated lymphocytes. Results are expressed as means + sd,
This process may mediate the local exchange of immunological 
information such as the secretion of lymphokines. An element of the 
immunomodulatory activity of progesterone appears to be attributable, 
in part, by an interference with cell-cell contact. Crude decidual 
extracts which had been shown to exhibit suppressive activity and 
whose activity was related to the PP14 content did not inhibit 
lymphocyte aggregation induced on activation with PHA as compared to 
control cultures. Representative results are shown in Plate 3.2.
3.13 Non-specific Cellular Effects of PP14
3The suppression of H-Tdr uptake induced by the decidual 
extracts was not due to a non-specific toxic effect on the cultured 
cells as after 5 days of culture under these conditions cell 
viability, as assessed by Trypan Blue dye exclusion, did not 
significantly decrease as compared to the control (Fig 3.13). The 
viability of both resting and stimulated lymphocytes in the presence 
of decidual extracts was 87.5% as compared to 88.5% for the control.
There is the possibility that PP14 may be a non-specific 
inhibitor of cellular growth and proliferation. This was shown not 
to be the case. Incubation of the human T leukaemic cell line K562 
(Lozzio and Lozzio 1975), the choriocarcinoma cell line SW802 and the
myeloid monocytic cell line U937 with decidual extract had no effect
3 .on the incorporation of H-Tdr into the DNA of the proliferating
cells (Table 3.10).
3.14 The Interaction of PP14 with Phytohaemagglutinin
An inhibition of mitogenic responsiveness may be due to an 
interaction of PP14 with the mitogenic lectin. PP14 is known to bind
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Incorporation of 3H-Thymidine (cpm).
Control 
+ DE
Table 3.10
SW 802
15610 + 523 
15140 + 500
U 937
18180 + 1562 
21378 + 2274
K 562
31752 + 550 
29949 + 4999
The effect of crude decidual extracts on the 
incorporation of 3H-Tdr into the DNA of three 
different cell lines. Results are expressed as means + 
sd, n = 5.
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to concanavalin A and binding to PHA may be the primary mediator of 
the modulatory activity.
The binding of radiolabelled PP14 to solid phase linked PHA was 
higher than its binding to either the BSA linked solid phase or the 
control sdLid phase. The observed binding to the PHA solid phase was 
also higher than the binding of radiolabelled CA III which was used 
as a non-specific control (Table 3.11). The binding of PP14 to PHA 
was 5.0% higher than its binding to control solid phases and the 
binding of radioiodinated CA in, which has no carbohydrate content. 
Such a low level of Interaction would not be expected to account for 
the inhibitory activity of the protein.
The suppressive activity of decidual tissue extracts was not 
dependent on the PHA concentration (Fig 3.14). This would appear to 
eliminate the possibility that PP14 exerts its immunosuppressive 
activity by the formation of an inactive complex with PHA thereby 
making it unavailable for cell transformation. If there is binding 
of PHA by PP14, then it is likely that a depression of lymphocyte 
reactivity could be overcome by increasing concentrations of PHA. 
However, as seen in Fig 3.14, the inhibition of lymphocyte reactivity 
could not be removed by an elevation in PHA concentrations even up to 
16 times the optimal.
3.15 The Effect of PP14 at the IL-2 Level of the Immune Response
Incorporation of 6 individual extracts (PP14 concentrations 1.6 
- 20 ug/ml) into the mitogenic stimulation assay inhibited the uptake
3of H-Tdr into PHA-stimulated lymphocytes (40 + 14% inhibition, 
P<0.001) as compared to the control. The observed inhibition was
128
Binding of Radiolabelled Protein (%).
125I-PP14
125i-CAIII
Table 3.11
PHA solid BSA solid control solid 
phase phase phase
6% 1% 1%
2% 1% 1%
The binding of radiolabelled proteins (PP14 and CAIII) 
to PHA, BSA and control solid phases. Results are 
expressed as the percentage of the total activity. 
Total activity for PP14 6215 + 128 cptn; total activity 
for CAIII 11769 + 222 cpm.
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Figure 3.14 The effect of PHA concentration on the inhibition3of H-Tdr uptake into stimulated lymphocytes by 
crude decidual extracts (PP14 concentration
9.0 ug/ml). Results are expressed as means + sd, 
n = 3.
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significantly reduced (P<0.002, paired Student t test) by the 
addition of 2.5 units/ml recombinant IL-2 (21 + 13% inhibition, 
P<0.002; Table 3.12). These data suggest an involvement of PP14 at 
the IL-2 level of the immune response.
The proliferative response of PHA blasts to recombinant IL-2 
(rIL-2, 2.5 U/ml) was minimally suppressed by PP14. However the same 
concentrations of PP14 inhibited the proliferation of the blasts to 
PHA (Fig 3.15). These results suggest that PP14 does not mediate its 
suppressive activity by blocking the binding of IL-2 to the IL-2R.
A typical standard curve for IL-2 determinations is shown in Fig 
3.16. The minimum detectable level of IL-2 by this test has been 
shown to be 0.05 U/ml. Detectable levels of IL-2 (0.25 U/ml) were 
observed after 18 hours of PHA stimulation (Fig 3.17). The maximum 
level of IL-2 detectable in the culture supernatants of PHA 
stimulated lymphocytes occured after around 66 hours of incubation 
(Fig 3.17). Unadsorbed decidual extract inhibited IL-2 production 
throughout the culture period investigated (0 to 90 hours) as 
compared to immunoadsorbed extract as control (Fig 3.18), with the 
suppressive activity being dose-dependent over the range of PP14 
concentrations investigated (Fig 3.19). Maximum inhibition occured 
after 66 hours which coincided with maximum IL-2 levels (Fig 3.20). 
Such data support the observations that exogenous IL-2 was able to 
partially reverse the suppressive activity of decidual tissue 
extracts. It may be that there is a threshold of IL-2 concentration 
above which normal proliferation occurs. Addition of the extract
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Inhibition of ^ H-Thymidine uptake (%)
without IL-2 with IL-2
DE A 31.0 + 1.0 15.0 + 1.8
DE B 46.0 + 1.7 18.0 + 0.9
DE C 48.0 + 7.3 36.0 + 5.7
DE D 20.0 + 3.2 0
DE E 35.0 + 9.5 25.0 + 3.1
DE F 58.0 + 14.5 33.0 + 3.6
Mean 40.0 + 14.0 21.0 + 13.2*
* P<0.002 (paired Student t test)
Table 3.12 The effect of exogenous rIL-2 (2.5 U/ml) on the 
inhibition of 3H-Tdr uptake into PHA stimulated
lymphocytes by 6 individual decidual tissue extracts 
(PP14 concentrations 1.6 ug/ml - 20.0 ug/ml). Results 
are expressed as means + sd.
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Figure 3.15 The effect of PP14 on the incorporation 
of ^H-Tdr into ’PHA blasts’ stimulated 
with either 2.5 units/ml of rIL-2 (0) 
or 2.5 ug/ml PHA (•). Results are 
expressed as means + sd. n = 3.
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Figure 3.16 A typical standard curve for 
interleukin-2 determinations.
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Figure 3.17 The release of IL-2 from unstimulated (O ) and PHA
stimulated lymphocytes (#•). Results are expressed as 
means + sd, n = 3.
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lymphocytes by unadsorbed decidual extracts (PP14 concentration 
8.0 ug/ml) as compared to the control (immunoadsorbed decidual 
extract, PP14 concentration 1.0 ug/ml). Results are means of 
duplicate experiments which were concordant in their interpretation.
after 36 hours may allow such a threshold to be attained and may 
explain the observed lack of suppression following the delayed 
addition of decidual tissue extract.
3.16 The Effect of PP14 at the IL-2R Level of the Immune Response
Peak Tac antigen expression on PHA stimulated lymphocytes 
occured after 72 hours. The peak expression was preceded at 48 hours 
by the maximum mean channel of fluorescence (peak antigen density) 
(Fig 3.21). The number of cells expressing Tac antigen declined 
after 72 hours and reached a plateau towards the end of the culture 
period investigated (10 days). Tac antigen density decreased after 
48 hours and continued to fall for the remainder of the culture 
period (Fig 3.21). Immunoadsorbed and unadsorbed decidual extract 
had no effect either on the number of cells expressing the Tac 
antigen (Fig 3.22) nor on Tac antigen density (Fig 3.23) over the 
culture period.
The observation of an apparent suppression of IL-2 levels, yet a
normal expression of Tac antigen is not consistent with the
observations of Diamantstein and Chen (1982), who postulated that the
induction of IL-2R required two signals, one from the activating
factor (antigen or mitogen) and a second from IL-2 itself. It may be
that the suppression of IL-2 levels may not be sufficient to elicit
control on IL-2R expression. Different signalling requirements exist
for the induction of the IL-2R and IL-2 genes (Isakov and Altman
1985), with the genes controlling IL-2 and IL-2R expression having
2 +different intracellular [Ca ] requirements for their maximal 
expression (Chopra et al., 1987). In addition, protein kinase C
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Figure 3.21 The kinetics of Tac antigen expression (O ) and
antigen density (•) on PHA stimulated lymphocytes. 
Data are summarised from control data presented in 
Figs 3.22 and 3.23.
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Figure 3.22 The effect of unadsorbed ( A , PP14 concentration
2.0 - 8.0 ug/ml) and immunoadsorbed (•, PP14
concentration 0-0.1 ug/ml) decidual extract on
✓the expression of the Tac antigen on PHA stimulated 
lymphocytes as compared to the control (O ). Results 
are expressed as means + sd> n=5.
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Figure 3.23 The ^effect of unadsorbed (A , PP14 concentration
2.0 - 8.0 ug/ml) and immunoadsorbed (• , PP14 
concentration 0 - Oil ug/ml) decidual extract on 
Tac antigen density on PHA stimulated lymphocytes 
as compared to the control (O ). Results are 
expressed as means + sd , n = 5.
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activation is a sufficient signal for IL-2R expression, but not for 
IL-2 secretion. Such observations may explain the apparent 
paradoxical results obtained here.
A typical standard curve for soluble interleukin-2 receptor 
(sIL-2R) is shown in Fig 3.24. The detection limit of the 
interleukin-2 receptor test kit is approximately 50 U/ml IL-2R. 
Maximum levels of sIL-2R from PHA stimulated lymphocytes were 
observed after around 40 hours of culture, with the levels remaining 
constant for the remainder of the culture period. Peak sIL-2R levels 
preceded peak IL-2 levels by around 24 hours (Fig 3.25). Soluble 
IL-2R vere not detectable in the culture supernatants of unstimulated 
cells at any time during the culture period.
There was a small, but significant (P<0.001, Student paired t 
test) inhibition of SIL-2R levels by unadsorbed decidual extract as 
compared to immunoadsorbed extract over the whole culture period, 
with the observed inhibition of sIL-2R levels decreasing towards the 
end of the culture period (Fig 3.26).
Whether this observation reflects the general decrease in 
proliferative activity caused by PP14 or whether it is a more 
specific marker of an effect at the IL-2R level of the response is 
uncertain. Certainly binding of IL-2 to the 75 kDa protein of the 
IL-2R on stimulated lymphocytes has been reported to mediate rapid 
internalisation of membrane bound IL-2 and the possible release of 
IL-2R into the culture supernatant (Robb and Greene 1987). Reduced 
sIL-2R levels may indicate a control at this level.
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3.17 Cell-surface Associated IL-2 and the Effect of PP14
PHA stimulated lymphocytes incubated in the presence/absence of 
decidual extract for 72 hours were analysed by flow cytometry for 
cell-surface associated IL-2 using anti-IL-2 monoclonal antibody. 
The presence of cell surface IL-2 possibly reflects the degree of 
internalisation of IL-2 once bound to its surface receptor. 
A low number (7.0%) of unstimulated cells were observed to be
•J- -f"IL-2 . Stimulation of cells by PHA increased the number of IL-2 
cells to 13% (Table 3.13). Incubation of the stimulated cells with 
unadsorbed decidual extract (PP14 concentration 5.0 ug/ml) increased 
the number of IL-2+ cells (32.0%, P<0.001, paired Student t test) 
as compared to both the stimulated control cells and cells incubated 
with immunoadsorbed decidual extract (20%; PP14 concentration 0.10 
ug/ml, Table 3.13). There was no difference in cell surface 
associated IL-2 density observed between unstimulated, stimulated and 
decidual extract containing cultures (Table 3.13).
The increase in cell surface associated IL-2 in the presence of 
PP14 may confirm the data obtained on the assay of cell culture 
supernatants for SIL-2R. The lower number of IL-2+ cells observed 
in stimulated control cultures as compared to PP14 containing 
cultures may reflect differing degrees of internalisation of IL-2 
once bound to its cell surface receptor. The internalisation of IL-2 
once bound to the Tac antigen of the IL-2 receptor is negligible 
(Robb and Smith 1987). These data suggest that PP14 may alter the 
relative numbers of the IL-2R 75 kDa and Tac antigen chains and 
influence the IL-2R affinity on PHA stimulated lymphocytes.
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Cell-Surface Associated IL-2
% Cells Mean Channel
Unstiimilated 7 + 3.0
Stimulated control 13 + 3.0
I/A DE 20 + 13
U/A DE 32 + 13*
* P<0.001 (paired Student t test)
63 + 12 
62 + 27 
74 + 35 
70 + 42
Table 3.13 The effect of immunoadsorbed decidual extract (I/A DE, 
PP14 concentration 0.1 ug/ml), and unadsorbed decidual 
extract (U/A DE, PP14 concentrations 5.0 ug/ml) on the 
expression of cell-surface associated IL-2 on PHA 
stimulated lymphocytes. Results are means + sd, n = 5.
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3.18 The Effect of PP14 on High Affinity IL-2R Expression
Avidity is defined as the energy of binding of an antibody for 
its antigen and is denoted by K. K is numerically equal to the 
energy of binding of antigen for its antibody. The term avidity 
refers to the properties of an antibody, and affinity to those of the 
antigen. An antibody-antigen reaction is reversible and obeys the 
Law of Mass Action
Ag + Ab AgAb 
at equilibrium K= = [AgAb]
k2 [Ag] [Ab]
The avidity of an antiserum may be measured in a number of ways, but 
is usually determined by means of a Scatchard plot (S catch ard 1949). 
For the Scatchard plot, the above equation was rearranged
B = n - B.K"1 
F
where B = concentration of bound ligand or bound antibody
F = concentration of free ligand
n = total concentration of binding sites present
If the ratio of bound to free ligand is plotted against the
concentration of bound ligand, the slope is -K which has the 
dimensions of litres/mole and reflects the affinity of the binding of 
the ligand to its receptor (Scatchard 1949). The intercept on the
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abscissa gives the total number of binding sites present. The
Scatchard plot obtained may consist of a single straight line
indicating that the cells are expressing entirely high affinity
receptors for IL-2. The Scatchard plot may be composed of two
straight lines which intersect at an angle. The one with the steeper
slope relates to the presence of higher avidity binding sites, whilst
the one with the shallower slope represents binding sites of
apparently lower avidity.
Scatchard analysis is able to determine the affinity of the cell
surface receptors for the ligand, and also the concentration of the
binding sites (receptors) present. Scatchard analysis of the
equilibrium binding data for lymphocytes stimulated in the presence
of unadsorbed and immunoadsorbed decidual extracts and control
cultures are shown in Fig 3.27. The specific radioactivity of the 
125I-IL-2 (600 Ci/mMol) was used to convert the slopes of the lines 
into values of the dissociation constant (Kd). For all three 
cultures the Scatchard plots were composed of two straight lines 
indicating a mixed population of affinities of receptors, the data is 
summarised in Table 3.14. Incubation of lymphocytes in the presence 
of unadsorbed decidual tissue extract caused a reduction in the
affinity of the higher affinity population of receptors from 1.4 x
-14 -1410 M for the control (Fig 3.27 A) to 3.2 x 10 M for
cultures containing unadsorbed decidual extract (Fig 3.27 C).
Stimulated lymphocytes incubated with immunoadsorbed extract
displayed IL-2 receptors with an affinity comparable to that of the
-14control cultures (1.4 x 10 M, Fig 3.27 B). Conversion of the 
intercept of the abscissa into the total number of binding sites
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Dissociation constant (Kd) 
(x 10-14 M)
Binding sites 
(x 10-3 pM)
Higher affinity 
receptors
Lower affinity 
receptors
Higher affinity 
receptors
Unstim 4.0
Stim control 1.4
I/A DE 
U/A DE
1.4
3.2
42.0
28.0 
22.0
6.0
1.3
5.4 
8.0
10.0
Table 3.14 The effect of immunoadsorbed decidual extract (I/A DE, 
PP14 concentration 1.0 ug/ml) and unadsorbed decidual 
extract (U/A DE, PP14 concentration 18.0 ug/ml) on the 
affinity and the total concentration of binding sites 
present on PHA stimulated lymphocytes. Representative 
results frcm 3 analyses.
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lymphocytes pre-stimulated with PHA alone (A) and in the presence of 
immunoadsorbed (B, PP14 concentration 1.0 ug/ml) and unadsorbed (C, 
PP14 concentration 18.0 ug/ml) decidual extract, n = 3.
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cell cycle following stimulation with PH A. The percentage of cells in S 
phase was obtained by computer fit analyses of the DNA distribution curves.
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lymphocytes pre-stimulated with PH A alone (A) and in the presence of 
immunoadsorbed (B, PP14 concentration 1.0 ug/ml) and unadsorbed (C, 
PP14 concentration 18.0 ug/ml) decidual extract, n = 3.
present indicated that there were a greater number of the higher
affinity receptors on cells incubated with unadsorbed extract (10.0 x
—3 “310 pM, Fig 3.27 C) as compared to the control (5.4 x 10 pM,
Fig 4.27 A) or cultures containing immunoadsorbed extract (8.0 x
_310 pM, Fig 3.27 B). The affinity of the lower affinity receptors
was greater on the cells incubated in the presence of unadsorbed
-14decidual extract (6 x 10 M) as compared to the control (28 x 
-1410 M) and cultures containing immunoadsorbed extract (22 x
-1410 M). An accurate determination of the number of the lower
affinity receptors was not possible, however they formed the majority 
of the surface receptors detectable. Unstimulated cells also
exhibited a dual population of receptors having affinities of 4.0 x
-14 -1410 M and 42 x 10 M. The higher affinity receptor was
_3expressed at 1.3 x 10 pM (Table 3.14).
Such observations indicate that PP14 may elicit a suppressive
activity by a modulation of the affinity, and hence biological
activity, of the IL-2R.
The affinities of the IL-2R reported here are somewhat higher
than those reported by Teshigawara et al., (1987) who reported that
the cell line designated YT exhibited high affinity IL-2R binding
-11with a Kd of around 10 M. Robb et al., (1985) have reported the
-12high affinity IL-2R on human PH A blasts to have a Kd of 4.1 x 10
M and IL-2R on the human cell line HUT 102B2 to have a Kd of 4.3 x
-12 10 M.
The reasons for the differing Kd values obtained are unknown. 
One explanation could be the differing experimental conditions 
utilised. Alternatively, the difference may be due to the different
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preparations of IL-2 used in the studies. Robb et al., (1985) used 
radioiodinated immunoaffinity purified JURKAT cell line derived IL-2
for the binding studies, whereas Teshigawara et al., (19 87) used
125radioiodinated homogeneous recombinant IL-2. The I-IL-2 used m  
this study was obtained as the ala-125 analogue from Amersham 
International. This analogue contains an extra methionine residue at 
the N-terminus of the natural sequence which has no reported effect 
on the biological activity of the molecule (specification sheet). In 
addition the cysteine at position 125 has been substituted for by 
alanine which has resulted in a five-fold increase in the specific 
activity and a significant improvement in the stability of the 
molecule. This observation is supported by data suggesting that the 
region of the IL-2 molecule close to positions 58 and 125 may be 
important for the functional activity of IL-2 as the deletion of 
cysteine 125 or of amino acids in the vicinity removes nearly all of 
the biological activity (Liang et al., 1986). It may be that the 
substitution of cysteine 125 for alanine alters the binding 
characteristics of the IL-2 to the IL-2 receptor.
3.19 The Effect of PP14 on the Expression of Functional IL-2 
Receptors
The presence of functional IL-2R (i.e receptors capable of 
eliciting a proliferative response to IL-2) on PHA stimulated 
lymphocytes was studied by producing IL-2 dose-response curves. 
Lymphocytes were stimulated in the presence or absence of PP14 for 72 
hours and their sensitivity to subsequent stimulation by IL-2 
assessed by culturing the cells for a further 72 hours in the 
presence of different concentrations of IL-2.
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The dose-response curves for unstimulated, stimulated and test 
cultures were generated with different numbers of responding cells as 
detailed earlier (section 2.11). Representative results obtained in 
three independent analyses are displayed in Fig 3.28.
The cell numbers at which the dose-response curves ceased to 
shift (transition points: unstimulated cells 5 x 10^ cells/well
4[Fig 3.28A]? stimulated control 1.25 x 10 cells/well [Fig 3.2 8B];
4culture containing immunoadsorbed extract 1.25 x 10 cells/well
4[Fig 3.28D]; culture containing unadsorbed extract 2.4 x 10 
cells/well [Fig 3.28Cj) reflect the fact that all the activated cells 
expressed more high affinity receptors than did unstimulated cells. 
Cells incubated in the presence of unadsorbed decidual extract 
expressed a lower responsiveness as compared to the control with 
immunoadsorption of the extract removing such inhibitory activity.
The apparent difference in sensitivity to IL-2 between cells 
from control cultures and cells from unadsorbed decidual 
extract-containing cultures may reflect different affinities of the 
IL-2R present on the stimulated cells. These results confirm the 
earlier data obtained following Scatchard analysis and again suggest 
that PP14 may exert its immunoregulatory activity by affecting the 
affinity of the IL-2R present on stimulated lymphocytes.
3.20 The Effect of PP14 on gamma Interferon (gamma IFN) Production 
from PHA Stimulated Lymphocytes 
A typical standard curve and error profile for gamma IFN 
determinations is shown in Fig 3.29. The minimum detection limit of 
the assay was reported in the manufacturer's specifications as less
155
% 
of 
ma
xim
al 
res
pon
se 
0//° 
°f 
mQ
xiro
al 
res
po
ns
e
50-
25-
50 402010to 200603
IL-2 concentration (units/ml)
75-
50-
25-
40201-0 50 1020
IL-2 concentration (units/ml)
Figure 3.28 A,B Representative data for IL-2 dose-response 
curves for unstimulated (A) and PH A pre­
stimulated (B) lymphocytes. The number of 
cells per well was 1 x 10^  (O), 5 x 104 (•), 
2.5 x 104 (Q), 1.25 x 104 (■) and 0.625 x 104 
( A ), n = 3.
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Figure 3.28 C,D Representative data for IL-2 dose-response curves 
for cells stimulated in the presence of unadsorbed 
(C, PP14 concentration 18.0 ug/ml) and immunoadsorbed
(D, PP14 concentration 1.0 ug/ml) decidual extract.5 4The number of cells per well was 1 x 1 0  (O), 5 x 1 0
(•), 2.5 x 104 (d), 1.25 x 104 (■) and 0.625 x 104
(A ), n = 3.
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Figure 3.29 A typical standard curve ( •) and 
error profile (■ ) for the IRMA of 
gamma IFN.
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than 1.0 U/ml of gamma interferon. The minimum detection limit 
observed in this study was 0.5 U/mL The working range of the assay 
was calculated to be 5.48 - 1024 U/ml. Detectable levels of gamma 
IFN (45 U/ml) were observed after 18 hours of PHA stimulation, with 
levels continuing to rise throughout the culture period investigated 
(0 - 90 hours, Fig 3.30). Gamma IFN was not detected in the 
supernatants of unstimulated cells at any time during the culture 
period investigated. Unadsorbed decidual extract inhibited gamma IFN 
production in the early stages of stimulation as compared to the 
immunoadsorbed extract control (0 - 42 hours), however no suppression 
was observed after 42 hours of stimulation (Fig 3.31).
IL-2 has been reported to cause the secretion of gamma 
interferon (Miedema et aL, 1985). The observed suppression of IL-2 
levels by PP14 are also partially reflected in an inhibition of gamma 
IFN level in culture supernatants of stimulated lymphocytes though 
the suppression of the gamma IFN levels are only observed at early 
stages of the culture period. This may be due to a threshold level 
of IL-2 being produced in the presence of PP14 , despite the fact 
that IL-2 levels are suppressed relative to the control. 
Alternatively there may be a pathway of IFN production which is 
distinct from an IL-2 dependency.
Exposure to IL-1 induces T cells to produce a number of 
lymphokines including gamma IFN and it may be that other factors 
produced during the mitogenic response may replace or substitute for 
IL-2 dependent gamma IFN production. Leukotrienes and cyclic GMP can 
substitute for IL-2 action to induce gamma IFN production (Johnson et 
aL, 1985) and a number of laboratories have reported that various
159
[gam
ma 
IFN
] 
(U
/m
l)
1000!
500-
100-
50-
i 1 »~ ■ i . ■ » — i —1 ■" i »10 30 50 70 90
Time (hours)
Figure 3.30 The kinetic analysis of the release of gamma IFN in 
the culture supernatants of PHA stimulated 
lymphocytes, results are means of duplicate experiments 
which were concordant in their interpretation.
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Figure 3.31 The suppression of gamma IFN production from PHA 
stimulated lymphocytes by unadsorbed decidual 
extract (PP14 concentration 8.0 ug/ml) as compared 
to the control (immunoadsorbed decidual extract, PP14 
concentration 1.0 ug/ml), results are means of duplicate 
experiments which were concordant in their interpretation.
mitogens increase the levels of cyclic GMP in lymphocytes. PHA 
activates both membrane and soluble forms of lymphocyte guanylate 
cyclase from intact stimulated lymphocytes (Coffey et al., 1981) and 
it may be that this mechanism of gamma IFN induction leads to an 
apparently normal level of IFN in the presence of suppressed levels 
of IL-2.
3.21 The Effect of PP14 on Cell Surface Marker Expression.
The maximum number of cells expressing the transferrin receptor 
(TFR) on stimulation with PHA occurred after 3 days of incubation. 
The levels fell slightly after 4 days and maintained the reduced 
level for the period of culture investigated (Fig 3.32). The peak 
TFR density on the stimulated cells coincided with the peak number of 
cells expressing the antigen (3 days), with the levels falling 
towards the end of the culture period (Fig 3.32). Detectable levels 
of TFR occurred after 24 hours of culture which was the earliest time 
point investigated (Fig 3.32). The presence of unadsorbed or 
immunoadsorbed decidual extract had no effect on either the number of 
cells expressing the TFR (Fig 3.33) nor on the density of the 
receptor expression (Fig 3.34) as compared to the control.
Expression of the transferrin receptor (TFR), which is essential 
for the stimulated cells to enter the S phase of cell division, is 
unaffected by PP14. RNA production for the TFR has been shown to be 
increased by IL-2 which suggests a similar situation to that observed 
for the expression of the Tac antigen (section 3.16), where despite a 
lower level of IL-2 normal transferrin receptor expression is 
observed. An alternative mechanism for TFR expression may be present
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Figure 3.32 The kinetics of transferrin receptor (TFR) 
expression (O ) and TFR density ( •) on 
PHA stimulated lymphocytes. Data are summarised 
from control data presented in Figs 3.33 and 3.34.
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Figure 3.33 The effect of unadsorbed (A , PP14 concentration
2.0 - 8.0 ug/ml) and immunoadsorbed (• , PP14 
concentration 0-0.1 ug/ml) decidual extract on 
expression of the transferrin receptor on PHA 
stimulated lymphocytes, as compared to the control 
(O). Results are expressed as means + sd , n=5.
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Figure 3.34 The effect of unadsorbed (A ,PP14 concentration 
2.0 - 8.0 ug/ml) and immunoadsorbed (■•*, PP14 
concentration 0-0.1 ug/ml) decidual extract 
on the transferrin receptor density on PHA 
stimulated lymphocytes, as compared to the control 
(O ). Results are expressed as mean + sd, n=5.
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or possibly a threshold has been attained. The normal expression of 
the TFR has, in part, been confirmed by DNA cell cycle analysis which 
indicated no difference in cell cycle distribution in the presence of 
PP14 as compared to the control.
Detectable levels of HLA-DR antigen were observed after only 24 
hours of culture with PHA with the number of HLA-DR cells peaking 
initially at 48 hours. The levels declined thereafter and rose after 
4 days and continued to rise towards the end of the culture period
(Fig 3.35). There was a decrease in antigen density which coincided
• "I" •with the initial peak in the number of HLA-DR cells. Antigen
density peaked at 72 hours and declined thereafter towards the end of
the culture period (Fig 3.35). The presence of unadsorbed or
immunoadsorbed decidual extract had no effect on either the number of
HLA-DR+ cells (Fig 3.36) nor on HLA-DR antigen density (Fig 3.37)
over the culture period investigated.
Gamma IFN has been shown to be implicated in the expression of 
HLA-DR antigens on cell surfaces (Nicholas et al., 1986). It is 
therefore somewhat surprising that PP14 had no apparent effect on the 
expression of HLA-DR on stimulated cells when the protein did appear 
to inhibit gamma IFN secretion during the early stages of the 
mitogenic response. It may be that the initial rise in HLA-DR 
expression is a direct result of PHA activation and independent of 
gamma IFN. Normal levels of IFN during the later stages of the 
culture would not be expected to affect HLA-DR expression.
The kinetic analysis of HLA-DR expression following mitogenic 
stimulation somewhat differs from that reported by Konttinen et al., 
(1986) where a maximum HLA-DR expression was observed after 1 day of
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and antigen density (• ) on PHA stimulated 
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Figure 3.36 The effect of unadsorbed (A , PP14 concentration
2.0 - 8.0 ug/ml) and immunoadsorbed (#, PP14 
concentration 0-0.1 ug/ml) decidual extract on 
the expression of HLA-DR on PHA stimulated 
lymphocytes, as compared to the control (O). 
Results are expressed as means + sd, n=5.
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Figure 3.37 The effect of unadsorbed (A , PP14 concentration 
2.0 - 8.0 ug/ml) and immunoadsorbed (• , PP14 
concentration 0-0.1 ug/ml) decidual extract on 
HLA-DR antigen density on PHA stimulated lymphocytes, 
as compared to the control ( O ). Results are 
expressed as means + sd, n=5.
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culture with the expression becoming insignificantly different from 
unstimulated control expression after 3 days of culture. In that 
study the culture period investigated was 5 days which, from the 
results obtained here, would not detect the secondary rise in HLA-DR 
observed after 4 - 5  days.
3.22 Cell-surface Associated PP14
PHA stimulated lymphocytes incubated in the presence of decidual 
extract v^re analysed by flow cytometry for cell-surface associated 
PP14 using monoclonal anti-PPl4 antibody. After 72 hours of culture 
unstimulated control ceLls incubated in the absence of PP14 showed 
low levels of anti-PP14 immunoreactivity (2.5% of the cells staining) 
and also a low antigen density as determined by the mean channel of 
fluorescence (Table 3.15). Stimulated control cells showed an 
elevated level of reactivity to the monoclonal antibody (10% cells 
staining), however the staining was again of low intensity. The 
apparent increase in binding to stimulated cells could be accounted 
for, in part, by an observed increase in the non-specific binding of 
the FITC-conjugate. There was no observed difference in either the 
number or intensity of PP14+ cells for cultures stimulated in 
either the absence of decidual extract or in the presence of 
unadsorbed (PP14 concentrations 2.0 - 8.0 ug/ml) or immunoadsorbed 
decidual tissue extracts (Table 3.15). This observation indicates 
that PP14 does not appear to exert its modulatory activity by binding 
to the surface of proliferating lymphocytes. These results do not 
exclude the possibility that the binding of PP14 to lymphocytes may 
mask the epitope recognised by the monoclonal antibody and thus give 
a false negative result.
170
Cell-Surface Associated PP14
% Cells Mean Channel
Unstimulated 3+4.0 6.0+7.0
Stimulated control 10 + 5.0 21 + 2.0
I/A DE 10 + 2.0 23 + 14
U/A DE 11 + 6.0 32 + 15
Table 3.15 The effect of immunoadsorbed decidual extract (I/A DE, 
PP14 concentration 0.10 ug/ml) and unadsorbed decidual 
extract (U/A DE, PP14 concentration 5.0 ug/ml) on the 
expression of cell-surface associated PP14 on PHA 
stimulated lymphocytes. Results are means + sd, n = 5.
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3.23 The Effect of PP14 on CD2 (Til) Antigen Expression
It has been reported that the blocking of the sheep red blood
cell receptor (CD2, Til) on T lymphocytes abolished PHA stimulated 
2+Ca fluxes (OfFlynn et al., 1985). Such an observation suggests 
that the mitogenic activity of PHA may in part be mediated via its 
binding to the CD2 molecule. Any molecule which binds to, or masks, 
such a receptor may modulate the cellular response to PHA. To 
investigate the possibility that PP14 may mask the CD 2 molecule, 
cultured lymphocytes were analysed by flow cytometry using monoclonal 
anti CD2 antibodies.
Following 72 hours of mitogenic stimulation 98% of the cells 
were observed to be CD2 as compared to 89% of the unstimulated 
cells (Table 3.16). Antigen density also increased on stimulation 
with unstimulated cells having a mean channel of fluorescence of 157 
as compared to 700 for stimulated cells. Incubation of stimulated 
cells with decidual extracts (both immunoadsorbed and unadsorbed) had 
no effect on the number of CD2 cells (Table 3.16). This makes 
unlikely the possibility that PP14 exerts its modulatory activity by 
binding and masking the CD2 receptor for PHA.
This observation was partially supported by the inability to 
demonstrate cell surface associated PP14 subsequent to incubation 
with decidual extract. However as stated earlier, binding of PP14 to 
the cell surface may mask the epitope recognised by the monoclonal 
antibody. Further investigations using monoclonal antibodies of 
differing specificities are required to confirm these data. Binding 
of PP14 to the CD2 antigen would not be expected to elicit a 
suppressive effect on the proliferative response to allogeneic 
stimulation.
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CD2 Antigen Expression
% Cells Mean Channel
Unstimulated 89 + 0.6 157 + 31
Stimulated control 98 + 3.0 700 + 338
I/A DE 98 + 4.0 650 + 574
U/A DE 96 + 6.0 656 + 204
Table 3.16 The effect of immunoadsorbed decidual extract (I/A DE, 
PP14 concentration 0 - 0.10 ug/ml) and unadsorbed
decidual extract (U/A DE, PP14 concentration 2.0 - 8.0 
ug/ml) on the expression of the CD2 antigen on PHA 
stimulated lymphocytes. Results are means + sd, n = 5.
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3.24 The Influence of PP14 on T Cell Subset Distribution
Flow cytometry was used to assess the effect of PP14 on T cell
subset distribution. Stimulation of lymphocytes with PHA caused a
+ +slight increase m  CD4 and CD8 cell numbers whilst having no
effect on antigen density (Table 3.17). Incubation of cells with
both immunoadsorbed and unadsorbed decidual extract had no
+ +significant effect on either CD4 and CD8 cell numbers nor on 
CD4 and CD8 antigen density (Table 3.17). From Table 3.17 the total 
number of cells expressing the CD4 and CD8 antigens following 
mitogenic stimulation by PHA appeared to be over 100%, suggesting 
that the antibody used may cross react with other antigenic 
determinants on the cells present. The Leu 3a antibody used in this 
study has been shown to cross react with monocytes (J. Lawry, 
personal communication) which may explain the results obtained. An 
alternative possibility is that the stimulation of peripheral blood 
lymphocytes by PHA causes the cells to de-differentiate leading to 
co-expression of the CD4 and CD8 antigens. Such co-expression has 
been observed on actively proliferating leukaemic cells (J. Lawry, 
personal communication). Further work using double staining and 
double fluorescence studies would clarify the situation. The CD4/CD8 
ratio of unstimulated cells (1.10, Table 3.18) was comparable to the 
quoted normal range of 1.65 + 0.5 (Macey 1988). Stimulation of the 
cells by PHA reduced the ratio indicating a shift in the population 
distribution towards the CD8+ subset (cytotoxic/suppressor). 
Incorporation of decidual extract into the cultures had no effect on 
the CD4/CD8 ratio nor on the ratio of the antigen density (Table 
3.18). The increase in the relative proportions of lymphocytes
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034 and CD8 Antigen Expression
Unstiimilated 
Stimulated 
I/A DE 
U/A DE
Table 3.17
% Cells Mean Channel.
CD4 CD8 CD4 CD8
44 + 2.0 40 + 2.0 160 + 55 413 + 250
48 + 8.0 57 + 14 162 + 42 389 + 370
54 + 7.0 71 + 11 129 + 25 248 + 46
58 + 3.0 77 + 4.0 148 + 16 201 + 100
The effect of irrmunoadsorbed decidual extract (I/A DE, 
PP14 concentration 0 - 0.10 ug/ml) and unadsorbed
decidual extract (U/A DE, PP14 concentration 2.0 - 8.0 
ug/ml) on the expression of CD4 and CD8 antigens on PHA 
stimulated lymphocytes. Results are means + sd, n = 5.
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CD4/CD8 Ratio.
% cells Mean Channel
Unstirnulated 1.10 + 0.05 0.45 + 0.20
Stimulated control 0.85 + 0.10 0.73 + 0.50
I/A DE 0.78 + 0.10 0.50 + 0.20
U/A DE 0.77 + 0.10 1.00 + 0.70
Table 3.18 The effect of immunoadsorbed decidual extract (I/A DE, 
PP14 concentration 0 - 0.1 ug/ml) and unadsorbed
decidual extract (U/A DE, PP14 concentration 2.0 - 8.0 
ug/ml) on the CD4/CD8 ratio of PHA stimulated
lymphocytes. Results are means + sd, n = 5.
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displaying the CD8 phenotype of cells of suppressor/cytotoxic 
character indicates that the proliferation evident in the H-Tdr 
incorporation assay may be predominant in this fraction.
The observation that PP14 does not alter the CD4/CD8 ratio 
suggests that the protein has no preferential suppressive activity on 
the T cell subsets present.
3.25 DNA Analysis of PHA Stimulated Lymphocytes
DNA analysis of PHA stimulated cells using the nuclear dye 
propidium iodide allows the analysis of the DNA content of the cells 
and is able to identify the proportion of cells in the G^, S and 
G2 phases of the cell cycle. For all samples, the fraction of the 
cells in each phase was obtained by a computer fit of the 
fluorescence (which is proportional to the DNA) distribution patterns 
obtained in both unstimulated and PHA stimulated cells.
Representative distribution patterns from unstimulated and PHA 
stimulated cells are shown in Fig 3.38. The cells in the larger peak 
represent cells in G^ phase (before DNA replication); the smaller 
peak represents cells in G2 (following DNA replication) or M 
(mitosis), with the cells in S phase (during DNA replication) lying 
between the two peaks. The fraction of cells in the various phases 
of the cell cycle was derived by computer analysis.
The proportion of stimulated cells in the S phase peaked at 
around 44 to 68 hours of culture with the levels declining thereafter 
towards the end of the culture period investigated (0 - 137 hours, 
Fig 3.39). The cell cycle analysis of mitogenically stimulated
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Figure 3.39 Kinetic analysis of the proportion of lymphocytes in the S phase of the 
cell cycle following stimulation with PHA. The percentage of cells in S 
phase was obtained by computer fit analyses of the DNA distribution curves.
3lymphocytes confirmed the H-Tdr uptake data presented earlier (Fig 
3.8). Incubation of PHA stimulated lymphocytes in the presence of 
decidual extracts having a range of PP14 concentrations (2.0 - 8.0 
mg/1) had no effect on the proportion of cells in S phase as compared 
to control cultures (Table 3.19). These data indicate that PP14 does 
not influence the distribution of stimulated cells through the cell 
cycle rather the protein may modulate the rate of passage.
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Proportion of Cells in the Cell Cycle (%)
G1 S G24M
Unstimulated 93 + 6 2 + 2 3 + 2
Stimd (control) 72 + 7 12 + 4 13 + 3
+ DE 67 + 6 14 + 6 15 + 3
Table 3.19 The effect of PPl4-containing decidual extracts (PP14 
concentrations 2.0 - 8.0 ug/ml) on the distribution of
PHA stimulated cells in the cell cycle. Results are 
expressed as means + sd, n = 5. Statistical analysis 
of data obtained at individual PP14 concentrations 
(paired Student t test) indicated no significant
difference in cell cycle distribution in the presence 
of PP14. For clarity of presentation, data are 
expressed as the means of the results obtained at all 
PP14 concentrations investigated.
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CHAPTER FOUR
FINAL DISCUSSION AND CONCLUDING REMARKS
4.1 Immunosuppression and Pregnancy
The whole area of immunosuppressive factors in pregnancy is 
contentious. The experimental basis for such studies depends on the 
use of lymphoproliferative assays and the inhibition of 
lymphoproliferation. All bioassays, by their very nature, have a 
high degree of variability and lymphoproliferation assays are no 
exception to this. Two factors have been identified as particularly 
contributing to variations in the latter assay, resulting in a high 
between-sample variation. These are differences in the frequency of 
responding units in the cell populations used and large differences 
in the gradient of the cell dose-response curves (Ross et al., 
1987). The experimental data from the lymphoproliferation assays 
presented here were obtained using blood samples from different 
individuals taken on different days, which may be reflected in the 
variability observed in the experiments.
Much previous work on the effect of pregnancy-associated 
proteins on the lymphoproliferative response has been suspect due to 
the question of purity of the protein preparations used, particularly 
concerning the specificity of the reaction and the possibility of 
impurities in the preparations used exhibiting inhibitory effects. 
In an attempt to overcome such problems, the present work employed an 
approach involving the specific removal of PP14 from crude tissue 
extracts by immunoadsorption with a monoclonal anti-PPl4 antibody.
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Lymphoproliferation assays are as yet ill understood at a 
molecular level, and the designation of a material as an 
immunosuppressor or immunomodulator solely by its effect on the 
incorporation of tritiated thymidine during such an assay is 
siirplistic. A more detailed exploration into the mode of action of a 
putative immunomodulator such as PP14 is more likely to indicate a 
specific rather than a non-specific immunomodulatory action.
4.2 Identification of Immunomodulatory Activities
There have been numerous reports as to the occurence of 
immunomodulatory activities, all of which appear to have specificity 
towards different levels of the immune response. The presence of 
PP14 may explain some of the observed activities described, however 
there are a large number of potentially immunosuppressive factors 
which are, as yet uncharacterised. Whether such activities are 
effective in vivo is unknown.
Daya et al., (1987) have reported that decidual supernatants 
were able to suppress the proliferative response of interleukin-2 
dependent cells with the peak suppressive activities being at 
molecular weights of 43 kDa and 21 kDa. The activity was 
specifically directed at IL-2 dependent cell lines and interfered 
with IL-2 action. The soluble factor was suggested to mediate its 
action via an interference with the binding of IL-2 to its receptor 
rather than a direct modification of the receptor affinity.
Human pregnancy serum inhibits the proliferation of T helper 
cells and their IL-2 synthesis in mixed lymphocyte cultures (Domingo 
et aL, 1985). The sera used in that study were obtained at 8 weeks
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of gestation and so WDuld contain measurable concentrations of PP14 
though at concentrations unlikely to be sufficient to elicit the 
immunomodulatory activity reported. It has also been shown that 
pregnancy serum (at the 8th week of gestation) interferes with the 
capacity of IL-1 to promote the production of IL-2, by rendering IL-2 
producer cells unable to synthesise IL-2 and subsequently to 
proliferate (Domingo et al., 1988). Other work has shown that the 
inhibition of the MLR by pregnancy sera could be reversed by the 
addition of supernatant from allogeneic MLR cultures and recombinant 
IL-2, but not IL-1 which suggests a level of control at the IL-2 
synthesis level ‘ (Nicholas et al., 1984).
Suppression of the MLR has been demonstrated in the presence of 
human first trimester pregnancy endometrium (Nakayama et al., 1985). 
The suppression was inversely related to the gestational age of the 
tissue with the maximal suppression being observed at around 6 weeks 
of gestation. The decidual cells had no effect on the proliferative 
response of IL-2 dependent cells and it was suggested that the effect 
was at the antigen recognition phase of the MLR.
Human non-decidualised endometrium has been shown to release 
soluble immunosuppressive factors. The factors were capable of 
suppressing both allogeneic and mitogenic stimulation with the 
activity in the supernatants of secretory phase endometrial cultures 
being higher than that from proliferative phase (Wang et al., 1987). 
Addition of progesterone into the explant cultures of proliferative 
endometria significantly increased the suppressive activity of the 
culture supernatant (Wang et al,, 1987). No enhancing of the 
suppressive activity of secretory phase endometria was observed which
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was possibly due to saturation of progesterone binding capacity by 
the endogenous progesterone from the corpus luteum. Addition of 
oestrogen had no effect. Progesterone has been found in higher 
concentrations in secretory endometrium than in the proliferative 
phase (Porias et al., 1978), and is considered essential for 
promoting a decidual response capable of blocking the afferent arm of 
the immunologic reflex (Beer et al., 1975). Non-pregnant human 
secretory endometrium is capable of synthesising PP14 in vitro with 
the synthesis being related to the action of progesterone (Julkunen 
et al., 1986a). It may be that the observed immunosuppressive 
activity is in part due to the PP14 content of the preparations.
Mechanisms of suppressor factor release into the uterine lumen 
during peri-ovulatory periods may mediate a protective mechanism for 
sperm migration in the genital tract and the implantation of the 
semi-allogeneic foetus on the secretory phase endometrium. The 
observation may also in part explain why the abnormalities of 
progesterone secretion in women with corpus luteum defect are 
associated with a high rate of infertility. It can be envisaged that 
such a deficiency would lead to inadequate secretion of 
immunosuppressive factor (s) from the endometrium which would, in turn 
lead to failure of implantation or early embryonic loss.
A number of reports have suggested the release of 
immunoregulatory molecules from human decidual tissue cultures. 
Using a cell line derived from human decidual tissue (TTK-1), Tatsumi 
et al. (1987) have reported the release of an immunoregulatory 
factor. The factor was found to strongly suppress the MLR and had an 
estimated molecular wsight of 43 - 67 kDa. The TTK-1 supernatant
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suppressed IL-2 dependent T cell lines, but not IL-2 independent cell 
lines. The results suggested that the released factor inhibited the 
MLR via an inhibitory effect on the action of IL-2 and exerted its 
inhibitory activity primarily at the proliferative stage of the 
assay. The factor appeared to inhibit allogeneic stimulation more 
markedly that PHA stimulation.
Golander et al. (1981) have shown that explants of human 
decidual tissue obtained at 8 - 12 weeks of gestation and cultured 
for 24 hours secreted a factor which suppressed lymphocyte 
reactivities to lectins (PHA, Concanavalin A and pokeweed mitogen) 
and their activity in the MLR. In a similar observation to that 
reported by Tatsumi et al. (1987) the suppressive activity of the 
factor was more pronounced in the MLR than the mitogen stimulation 
assay (2 fold difference).
In addition to human decidual tissue secreting a number of 
immunomodulatory molecules, it is well known that the urine of 
pregnant women contains potent immunosuppressive factors which block 
mitogen (Cemi et aL, 1977) and antigen-induced (Morse et al., 1976) 
lymphoproliferation of human blood lymphocytes in vitro. The 
immunosuppressive activity in both pregnancy serum and pregnancy 
urine was ascribed to a range of high and low molecular weight 
factors. One of the urine-derived pregnancy factors, termed 
uromodulin, has been purified to apparent homogeneity and appears to 
be an 85kDa glycoprotein (Muchmore and Decker 1985) with initial 
studies suggesting that uromodulin blocked antigen-induced 
lymphoproliferation at an early stage in the response. Results have 
since shown that uromodulin blocks the effects of recombinant IL-1 in
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a thymocyte proliferation assay and appears to bind to IL-1 (Brown et 
al., 1986). Whether such IL-1 inhibitory activity underlies its 
suppressive activity on human lymphocytes remains to be established.
In addition to an effect at the proliferative stages of the 
immune response, there may also be a requirement for immunomodulatory 
activity at the effector stage. Chaouat and Kolb (1985) have 
reported the production of soluble factors from the 
spongiotrophoblast in the mouse which can interfere in a 
dose-dependent manner with the action of cytotoxic T lymphocytes. It 
has also been suggested that defective production may mediate some 
cases of immunologic abortions. An effect of PP14 at the effector 
stage of the immune response has not been investigated in this 
study. What appears to be a specific effect at the IL-2R level would 
suggest such an effect to be unlikely, however the possibility 
requires experimental confirmation.
4.3 The Immunomodulatory Activity of PP14
PP14 is present in measurable concentrations in the circulation 
in non-pregnant women, although the levels increase markedly during 
the first trimester of pregnancy and reach a peak at around week 10 
of gestation (Julkunen et al., 1985). Higher levels are found in 
seminal plasma (Bolton et al., 1986a) with the highest levels of all 
being found in decidual tissue (Julkunen et al., 1985). Despite the 
high levels of PP14 found in the human reproductive system, little 
information has been published on the biological activities or 
physiological function of this protein.
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Experimental results obtained in this study indicate that PP14, 
in purified form and in crude extracts of decidual tissue, exhibit 
immunosuppressive activity on both allogeneically and mitogenically 
stimulated lymphocytes possibly indicating a mode of action of this 
protein at a level common to both of these in vitro systems. Whilst 
it is tempting to suggest that PP14 inhibits allogeneic stimulation 
in a similar manner to its effects on mitogenic stimulation, it is 
not possible until a full investigation has been performed.
Difficulties were encountered in obtaining sufficient blood 
samples to perform more detailed investigations into the effect of 
PP14 on allogeneically stimulated lymphocytes. The degree of 
stimulation obtained using the MLR is highly dependent on and 
variable due to the MHC class differences of the cell donors. The 
degree of activation following allogeneic stimulation was observed to 
be much lower using the MLR system (typically 30% Tac+ cells 
following 6 days of culture) as compared to the mitogenic system 
(typically 90% Tac cells following 3 days of culture).
It appears from the results presented here that PP14 is involved 
in inhibiting T lymphocyte proliferation and may therefore be an 
immunoregulatory molecule. The data suggest that the level of the 
inhibitory activity for PHA stimulated lymphocytes is at the level of 
the IL-2R and functions by modulating the affinity of such 
receptors. The inhibitory effect appears to be at the induction 
stage of the high affinity receptor as PP14 does not inhibit the 
cellular response to IL-2 once the receptor has been expressed. It 
is unknown at the present whether the activity of PP14 is directed 
towards the induction mechanism itself or whether there is an effect
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at an earlier stage in the induction of high affinity receptors. It
has been reported that IL-1 induces receptivity to IL-2 possibly by
increasing the receptor affinity rather than the receptor number
(Oppenheim et aL, 1986). Mizel (1987) has suggested that there may
be a lymphokine produced by T cells which augments the ability of
accessory cells to produce IL-1. Any effect at this level of the
response would lead to a secondary effect at the IL-2R level in
addition to modifying the secretion kinetics of IL-2 itself. A
similar effect would also be observed by an effect at the IL-1
receptor level. An additional mechanism could be a control at the
signal transduction level of the response. Results on the appearance
of IL-2 and IL-2R may possibly suggest a control on the activation of
2+protein kinase C or alternatively a modification of Ca fluxes. 
The mechanism by which such an effect would be mediated is as yet 
unknown.
The lower levels of IL-2 in the culture supernatant of 
stimulated lymphocytes in the presence of PP14 seen in this study may 
be secondary to the apparent lowering of the receptor affinity. In 
addition to augmenting the proliferation of alloantigen-specific 
cytotoxic lymphocytes, IL-2 also activates and stimulates the 
proliferation of natural killer cells and lymphokine activated killer 
cells which are effective against targets which are resistant to 
specific cytotoxic T lymphocytes. The mechanism which appears to be 
observed with PP14 not only inhibits the proliferative response of 
the cytotoxic T cell population via an effect on the IL-2R, but also 
modulates, via IL-2, the functionality of a number of other 
potentially cytotoxic effector cells.
189
As indicated above, the distribution of PP14 in the 
decidualising endometrium and seminal plasma is compatible with an 
immunoregulatory role. At the concentrations present in seminal 
plasma (15 - 500 mg/1, Bolton et al., 1986a), human uterine luminal 
fluid (about 4 mg/1, S.C. Bell, personal communication) and deciduum 
(about 9 mg/g vret \geight tissue, Bolton et aL, 1986b), PP14 would be 
expected to exert an effect on T lymphocyte proliferation (Figs 3.6; 
3.10). Although the maximal levels found in the peripheral 
circulation (up to 2.2 mg/1, median about 1 mg/1, Julkunen et al.,
1985) may be expected to exhibit some inhibition, such high 
concentrations are present only for a period of about 4 weeks in the 
first trimester of pregnancy and even at these concentrations only a 
minimal effect on T lymphocyte proliferation would be anticipated. 
This suggests that any immunoregulatory response would be largely 
restricted to the lumen of the female tract and the decidual tissue 
by the localisation of the concentration of PP14 present.
There is the possibility that the immunomodulatory activity is 
mediated by a molecule associated with PP14 and is not due to PP14 
itself. It has been suggested that the suppressive activity may be 
mediated by prostaglandin (S.C. Bell, personal communication). 
Prostaglandin synthesis by decidual tissue is well known (Antebi et 
aL, 1975). In the mouse, supernatants from short-term cultures of 
decidual tissue produced prostaglandins which were capable of 
suppressing the mixed lymphocyte reaction (Matthews and Searle 
1987). The suppression of the lymphocyte response appeared to be 
non-specific and was abrogated by dialysis.
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Prostaglandins are known to regulate T cell lymphoproliferative
responses by modulating the development of receptors for transferrin
(Chaouat et aL, 1985). Also IL-2 production and the expression of
the IL-2R (as detected by anti-Tac) are inhibited by prostaglandin
-9(PGE2) at concentrations of around 10 M (Vercammen and Ceupens
1987). The addition of exogenous recombinant IL-2 and purified IL-1
was unable to reverse the inhibition of IL-2R expression, but IL-2
was able to partially reverse the inhibitory activity of PGE2 on 
3H-Tdr uptake into stimulated lymphocytes (Vercammen and Ceupens
1987). PGE2 does not affect the IL-2 driven proliferation of
activated T cells, nor does it inhibit accessory cell function and it
has its effects at an early step in T cell activation.
The dialysis of the decidual tissue extracts as used in this
study would be expected to remove any PGE2 loosely associated with
PP14. Whilst certain elements of the immunosuppressive activity of
PP14 are similar to those exhibited by PGE2 such as the inhibition
3of IL-2 levels and the reversal of the inhibition of H-Tdr uptake 
into proliferating cells by the addition of exogenous IL-2, the 
observation that PP14 does not inhibit Tac antigen expression or the 
expression of the transferrin receptor makes unlikely the possibility 
of a role for PGE2 on PP14 induced immunosuppression.
The observation that PP14 may be progesterone controlled 
(Julkunen et aL, 1986b) may suggest that it is progesterone which 
mediates the suppressive activity of PP14. Progesterone has been 
shown to exhibit immunosuppressive activities (Clemens et al., 1979) 
and directly interferes with cell-cell contact thus altering the 
local exchange of immunological information (Van Vlasselaar et al.,
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1986). The observations made in this study that decidual tissue 
extracts do not interfere with cell-cell contact (Plate 3.2) indicate 
no role for progesterone in the immunosuppressive activity of PP14. 
This is supported by the finding that PP14 does not affect the 
activation stages of the in vitro response to both mitogenic and 
allogeneic stimulation as seen by the normal expression of activation 
antigens (Tac, HLA-DR and TFR) in the presence of PP14.
Whether such activities ascribed to PP14 are expressed in vivo 
and, if so, whether they are of physiological importance remains to 
be resolved. The mechanisms by which the mother and foetus 
immunologic ally tolerate each other during pregnancy are numerous and 
it would be fair to say that no single mechanism ensures the 
successful survival of the foetus in the potentially hostile 
environment of the mother. If PP14 does prove to be an important 
immunomodulatory factor associated with the reproductive tract, it 
will have exciting implications in the study of implantation and 
fertility. As such an activity is likely to be a highly localised 
phenomenon, it is perhaps less likely that the circulating levels of 
this protein will prove to be diagnostically useful. In a wider 
field, PP14 may prove a valuable tool in transplantation biology and 
the understanding of the cell mediated immune system and its control.
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APPENDIX I
Vacutainers (143 USP units LiHeparin). 
Dulbecco' s modification of Eagle's 
medium (DMEM).
Lymphopaque separation medium 
(relative density 1.084)
Plastic universals
Penicillin/ streptomycin solution
Cell culture grade biochemicals 
SFI serum-free hybridoma growth 
medium.
Trypan blue dye
Cell culture grade PBS
96 well and 24 well tissue culture
plates
Tritiated thymidine (90 Ci/mmol)
C02 incubator (Model 1500)
Laminar flew hood (Gelaire TC 48) 
Semi-autcmated cell harvester 
Trypsin EDTA
Liquid scintillation counter 
(Rackbeta 1212)
Scintillation cocktail 'O'
LKB 'HiSafe' scintillant 
Phytchaemagglutinin (PHA)
Phenyl methyl sulphonyl fluoride (PMSF) 
INTERTEST IL-2 ELISA test kit 
CELL-FREE IL-2R test kit 
SUCROSEP gamma interferon test kit
Recombinant IL-2 (ala-125)
lQmm x 64mm disposable polystyrene
tubes (LP3)
FITC-conj ugated goat anti-mouse IgG 
antibody 232
Beckton Dickinson (UK) Ltd. 
Flow Laboratories. 
Northumbria Biologicals Ltd. 
Nyccmed UK Ltd.
Sterilin Ltd.
Northern Media Supplies. 
Flow Laboratories. 
Northumbria Biologicals Ltd. 
Northumbria Biologicals Ltd. 
Northumbria Biologicals Ltd.
Flow Laboratories. 
Northumbria Biologicals Ltd. 
Linbro, Flow Laboratories.
Amersham International Ltd. 
Flow Laboratories.
Flow Laboratories.
Skatron AS, Lier, Norway. 
Flow Laboratories.
LKB Instruments Ltd.
BDH Chemicals Ltd.
LKB Instruments Ltd.
Sigma Chemical Co. Ltd.
Sigma Chemical Co. Ltd. 
Genzyme Corpn., USA.
T Cell Sciences Inc., USA. 
Boots-Celltech Diagnostics 
Ltd.
Amersham International. 
Northern Media Supplies.
Caltag Laboratories, USA.
Monoclonal antibodies for FACS 
analysis
Monoclonal anti IL-2 antibody 
RPMI 1640 growth medium
Foetal calf serum
125i-il-2
12nm x 75rrm disposable polystyrene 
tubes (LP4)
Silicone fluid DC 550
Liquid paraffin
Gamma counter (LKB Multigamma)
Nal25i (IMS 30)
Horse serum
Concanavalin-A-Sepharose 
Non-immune rabbit serum 
Donkey anti-rabbit serum 
Polyethylene glycol (PEG 6000) 
Cyanogen-bromide activated 
Sepharose-4B
Bovine serum albumin (BSA fraction V) 
Folin and Ciocalteau phenol reagent 
Freund's couplete/incomplete adjuvant 
LKB Multiphor electrophoresis equipment 
ELISA plate reader (CLS 962)
Glass fibre filter paper 
(for manual cell harvesting)
DAKO Ltd.
Genzyme Corpn., USA. 
Northumbria Biologicals Ltd. 
Flow Laboratories. 
Northumbria Biologicals Ltd. 
Flow Laboratories.
Amersham International. 
Northern Madia Supplies.
BDH Chemicals Ltd.
BDH Chemicals Ltd.
LKB Instruments Ltd. 
Amersham. International.
Sigma Chemical Co. Ltd.
Sigma Chemical Co. Ltd. 
Welcome Reagents Ltd. 
Imrmmodiagnosties Ltd.
Sigma Chemical Co. Ltd.
Sigma Chemical Co. Ltd.
Sigma Chemical Co. Ltd.
Sigma Chemical Co. Ltd.
Sigma Chemical Co. Ltd.
LKB Instruments Ltd. 
Cambridge Life Sciences pic. 
Whatman Ltd.
All other chemicals used were of reagent grade and obtained from 
either Sigma Chemical Co. Ltd. or BDH Chemicals Ltd.
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APPENDIX II
Buffers and Reagents
For two-dimensional crossed immunoelectrophoresis.
Tris/Barbitone buffer (pH 8.6) 22.4 g Diethylbarbituric acid
44.3 g Tris
0.533 g Ca-lactate
0.650 g sodium azide (NaN3)
Add distilled water to 1 litre to 
give a concentrated buffer. Dilute 
1:4 before use.
Agarose gel layer 1% agarose in barbitone 
buffer. Gel formed by steaming at 
100°C.
Washing solution 
Staining solution
0.1 M NaCl.
1 g Cocmassie Brilliant Blue 
90 ml ethanol 
20 ml glacial acetic acid 
90 ml H20. -
Destaining solution The same as the staining solution 
but without Cocmassie Brilliant 
Blue.
For Protein assay. 
BS7 Reagent 1 volume of Biuret reagent in 7 
volumes of 2.3% sodium 
carbonate.
Biuret Diluent 5 g KI in 0.25 mol NaOH/1
234
Stock Biuret Reagent 15.0 g of finely pulverised 
CuS04.5H20 were dissolved in 70 
- 80 ml water. A solution of 45.0
g potassium sodium tartrate, 
tetrahydrate in 600 - 700ml biuret 
diluent was prepared and slowly to 
which was added the CuS04
solution with stirring. Both 
solutions were at roan temperature 
when mixed to prevent reduction of 
Cu2+ by the tartrate. Biuret 
diluent was added to a volume of 
1000ml. Before use the solution 
was filtered through qualitative
paper to remove any deposited 
cuprous oxide. For the working 
biuret, the stock biuret was
diluted 5 fold with biuret
diluent.
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